10-Q

Table of Contents

UNITED STATES 

SECURITIES AND EXCHANGE COMMISSION 

Washington, D.C. 20549

FORM 10-Q

x QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended November 30, 2022

o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT

For the transition period from _______ to _______

SEC File No. 001-37954

SHIFTPIXY, INC.

(Exact name of registrant as specified in its charter)

Wyoming	47-4211438
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)
13450 W Sunrise Blvd, Suite 650, Sunrise FL	33323
(Address of principal executive offices)	(Zip Code)

Registrant’s telephone number: (888) 798-9100

N/A

(Former name, former address and former three months, if changed since last report)

Securities registered under Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.0001 per share	PIXY	The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	o	Accelerated filer	o
Non-accelerated filer	x	Smaller reporting company	x
Emerging growth company	x

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No x

The number of shares of the registrant’s only class of common stock issued and outstanding as of January 19, 2023, was 9,671,196.

TABLE OF CONTENTS

PART I — FINANCIAL INFORMATION
Item 1.	Condensed Consolidated Financial Statements	2
	Condensed Consolidated Balance Sheets as of November 30, 2022(Unaudited) and August 31, 2022	2
	Condensed Consolidation Statements of Operations for the Three Months ended November 30, 2022 and November 30, 2021 (Unaudited)	3
	Condensed Consolidated Statements of Stockholders' Deficit for the Three Months ended November 30, 2022 and November 30, 2021 (Unaudited)	4
	Condensed Consolidated Statements of Cash Flows for the three months ended November 30, 2022 and November 30, 2021 (Unaudited)	5
	Notes to the Condensed Consolidated Financial Statements	6
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	31
Item 3.	Quantitative and Qualitative Disclosure about Market Risk	42
Item 4.	Controls and Procedures	43
PART II — OTHER INFORMATION
Item 1.	Legal Proceedings	44
Item 1A.	Risk Factors
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	44
Item 3.	Defaults Upon Senior Securities	44
Item 4.	Mine Safety Disclosures	44
Item 5.	Other Information	44
Item 6.	Exhibits	44
Signatures		46

Table of Contents

PART I — FINANCIAL INFORMATION

Item 1. Condensed Consolidated Financial Statements

ShiftPixy, Inc. 

Condensed Consolidated Balance Sheets

	November 30, 2022		August 31, 2022
	(Unaudited)
ASSETS
Current assets
Cash	$	864,000	$	618,000
Accounts receivable	238,000		279,000
Unbilled accounts receivable	2,706,000		2,105,000
Prepaid expenses	480,000		696,000
Other current assets	288,000		187,000
Cash and marketable securities held in Trust Account (See Notes 2 and 4)	117,770,000		116,969,000
Total current assets	$	122,346,000	$	120,854,000
Fixed assets, net	3,020,000		2,769,000
Right-of -use operating lease	3,965,000		4,076,000
Deposits and other assets	920,000		919,000
Total assets	$	130,251,000	$	128,618,000
LIABILITIES AND STOCKHOLDERS' DEFICIT
Current liabilities
Accounts payable and other accrued liabilities	$	15,827,000	$	17,122,000
Payroll related liabilities	18,766,000		16,055,000
Accrued workers’ compensation costs	575,000		567,000
Current liabilities of discontinued operations	1,438,000		1,362,000
Class A common shares of SPAC mandatory redeemable 11,500,000 shares as of November 30, 2022 and August 31, 2022 (See Notes 2 and 4)	117,770,000		116,969,000
Total current liabilities	$	154,376,000	$	152,075,000
Non-current liabilities
Operating lease liability, non-current	3,453,000		3,541,000
Accrued workers’ compensation costs	1,196,000		1,227,000
Non-current liabilities of discontinued operations	3,394,000		3,269,000
Total liabilities	162,419,000		160,112,000
Commitments and contingencies
Stockholders’ deficit
Preferred stock, 50,000,000 authorized shares; $0.0001 par value: 0 and 8,600,000 shares issued and outstanding as of November 30, 2022 and August 31, 2022.	—		1,000
Common stock, 750,000,000 authorized shares; $0.0001 par value; 9,671,196 and 513,349 shares issued as of November 30, 2022 and August 31, 2022.	1,000		—
Additional paid-in capital	156,485,000		151,736,000
Accumulated deficit	(198,148,000)		(192,725,000)
Total ShiftPixy, Inc. Stockholders' deficit	(41,662,000)		(40,988,000)
Non-controlling interest in consolidated subsidiary (See Note 5)	$	9,494,000	$	9,494,000
Total stockholders' deficit	$	(32,168,000)	$	(31,494,000)
Total liabilities and stockholders' deficit	$	130,251,000	$	128,618,000

The accompanying notes are an integral part of these condensed consolidated financial statements.

2

Table of Contents

ShiftPixy, Inc. 

Condensed Consolidated Statements of Operations 

(Unaudited)

	For the Three Months Ended
	November 30, 2022		November 30, 2021
Revenues (See Note 2)	$	5,266,000	$	8,940,000
Cost of revenue	4,845,000		8,245,000
Gross profit	421,000		695,000
Operating expenses:
Salaries, wages, and payroll taxes	2,259,000		3,890,000
Commissions	10,000		27,000
Professional fees	1,195,000		1,737,000
Software development	60,000		1,161,000
Depreciation and amortization	149,000		123,000
General and administrative	1,971,000		2,340,000
Total operating expenses	5,644,000		9,278,000
Operating Loss	(5,223,000)		(8,583,000)
Other (expense) income:
Interest expense	—		(1,000)
Other income	—		5,000
Total other expense	—		4,000
Loss from continuing operations	(5,223,000)		(8,579,000)
Loss from discontinued operations, net of tax	(200,000)		(134,000)
Net loss	(5,423,000)		(8,713,000)
Preferred stock preferential dividend	(127,145,000)		—
Net loss attributable to ShiftPixy, Inc. shareholders	$	(132,568,000)	$	(8,713,000)
Net loss  per share, Basic and diluted
Continuing operations	$	(13.88)	$	(24.00)
Discontinued operations	(0.02)		—
Net  loss per common share – Basic and diluted	$	(13.90)	$	(24.00)
Weighted average common shares outstanding – Basic and diluted	9,533,982		359,452

The accompanying notes are an integral part of these condensed consolidated financial statement.

3

Table of Contents

ShiftPixy, Inc. 

Condensed Consolidated Statements of Stockholders' Deficit 

For the Three Months Ended November 30, 2022

(Unaudited)

	Preferred Stock Issued			Common Stock Issued			Additional Paid-In Capital		Accumulated Deficit		Total Stockholders’ Deficit ShiftPixy, Inc.		Noncontrolling interest		Total Stockholders' Deficit
	Shares	Amount		Shares	Amount
Balance, September 1, 2022	8,600,000	$	1,000	513,349	$	—	$	151,736,000	$	(192,725,000)	$	(40,988,000)	$	9,494,000	$	(31,494,000)
Fair Market value increase of preferred stock prior to reverse stock split	—	—		—	—		127,145,000		—		127,145,000		—		$	127,145,000
Preferential dividend of preferred stock	—	—		—	—		(127,145,000)		—		(127,145,000)		—		$	(127,145,000)
Common stock issued on exercised prefunded warrants	—	—		124,204	—		1,000		—		1,000		—		$	1,000
Common stock issued for private placement, net of offering cost	—	—		416,667	—		4,387,000		—		4,387,000		—		$	4,387,000
Common stock issued on conversion or preferred shares	(8,600,000)	(1,000)		8,600,000	1,000		—		—		—		—		$	—
Stock-based compensation expense	—	—		—	—		255,000		—		255,000		—		$	255,000
Warrant modification expense	—	—		—	—		106,000		—		106,000		—		$	106,000
Additional Shares issued due to reverse stock split	—	—		16,976	—						—		—		$	—
Net loss	—	—		—	—		—		(5,423,000)		(5,423,000)				$	(5,423,000)
Balance, November 30, 2022	—	$	—	9,671,196	$	1,000	$	156,485,000	$	(198,148,000)	$	(41,662,000)	$	9,494,000	$	(32,168,000)

ShiftPixy, Inc.

Condensed Consolidated Statements of Equity (Deficit) 

For the Three Months Ended November 30, 2021

(Unaudited)

	Preferred Stock Issued			Common Stock Issued			Additional Paid-In Capital		Accumulated Deficit		Total Stockholders’ Deficit ShiftPixy, Inc.		Noncontrolling interest		Total Shareholders' Equity
	Shares	Amount		Shares	Amount
Balance, September 1, 2021	—	$	—	258,631	$	—	$	142,786,000	$	(149,338,000)	$	(6,552,000)	$	47,472,000	$	40,920,000
Common stock issued on exercised warrants, net of offering costs	—	—		28,500	—		4,183,000		—		$	4,183,000	—		$	4,183,000
Stock-based compensation expense	—	—		—	—		408,000		—		408,000		—		$	408,000
Remeasurement of IHC temporary equity							(13,270,000)				(13,270,000)				$	(13,270,000)
Net loss	—	—		—	—		—		(8,713,000)		(8,713,000)		—		$	(8,713,000)
Balance, November 30, 2021	—	$	—	287,131	$	—	$	140,968,000	$	(158,051,000)	$	(17,083,000)	$	47,472,000	$	30,389,000

The accompanying notes are an integral part of these condensed consolidated financial statements.

4

Table of Contents

ShiftPixy, Inc.

Condensed Consolidated Statements of Cash Flows

(Unaudited)

	For the Three Months Ended
	November 30, 2022		November 30, 2021
OPERATING ACTIVITIES
Net loss	$	(5,423,000)	$	(8,713,000)
Loss from discontinued operations	(200,000)		(134,000)
Net loss from continuing operations	(5,223,000)		(8,579,000)
Adjustments to reconcile net loss from continuing operations to net cash used in continuing operating activities:
Depreciation and amortization	149,000		123,000
Stock-based compensation	255,000		408,000
Warrant modification expense	106,000		—
Amortization of operating lease	23,000		—
Changes in operating assets and liabilities:
Accounts receivable	41,000		98,000
Unbilled accounts receivable	(601,000)		41,000
Prepaid expenses and other current assets	115,000		(366,000)
Deposits – workers’ compensation	—		200,000
Deposits and other assets	(1,000)		(73,000)
Accounts payable and other accrued liabilities	(1,295,000)		1,116,000
Payroll related liabilities	2,711,000		743,000
Accrued workers’ compensation costs	(23,000)		(384,000)
Total Adjustments	1,480,000		1,906,000
Net cash used in continuing operating activities	(3,743,000)		(6,673,000)
Net cash provided by (used in) discontinued operating activities	1,000		(1,000)
Net cash used in operating activities	(3,742,000)		(6,674,000)
INVESTING ACTIVITIES
Investment of IHC IPO proceeds into Trust Account	—		(116,725,000)
Purchase of fixed assets	(400,000)		(349,000)
Net cash used in investing activities	(400,000)		(117,074,000)
FINANCING ACTIVITIES
Deferred offering costs	—		(3,502,000)
Proceeds from initial public offering of IHC	—		116,725,000
Proceeds from prefunded warrant exercises	1,000		—
Proceeds from private placement, net of offering costs	—		4,183,000
Proceeds from private placement prefunded warrants, net of offering costs	4,387,000		6,861,000
Net cash provided by financing activities	4,388,000		124,267,000
Net increase in cash	246,000		519,000
Cash - Beginning of Period	618,000		1,199,000
Cash -End of Period	$	864,000	$	1,718,000
Supplemental Disclosure of Cash Flows Information:
Cash paid for interest	$	—	$	1,000
Cash paid for income taxes	—		—
Non-cash Investing and Financing Activities:
Deferred Offering costs SPACs	$	—	$	9,464,000
Increase in Marketable securities in trust account and Class A mandatory redeemable common shares	$	801,000	$	13,270,000
Transfer of preferred shares to common shares	$	1,000

The accompanying notes are an integral part of these condensed consolidated financial statements.

5

Table of Contents

ShiftPixy, Inc. 

Notes to the Condensed Consolidated Financial Statements 

(Unaudited)

Note 1: Nature of Operations

ShiftPixy, Inc. (the "Company") was incorporated on June 3, 2015, in the State of Wyoming. The Company is a specialized Human Capital service provider that provides solutions for large, contingent, part-time workforce demands, primarily in the restaurant and hospitality service trades. The Company’s historic focus has been on the quick service restaurant industry in Southern California, but the Company has expanded into other geographic areas and industries that employ temporary or part-time labor sources, notably including the healthcare industry.

The Company functions as an employment administrative services (“EAS”) provider primarily through its wholly-owned subsidiary, ReThink Human Capital Management, Inc. (“HCM”), as well as a staffing provider through another of its wholly-owned subsidiaries, ShiftPixy Staffing, Inc. (“Staffing”). These subsidiaries provide a variety of services to our clients (as a co-employer through HCM and a direct employer through Staffing), including the following: administrative services, payroll processing, human resources consulting, and workers’ compensation administration and coverage (as permitted and/or required by state law). The Company has built a human resources information systems (“HRIS”) platform to assist in customer acquisition that simplifies the onboarding of new clients into the Company’s closed proprietary operating and processing information system (the “ShiftPixy Ecosystem”). We expect this HRIS platform to facilitate additional value-added services in future reporting periods.

In January 2020, the Company sold the assets of Shift Human Capital Management Inc. (“SHCM”), a wholly-owned subsidiary of the Company, pursuant to which the Company assigned the majority of the Company’s billable clients at the time of the sale to a third party for cash. The continuing impact of this transaction on the Company’s financial statements is described below in Note 3, Discontinued Operations.

Effective August 31, 2022, the Company filed articles of amendment to the Company’s articles of incorporation to effect a one-for-one hundred (1:100) reverse split of the Company’s issued and outstanding shares of Common Stock. The reverse split became effective on Nasdaq September 1, 2022. All share related numbers in this Report on Form 10-Q give effect to this reverse split.

Note 2: Summary of Significant Accounting Policies

Basis of Presentation

The accompanying condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and the rules of the Securities and Exchange Commission (“SEC”) applicable to interim reports of companies filing as a small reporting company. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for fair presentation have been included. The results of condensed operations for the three months ended November 30, 2022 are not necessarily indicative of the results that may be expected for the full year ending August 31, 2023.

For further information, refer to the consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K and 10-K/A for the fiscal year ended August 31, 2022 (“Fiscal 2022”), filed with the SEC on December 13, 2022 and December 14, 2022, respectively.

Principles of Consolidation

The condensed consolidated financial statements include the accounts of ShiftPixy, Inc., and its wholly-owned subsidiaries. The condensed consolidated financial statements also include the accounts of (a) Industrial Human Capital, Inc. ("IHC"), which is a special purpose acquisition company, or "SPAC", for which we serve as the financial sponsor (as described below), and which is deemed to be controlled by us as a result of the Company's 15% equity ownership stake, the overlap of three of our executive officers as executive officers of IHC, and significant influence that we currently exercise over the funding and acquisition of

6

Table of Contents

new operations for an initial business combination ("IBC"). (See Note 2, Variable Interest Entity). All intercompany balances have been eliminated in consolidation.

Use of Estimates

The preparation of financial statements in conformity with GAAP requires the Company to make estimates and assumptions that affect certain reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include:

•Assumption as a going concern; management assumes that the Company will continue as a going concern , which contemplates continuity of operations, realization of assets and liquidation of all liabilities in the normal course of business;

•Liability for legal contingencies;

•Useful lives of property and equipment;

•Deferred income taxes and related valuation allowance;

•Valuation of illiquid non-controlling interest in SPAC shares transferred; and

•Projected development of workers’ compensation claims.

These significant accounting estimates or assumptions bear the risk of change due to the fact that there are uncertainties attached to these estimates or assumptions are difficult to measure of value.

Management regularly reviews the key factors and assumptions to develop the estimates utilizing currently available information, changes in facts and circumstances, historical experience, and reasonable assumptions. After such valuation, if deemed appropriate, those estimates are adjusted accordingly.

Revenue and Direct Cost Recognition

For the year ended August 31, 2021 ("Fiscal 2021"), we adopted Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (Topic 606), using the modified retrospective approach. Under this method, the guidance is applied only to the most current period presented in the financial statements. ASU No. 2014-09 outlines a single comprehensive revenue recognition model for revenue arising from contracts with customers and superseded most of the previous revenue recognition guidance, including industry-specific guidance. Under ASU No. 2014-09, an entity recognizes revenue for the transfer of promised goods or services to customers in an amount that reflects the consideration for which the entity expects to be entitled in exchange for those goods or services. The Company's revenue recognition policies remained substantially unchanged as a result of the adoption of ASU No. 2014-09 and the Company did not have any significant changes in the Company's business processes or systems.

The Company’s revenues are primarily disaggregated into fees for providing staffing solutions and EAS/HCM services. The Company enters into contracts with its clients for Staffing or EAS based on a stated rate and price in the contract. Contracts generally have a term of 12 months, however are cancellable at any time by either party with 30 days’ written notice. The performance obligations in the agreements are generally combined into one performance obligation, as they are considered a series of distinct services, and are satisfied over time because the client simultaneously receives and consumes the benefits provided as the Company performs the services. Payments for the Company’s services are typically made in advance of, or at the time that the services are provided. The Company does not have significant financing components or significant payment terms for its customers and consequently has no material credit losses. The Company uses the output method based on a stated rate and price over the payroll processed to recognize revenue, as the value to the client of the goods or services transferred to date appropriately depicts the Company's performance towards complete satisfaction of the performance obligation.

Staffing Solutions

The Company records gross billings as revenues for its staffing solutions clients. The Company is primarily responsible for fulfilling the staffing solutions services and has discretion in establishing price. The Company includes the payroll costs in

7

Table of Contents

revenues with a corresponding increase to cost of revenues for payroll costs associated with these services. As a result, we are the principal in this arrangement for revenue recognition purposes.

EAS Solutions

EAS solutions revenue is primarily derived from the Company’s gross billings, which are based on (i) the payroll cost of the Company’s worksite employees (“WSEs”) and (ii) a mark-up computed as a percentage of payroll costs for payroll taxes and workers’ compensation premiums.

Gross billings are invoiced to each EAS client concurrently with each periodic payroll of the Company’s WSEs, which coincides with the services provided and which is typically a fixed percentage of the payroll processed. Revenues, which exclude the payroll cost component of gross billings and therefore consist solely of markup, are recognized ratably over the payroll period as WSEs perform their services at the client worksite. Although the Company assumes responsibility for processing and remitting payroll and payroll related obligations, it does not assume employment-related responsibilities such as determining the amount of the payroll and related payroll obligations. As a result, the Company records revenue on a “net” basis in this arrangement for revenue recognition purposes. Revenues that have been recognized but not invoiced for EAS clients are included in unbilled accounts receivable on the Company’s consolidated balance sheets and were $2,706,000 and $2,105,000, as of November 30, 2022 and August 31, 2022, respectively.

Consistent with the Company’s revenue recognition policy for EAS clients, direct costs do not include the payroll cost of its WSEs. The cost of revenue associated with the Company’s revenue generating activities is primarily comprised of all other costs related to its WSEs, such as the employer portion of payroll-related taxes, employee benefit plan premiums and workers’ compensation insurance costs.

The fees collected from the worksite employers for benefits (i.e. zero-margin benefits pass-through), workers’ compensation and state unemployment taxes are presented in revenues and the associated costs of benefits, workers’ compensation and state unemployment taxes are included in operating expenses for EAS clients, as the Company does retain risk and acts as a principal with respect to this aspect of the arrangement. With respect to these fees, the Company is primarily responsible for fulfilling the service and has discretion in establishing price.

Disaggregation of Revenue

The Company’s primary revenue streams include HCM and staffing services. The Company’s disaggregated revenues for the three months ended November 30, 2022 and November 30, 2021, respectively, were as follows:

	For the Three Months Ended
Revenue (in millions):	November 30, 2022		November 30, 2021
	(Unaudited)
HCM1	$	1.5	$	1.8
Staffing	3.8		7.1
	$	5.3	$	8.9

1 HCM revenue is presented net, $11.7 million gross billings less WSE payroll costs of $10.3 million for the three months ended November 30, 2022 and $14.1 million gross billings less WSE payroll costs of $12.3 million for the three months ended November 30, 2021.

During Fiscal 2021 the Company announced the launch of ShiftPixy Labs. ShiftPixy Labs generated no revenue for any periods presented in these financial statements.

For the three months ended November 30, 2022 and November 30, 2021, respectively, the following geographical regions represented more than 10% of total revenues:

8

Table of Contents

	For the Three Months Ended
Region:	November 30, 2022		November 30, 2021
	(Unaudited)
California	48.8	%	53.7	%
Washington	12.2	%	13.3	%
New Mexico	10.2	%	6.73

Incremental Cost of Obtaining a Contract

Pursuant to the “practical expedients” provided under ASU No 2014-09, the Company expenses sales commissions when incurred because the terms of its contracts are cancellable by either party upon 30 days' notice. These costs are recorded in commissions in the Company’s condensed consolidated statements of operations.

Segment Reporting

Prior to August 31, 2021, the Company operated as one reportable segment under ASC 280, Segment Reporting. The chief operating decision maker regularly reviews the financial information of the Company at a consolidated level in deciding how to allocate resources and in assessing performance. During Fiscal 2021, the Company entered into new business lines and geographic areas that, to date, are not material. However, with the migration to Staffing during the fiscal quarter ending May 31, 2021, the Company is beginning to manage the business on a segmented basis and therefore intends to report such information once systems and processes are updated accordingly. Reporting and monitoring activities on a segment basis will allow the chief operating decision maker to evaluate operating performance more effectively.

Cash and Cash Equivalents

The Company considers all highly liquid investments with an original maturity of three months or less when purchased as cash equivalents. The Company had no cash equivalent as of November 30, 2022 and August 31, 2022.

Marketable Securities Held in Trust Account

As of November 30, 2022 and August 31, 2022, substantially all of the assets held in the Trust Account were invested in U.S. Treasury securities with maturities of 180 days or less. These funds are restricted for use and may only be used for purposes of completing an initial business combination ("IBC") or redemption of the public common shares of IHC. In December 2022, the Company distributed $117,574,000 to the shareholder's of IHC.

Concentration of Credit Risk

The Company maintains cash with a commercial bank, which is insured by the Federal Deposit Insurance Corporation (“FDIC”). At various times, the Company has deposits in this financial institution in excess of the amount insured by the FDIC. The Company has not experienced any losses related to these balances and believes its credit risk to be minimal. As of November 30, 2022 and August 31, 2022, there was $463,000 and $615,000, respectively, of cash on deposit in excess of the amounts insured by the FDIC.

For the three months ended November 30, 2022, three individual clients represented more than 10% of revenues. However, seven clients represented 88% of total accounts receivable as of November 30, 2022. For the three months ended November 30, 2021, no individual client represented more than 10% of revenues and three clients represented 98% of total accounts receivable.

Fixed Assets

Fixed assets are recorded at cost, less accumulated depreciation and amortization. Expenditures for major additions and improvements are capitalized and minor replacements, maintenance, and repairs are charged to expense as incurred. When fixed assets are retired or otherwise disposed of, the cost and accumulated depreciation are removed from the accounts and any resulting gain or loss is included in the results of operations for the respective period. Leasehold improvements are amortized over the shorter of the useful life or the initial lease term.

9

Table of Contents

Fixed assets are recorded at cost and are depreciated over the estimated useful lives of the related assets using the straight-line method. The estimated useful lives of property and equipment for purposes of computing depreciation are as follows:

Equipment:	5 years
Furniture & Fixtures:	5 - 7 years
Leasehold improvements	Shorter of useful life or the remaining lease term, typically 5 years

Depreciation and amortization expense is included on the condensed consolidated statements of operations.

Computer Software Development

Software development costs relate primarily to software coding, systems interfaces and testing of the Company’s proprietary employer information systems and are accounted for in accordance with ASC 350-40, Internal Use Software.

Internal software development costs are capitalized from the time the internal use software is considered probable of completion until the software is ready for use. Business analysis, system evaluation and software maintenance costs are expensed as incurred. The capitalized computer software development costs are reported under the section fixed assets, net in the consolidated balance sheets and are amortized using the straight-line method over the estimated useful life of the software, generally three to five years from when the asset is placed in service.

The Company determined that there were no material capitalized internal software development costs for the three months ended November 30, 2022. All capitalized software recorded was purchased from third party vendors. Capitalized software development costs are amortized using the straight-line method over the estimated useful life of the software, generally three to five years from when the asset is placed in service.

The Company incurred research and development costs of $0.7 million for the three months ended November 30, 2022. During the three months ended November 30, 2021 the Company incurred research and development costs of approximately $2.2 million. All costs were related to internally developed or externally contracted software and related technology for the Company’s HRIS platform and related mobile application. In addition, no software costs were capitalized for the three months ended November 30, 2022 and November 30, 2021, respectively.

Lease Recognition

In February 2016, the FASB established Topic 842, Leases, by issuing ASU No. 2016-02 (“ASC 842”), which required lessees to recognize leases on-balance sheet and disclose key information about leasing arrangements. Topic 842 was subsequently amended by ASU No. 2018-01, Land Easement Practical Expedient for Transition to Topic 842; ASU No. 2018-10, Codification Improvements to Topic 842, Leases; and ASU No. 2018-11, Targeted Improvements. The standard established a right-of-use model (“ROU”) that required a lessee to recognize an ROU asset and lease liability on the balance sheet for all leases with a term longer than 12 months. Leases are classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the condensed consolidated statement of operations.

The Company adopted the standard on December 1, 2021 with an effective date of September 1, 2021. A modified retrospective transition approach was required, applying the standard to all leases existing at the date of initial application. An entity could choose to use either (1) the effective date of the standard or (2) the beginning of the earliest comparative period presented in the financial statements as its date of initial application. If an entity chose the second option, the transition requirements for existing leases also applied to leases entered into between the date of initial application and the effective date. The entity had to also recast its comparative period financial statements and provide the disclosures required by the standard for the comparative periods. The Company elected to use the effective date as its date of initial application. Consequently, financial information was not updated and the disclosures required under the standard were not provided for dates and periods prior to September 1, 2021.

The standard provided a number of optional practical expedients as part of transition accounting. The Company elected the “package of practical expedients”, which allowed the Company to avoid reassessing its prior conclusions about lease identification, lease classification and initial direct costs under the standard. The Company did not elect the use-of-hindsight or the practical expedient pertaining to land easements as these were not applicable to the Company.

The standard had a material effect on the Company’s Condensed Consolidated Financial Statements. The most significant changes related to (1) the recognition of ROU assets and lease liabilities on the Condensed Consolidated Balance Sheet for the Company's office equipment and real estate operating leases and (2) providing significant disclosures about the Company’s leasing activities.

10

Table of Contents

Upon adoption, the Company recognized additional operating liabilities of approximately $7.7 million, with corresponding ROU operating lease asset, based on the present value of the remaining minimum rental payments under current leasing standards for existing operating leases. The Company determined if an arrangement was a lease at inception. The Company used an incremental borrowing rate based on the information available at the commencement date of the lease to determine the present value of lease payments. In determining the ROU asset and lease liability at lease inception, the lease terms could include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term.

The standard also provided practical expedients for an entity’s ongoing accounting for leases. The Company elected the short-term lease recognition exemption for office equipment leases. For those current and prospective leases that qualify as short-term, the Company will not recognize ROU assets or lease liabilities. The Company also elected the practical expedient to not separate lease and non-lease components for all of its real estate leases.

Impairment and Disposal of Long-Lived Assets

The Company periodically evaluates its long-lived assets for impairment in accordance with ASC 360-10, Property, Plant, and Equipment. ASC 360-10 requires that an impairment loss be recognized for assets to be disposed of or held-for-use when the carrying amount of an asset is deemed not to be recoverable. If events or circumstances were to indicate that any of the Company's long-lived assets might be impaired, the Company would assess recoverability based on the estimated undiscounted future cash flows to be generated from the applicable asset. In addition, the Company may record an impairment loss to the extent that the carrying value of the asset exceeds the fair value of the asset. Fair value is generally determined using an estimate of discounted future net cash flows from operating activities or upon disposal of the asset. There were no indicators noted of impairments during the three months ended November 30, 2022 and November 30, 2021, respectively.

Workers’ Compensation

Everest Program

Until July 2018, a portion of the Company’s workers’ compensation risk was covered by a retrospective rated policy through Everest National Insurance Company, which calculates the final policy premium based on the Company’s loss experience during the term of the policy and the stipulated formula set forth in the policy. The Company funds the policy premium based on standard premium rates on a monthly basis and based on the gross payroll applicable to workers covered by the policy. During the policy term and thereafter, periodic adjustments may involve either a return of previously paid premiums or a payment of additional premiums by the Company or a combination of both. If the Company’s losses under that policy exceed the expected losses under that policy, then the Company could receive a demand for additional premium payments. The Company is currently engaged in litigation regarding such a demand for additional premium payments, which we believe to be without merit, as discussed at Note 11, Contingencies, Everest Litigation, below.

Sunz Program

From July 2018 through February 28, 2021, the Company’s workers’ compensation program for its WSEs was provided primarily through an arrangement with United Wisconsin Insurance Company and administered by Sunz Insurance Solutions, LLC (“Sunz”). Under this program, the Company has financial responsibility for the first $0.5 million of claims per occurrence. The Company provides and maintains a loss fund that is earmarked to pay claims and claims related expenses. The workers’ compensation insurance carrier establishes monthly funding requirements comprised of premium costs and funds to be set aside for payment of future claims (“claim loss funds”). The level of claim loss funds is primarily based upon anticipated WSE payroll levels and expected workers’ compensation loss rates, as determined by the insurance carrier. Monies funded into the program for incurred claims expected to be paid within one year are recorded as Deposit - workers’ compensation, a short-term asset, while the remainder of claim funds are included in Deposit- workers’ compensation, a long-term asset in our condensed consolidated balance sheets. The Company is currently engaged in litigation regarding demands by Sunz for additional claims loss funds, which we believe to be without merit, as discussed at Note 11, Contingencies, Sunz Litigation, below.

Under the Everest and Sunz programs, the Company utilized a third party to estimate its loss development rate, which was based primarily upon the nature of WSEs’ job responsibilities, the location of WSEs, the historical frequency and severity of workers’ compensation claims, and an estimate of future cost trends. Each reporting period, changes in the assumptions resulting from changes in actual claims experience and other trends are incorporated into its workers’ compensation claims cost estimates.

There were no workers compensation deposits related to theses programs as of November 30, 2022 and as of August 31, 2022, respectively..

11

Table of Contents

Current Program

Effective March 1, 2021, the Company migrated its clients to a guaranteed cost program. Under this program, the Company’s financial responsibility is limited to the cost of the workers’ compensation premium. The Company funds the workers’ compensation premium based on standard premium rates on a monthly basis and based on the gross payroll applicable to workers covered by the policy. Any final adjustments to the premiums are based on the final audited exposure multiplied by the applicable rates, classifications, experience modifications and any other associated rating criteria.

The Company’s estimate of incurred claim costs expected to be paid within one year is included in short-term liabilities, while its estimate of incurred claim costs expected to be paid beyond one year is included in long-term liabilities on its consolidated balance sheets. As of November 30, 2022 and August 31, 2022, the Company had short term accrued workers’ compensation costs of $0.6 million and $0.6 million, and long term accrued workers’ compensation costs of $1.2 million and $1.2 million, respectively.

The Company retained workers’ compensation asset reserves and workers’ compensation related liabilities for former WSEs of clients transferred to Shiftable HR Acquisition, LLC, a wholly-owned subsidiary of Vensure Employer Services, Inc. (“Vensure”), in connection with the Vensure Asset Sale described in Note 3, Discontinued Operations, below. As of November 30, 2022, the retained workers’ compensation assets and liabilities are presented as a discontinued operation net asset or liability. As of November 30, 2022, the Company had $1.4 million in short term liabilities, and $3.4 million in long term liabilities. The Company had no related worker's compensation assets as of November 30, 2022 and August 31, 2022, respectively.

Because the Company bears the financial responsibility for claims up to the level noted above, such claims, which are the primary component of its workers’ compensation costs, are recorded in the period incurred. Workers’ compensation insurance includes ongoing health care and indemnity coverage whereby claims are paid over numerous years following the date of injury. Accordingly, the accrual of related incurred costs in each reporting period includes estimates, which take into account the ongoing development of claims and therefore requires a significant level of judgment. In estimating ultimate loss rates, the Company utilizes historical loss experience, exposure data, and actuarial judgment, together with a range of inputs that are primarily based upon the WSE’s job responsibilities, their location, the historical frequency and severity of workers’ compensation claims, and an estimate of future cost trends. For each reporting period, changes in the actuarial assumptions resulting from changes in actual claims experience and other trends are incorporated into the Company’s workers’ compensation claims cost estimates. The estimated incurred claims are based upon: (i) the level of claims processed during each quarter; (ii) estimated completion rates based upon recent claim development patterns under the plan; and (iii) the number of participants in the plan.

The Company has had very limited and immaterial COVID-19 related claims between March 2020 through the date of this Quarterly Report, although there is a possibility of additional workers’ compensation claims being made by furloughed WSEs as a result of the employment downturn caused by the pandemic. On May 4, 2020, the State of California indicated that workers who become ill with COVID-19 would have a potential claim against workers’ compensation insurance for their illnesses. There is a possibility that additional workers’ compensation claims could be made by employees required to work by their employers during the COVID-19 pandemic, which could have a material impact on the Company's workers’ compensation liability estimates. While the Company has not seen significant additional expenses as a result of any such potential claims to date, which would include claims for reporting periods after November 30, 2022, we continue to monitor closely all workers’ compensation claims made as the COVID-19 pandemic continues.

Fair Value of Financial Instruments

ASC 820, Fair Value Measurement, requires entities to disclose the fair value of financial instruments, both assets and liabilities recognized and not recognized on the balance sheet, for which it is practical to estimate fair value. ASC 820 defines fair value of a financial instrument as the amount at which the instrument could be exchanged in a current transaction between willing parties. As of November 30, 2022 and August 31, 2022, the carrying value of certain financial instruments (cash, accounts receivable and payable) approximated fair value due to the short-term nature of the instruments. Notes Receivable is valued at the Company's estimate of expected collections value as described below and in Note 3, Discontinued Operations.

The Company measures fair value under a framework that utilizes a hierarchy prioritizing the inputs to relevant valuation techniques. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or

12

Table of Contents

liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of inputs used in measuring fair value are:

•Level 1: Inputs to the valuation methodology are unadjusted quoted prices for identical assets or liabilities in active markets that the Company has the ability to access.

•Level 2: Inputs to the valuation methodology include:

◦Quoted prices for similar assets or liabilities in active markets;

◦Quoted prices for identical or similar assets or liabilities in inactive markets;

◦Inputs other than quoted prices that are observable for the asset or liability;

◦Inputs that are derived principally from or corroborated by observable market data by correlation or other means; and

◦If the asset or liability has a specified (contractual) term, the Level 2 input must be observable for substantially the full term of the asset or liability.

•Level 3: Inputs to the valuation methodology are unobservable and significant to the fair value measurement.

Funds held in trust represent U.S. treasury bills that were purchased with funds raised through the initial public offering of IHC. The funds raised from SPACs are held in trust accounts that are restricted for use and may only be used for purposes of completing an IBC or redemption of the public shares of common stock of the SPACs as set forth in their respective trust agreements. The funds held in trust are included within Level 1 of the fair value hierarchy and included in Cash and marketable securities held in Trust Account in the accompanying condensed consolidated balance sheets.

The Company did not have other Level 1 or Level 2 assets or liabilities at November 30, 2022 or August 31, 2022. We recorded the fair value of the SPAC founder shares that the Company transferred to the underwriters using non-recurring Level 3 assumptions, including quoted asset prices for SPAC shares and warrants and estimates of the likelihood of the IPOs and IBCs of the Company's sponsored SPACs being consummated. See also Note 4, Special Purpose Acquisition company (SPAC) and Note 5, Deferred Offering Costs – SPACS, below.

When the Company changes its valuation inputs for measuring financial assets and liabilities at fair value, either due to changes in current market conditions or other factors, it could be required to transfer those assets or liabilities to another level in the hierarchy based on the new inputs used. The Company recognizes these transfers at the end of the reporting period that the transfers occur. The development and determination of the unobservable inputs for Level 3 fair value measurements and the fair value calculations are the responsibility of the Company’s chief financial officer and are approved by the chief executive officer. There were no transfers out of Level 3 for the three months ended November 30, 2022.

Advertising Costs

The Company expenses all advertising as incurred. The Company incurred advertising costs totaling $0.7 million for the three months ended November 30, 2022 and $1.4 million for the three months ended November 30, 2021, respectively.

Income Taxes

The Company accounts for income taxes pursuant to ASC 740, Income Taxes. Under ASC 740, deferred income taxes are provided on a liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss carryforwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. The provision for income taxes represents the tax expense for the period, if any, and the change during the period in deferred tax assets and liabilities. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. ASC 740 also provides criteria for the recognition, measurement, presentation and disclosure of uncertain tax positions. Under ASC 740, the impact of an uncertain tax position on the income tax return may

13

Table of Contents

only be recognized at the largest amount that is more-likely-than-not to be sustained upon audit by the relevant taxing authority. A full valuation allowance was recorded as of November 20, 2022 and August 31, 2022, respectively,

Earnings (Loss) Per Share

The Company utilizes ASC 260, Earnings per Share. Basic Net Income (Net Loss) per common share is computed by dividing Net Income (Net Loss) attributable to common shareholders by the weighted-average number of shares of common stock outstanding during the reporting period. Common stock outstanding for purposes of Net Income (Net Loss) per share calculations include unexercised Preferred Options and unexercised prefunded warrants, as described in Note 7, Stockholders' Equity, below. Diluted earnings (loss) per share is computed similar to basic earnings (loss) per share except that the denominator is increased to include additional common stock equivalents available upon exercise of stock options and warrants using the treasury stock method. Dilutive common stock equivalents include the dilutive effect of in-the-money stock equivalents, which are calculated based on the average share price for each period using the treasury stock method, excluding any common stock equivalents if their effect would be anti-dilutive. In periods in which a net loss has been incurred, all potentially dilutive common stock shares are considered anti-dilutive and thus are excluded from the calculation. Securities that are excluded from the calculation of weighted average dilutive common stock, because their inclusion would have been antidilutive, are:

For the Three Months Ended	November 30, 2022	November 30, 2021
	(Unaudited) )	(Unaudited)
Options (See Note 8)	10,603	4,023
Warrants (See Note 7)	1,252,748	174,918
Total potentially dilutive shares	1,263,351	178,941

For the table above, “Options” represent all options granted under the Company’s 2017 Stock Option/Stock Issuance Plan (the "Plan"), as described in Note 8, Stock Based Compensation, below.

Stock-Based Compensation

As of November 30, 2022, the Company had one stock-based compensation plan under which the Company may issue awards, as described in Note 8, Stock Based Compensation, below. The Company accounts for the Plan under the recognition and measurement principles of ASC 718, Compensation-Stock Compensation, which requires all stock-based payments to employees, including grants of employee stock options, to be recognized in the condensed consolidated statements of operations at their fair values.

The grant date fair value is determined using the Black-Scholes-Merton (“Black-Scholes”) pricing model. For all employee stock options, the Company recognizes expense on an accelerated basis over the employee’s requisite service period (generally the vesting period of the equity grant).

The Company’s option pricing model requires the input of highly subjective assumptions, including the expected stock price volatility and expected term. The expected volatility is based on the historical volatility of the Company’s common stock since the Company's initial public offering. Any changes in these highly subjective assumptions significantly impact stock-based compensation expense.

The Company elects to account for forfeitures as they occur. As such, compensation cost previously recognized for an unvested award that is forfeited because of the failure to satisfy a service condition is revised in the period of forfeiture.

The methods and assumptions used in the determination of the fair value of stock-based awards are consistent with those described in the Company's Annual Report on Form 10-K and 10-K/A for Fiscal 2022, filed with the SEC on December 3, 2021 and on February 28, 2022, respectively, which includes a detailed description of the Company's stock-based compensation awards, including information related to vesting terms, service and performance conditions, payout percentages, and process for estimating the fair value of stock options granted.

Financial Instruments-Credit Losses

In June 2016, the FASB issued ASU 2016-13, “Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” (“ASU 2016-13”). This standard requires an impairment model (known as the current expected credit loss (“CECL”) model) that is based on expected losses rather than incurred losses. Under the new guidance, each reporting entity should estimate an allowance for expected credit losses, which is intended to result in more timely

14

Table of Contents

recognition of losses. This model replaces multiple existing impairment models in current U.S. GAAP, which generally requires a loss to be incurred before it is recognized. The new standard applies to trade receivables arising from revenue transactions such as contract assets and accounts receivable. Under ASC 606, revenue is recognized when, among other criteria, it is probable that an entity will collect the consideration it is entitled to when goods or services are transferred to a customer. When trade receivables are recorded, they become subject to the CECL model and estimates of expected credit losses on trade receivables over their contractual life will be required to be recorded at inception based on historical information, current conditions, and reasonable and supportable forecasts. This guidance is effective for smaller reporting companies for annual periods beginning after December 15, 2022, including the interim periods in the year. Early adoption is permitted. The Company will adopt the guidance when it becomes effective.

Recent Accounting Standards

As of November 30,2022, there were no new accounting standards that would need to be disclosed.

Variable Interest Entity

The Company has been involved in the formation of various entities considered to be Variable Interest Entities (“VIEs”). The Company evaluates the consolidation of these entities as required pursuant to ASC Topic 810 relating to the consolidation of VIEs. These VIEs are SPACs.

The Company’s determination of whether it is the primary beneficiary of a VIE is based in part on an assessment of whether or not the Company and its related parties are exposed to the majority of the risks and rewards of the entity. Typically, the Company is entitled to substantially all or a portion of the economics of these VIEs. The Company is the primary beneficiary of the VIE entities.

During the Fiscal 2022, the Company's sponsored SPAC, IHC, completed its IPO, selling 11,500,000 units (the "IHC Units") pursuant to a registration statement and prospectus, as described below. The IPO closed on October 22, 2021, raising gross proceeds of $115 million. These proceeds were deposited in a trust account established for the benefit of the IHC public shareholders and, along with an additional $1.7 million deposited in trust by the Company reserved for interest payments for future possible redemptions by IHC stockholders, are included in Cash and marketable securities held in Trust Account in the accompanying condensed consolidated balance sheet at November 30, 2022. These proceeds are invested only in U.S. treasury securities in accordance with the governing documents of IHC.

Each IHC Unit had an offering price of $10.00 and consisted of one share of IHC common stock and one redeemable warrant. Each warrant entitles the holder thereof to purchase one share of IHC common stock at a price of $11.50 per share. The IHC public stockholders have a right to redeem all or a portion of their shares of IHC common stock upon the completion of its IBC, subject to certain limitations. Under the terms of the registration statement and prospectus, IHC is required to consummate its IBC within 12 months of the completion of the IPO. If IHC is unable to meet this deadline, IHC could request an extension. If no extension is granted, then IHC will redeem 100% of the public shares of common stock outstanding for cash, subject to applicable law and certain conditions. In December 2022, the Company distributed $117,574,000 to the shareholders of IHC as described below and in Note 12, Subsequent Events.

In connection with the IPO, we purchased, through the Company's wholly-owned subsidiary, ShiftPixy Investments, Inc. ("Investments" or the "Sponsor"), 4,639,102 private placement warrants ("Placement Warrants") at a price of $1.00 per warrant, for an aggregate purchase price of $4,639,102, and we currently own 2,110,000 Founder Shares of IHC common stock, representing approximately 15% of the issued and outstanding common stock of IHC. Before the closing of the IPO, the Sponsor transferred 15,000 Founder Shares to IHC's independent directors, reducing its shareholdings from 2,125,000 to 2,110,000. Each Placement Warrant is identical to the warrants sold in the IPO, except as described in the IPO registration statement and prospectus. Following the completion of the IHC IPO, we determined that IHC is a Variable Interest Entity ("VIE") in which we have a variable interest because IHC does not have enough equity at risk to finance its activities without additional subordinated financial support. We have also determined that IHC's public stockholders do not have substantive rights, and their equity interest constitutes temporary equity, outside of permanent equity, in accordance with ASC 480-10-S99-3A. As such, we have concluded that we are currently the primary beneficiary of IHC as a VIE, as we have the right to receive benefits or the obligation to absorb losses of the entity, as well as the power to direct a majority of the activities that significantly impact IHC's economic performance. Since we are the primary beneficiary, IHC is consolidated into the Company condensed consolidated financial statements.

15

Table of Contents

Shares Subject to Possible Redemption

The Company accounts for its common stock holdings in its sponsored SPACs (which are consolidated in the Company condensed consolidated financial statements) that are subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Shares of common stock subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable shares of common stock (including shares of common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, shares of common stock are classified as shareholders’ equity. Each sponsored SPAC's shares of common stock feature certain redemption rights that are considered to be outside of the SPAC's control and subject to occurrence of uncertain future events. Accordingly, as of November 30, 2022, shares of common stock subject to possible redemption are presented as temporary equity, outside of the shareholders’ equity section of the Company’s condensed consolidated balance sheets.

The Company recognizes changes in redemption value of these shares immediately as they occur and adjusts the carrying value of redeemable shares of common stock to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of the redeemable common stock are affected by charges against additional paid in capital and accumulated deficit. As of November 30, 2022, the carrying amount of the sponsored SPAC shares of IHC common stock subject to redemption was recorded at their redemption value of $117.8 million. The remeasurement of the redemption value of the redeemable shares of common stock is recorded in equity. The remeasurement in equity comprised of offering cost incurred in connection with the sale of public shares of the SPACs was $13 million, consisting of approximately $9.5 million of offering costs related to the Founder Shares transferred to the SPACs’ underwriter representative as described in Note 5, Deferred Offering Costs, and $3.5 million in other offering costs related to the IPO paid at closing in cash. The Company accounts for the warrants as equity-classified.

Note 3: Discontinued Operations

On January 3, 2020, the Company executed an asset purchase agreement assigning client contracts comprising approximately 88% of its quarterly revenue through the date of the transaction, including 100% of its existing professional employer organization (“PEO”) business effective as of December 31, 2019, and transferring $1.5 million of working capital assets, including cash balances and certain operating assets associated with the assigned client contracts included in the agreement, to a wholly owned subsidiary of Vensure (the “Vensure Asset Sale”). Gross proceeds from the Vensure Asset Sale were $19.2 million, of which $9.7 million was received at closing and $9.5 million was scheduled to be paid out in equal monthly payments over the four years following the closing of the transaction (the “Note Receivable”), subject to adjustments for working capital and customer retention (as measured by a gross wage guarantee included in the governing agreement), over the twelve month period following the Vensure Asset Sale.

For Fiscal 2020, the Company estimated the value of the Note Receivable at fair value as discussed in Note 2, Summary of Significant Accounting Policies, above. For the period ended November 30, 2022, the Company recorded the Note Receivable based on the Company's estimate of expected collections which, in turn, was based on additional information obtained through discussions with Vensure and evaluation of the Company's records. On March 12, 2021, the Company received correspondence from Vensure proposing approximately $10.7 million of working capital adjustments under the terms of the Vensure Asset Sale agreement which, if accepted, would have had the impact of eliminating any sums owed to the Company under the Note Receivable. As indicated in the reconciliation table below, the Company has recorded $2.6 million of working capital adjustments, subject to final review and acceptance, and has provided for an additional reserve of $2.9 million for potential claims. By letter dated April 6, 2021, the Company disputed Vensure’s proposed adjustments and maintains that the amount Vensure owes the Company pursuant to the Note Receivable is as much as $9.5 million. The Company assessed the collectibility of this note during the reporting of its Fiscal Year End of August 31, 2022, and determined that it was probable that all contractually required payments will not be collected and recorded a reserve on collectibility of approximately $4.0 million. The disputes between the Company and Vensure regarding working capital adjustments under the Vensure Asset Sale agreement are currently the subject of litigation pending in the Delaware Chancery Court, as discussed at at Note 11, Contingencies, Vensure Litigation, below.

16

Table of Contents

The following reconciliation of the gross proceeds to the net proceeds from the Vensure Asset Sale is presented in the condensed consolidated balance sheets for the period ended November 30, 2022 and August 31, 2022.

	As of
	November 30, 2022 (Unaudited)		August 31, 2022
Gross proceeds	$	19,166,000	$	19,166,000
Cash received at closing – asset sale	(9,500,000)		(9,500,000)
Cash received at closing – working capital	(166,000)		(166,000)
Gross note receivable	$	9,500,000	$	9,500,000
Less:  Transaction reconciliation – estimated working capital adjustments	(2,604,000)		(2,604,000)
Adjusted Note Receivable	6,896,000		6,896,000
Reserve for estimated potential claims	(2,892,000)		(2,892,000)
Reserve for potential collectability concerns	$	(4,004,000)	$	(4,004,000)
Long-term note receivable, estimated net realizable value	$	—	$	—

As of November 30, 2022 and August 31, 2022, as discussed above the Notes Receivables asset has been impairment to adjust the net realizable value of the long-term note receivable to zero.

The Vensure Asset Sale generated a gain of $15.6 million for during the fiscal year end August 31, 2020. The Company expected a minimal tax impact from the Vensure Asset Sale as it utilized its net operating losses accumulated since inception to offset the gain resulting from discontinued operations tax provision with a corresponding offset to the valuation allowance.

The Vensure Asset Sale met the criteria of discontinued operations set forth in ASC 205 and as such the Company has reclassified its discontinued operations for all periods presented and has excluded the results of its discontinued operations from continuing operations for all periods presented.

The terms of the Vensure Asset Sale call for adjustments to the Note Receivable either for: (i) working capital adjustments or (ii) in the event that the gross wages of the business transferred is less than the required amount.

(i) Working capital adjustments: Through November 30, 2022, the Company has identified $2.6 million of likely working capital adjustments, including $0.1 million related to lower net assets transferred at closing, and $2.5 million of cash remitted to the Company’s bank accounts, net of cash remitted to Vensure’s bank accounts. Under the terms of the Vensure Asset Sale, a reconciliation of the working capital was to have been completed by April 15, 2020. Due to operational difficulties and quarantined staff caused by the outbreak of COVID-19, Vensure requested a postponement of the working capital reconciliation that was due in Fiscal 2020. Although Vensure provided the Company with its working capital reconciliation on March 12, 2021, it failed to provide adequate documentation to support its calculations. Accordingly, the working capital adjustment recorded as of November 30, 2022, represents the Company’s estimate of the reconciliation adjustment by using Vensure’s claims and the limited supporting information Vensure provided as a starting point, and then making adjustments for amounts in dispute based upon the Company's internal records and best estimates. There is no assurance that the working capital change identified as of November 30, 2022, represents the final working capital adjustment.

(ii) Gross billings adjustment: Under the terms of the Vensure Asset Sale, the proceeds of the transaction are reduced if the actual gross wages of customers transferred for Calendar 2020 are less than 90% of those customers’ Calendar 2019 gross wages. The Company has prepared an estimate of the Calendar 2020 gross wages based on a combination of factors including reports of actual transferred client billings in early Calendar 2020, actual gross wages of continuing customers of the Company, publicly available unemployment reports for the Southern California markets and the relevant COVID-19 impacts on employment levels, and other information. Based on the information available, the Company estimated that it would receive additional consideration below the required threshold and reduced the contingent consideration by $1.4 million. Vensure has not identified any such adjustments to date. Based on the information available, the Company reclassified the previously recorded gross wages claim to a general potential claims reserve during Fiscal 2021. No additional adjustment was made during the period ended November 30, 2022.

17

Table of Contents

The carrying amounts of the classes of assets and liabilities from the Vensure Asset Sale included in discontinued operations are as follows:

	As of
	November 30, 2022		August 31, 2022
	(Unaudited)
Deposits – workers’ compensation	—		—
Total current assets	—		—
Deposits – workers’ compensation	—		—
Total assets	$	—	$	—
Accrued workers’ compensation cost	1,438,000		1,362,000
Total current liabilities	1,438,000		1,362,000
Accrued workers’ compensation cost	3,394,000		3,269,000
Total liabilities	4,832,000		4,631,000
Net liability	$	(4,832,000)	$	(4,631,000)

Reported results for the discontinued operations by period were as follows:

	For the Three Months Ended
	November 30, 2022		November 30, 2021
	(Unaudited)
Revenues	$	—	$	—
Cost of revenue	200,000		134,000
Gross profit (loss)	(200,000)		(134,000)
Total operating expenses	—		—
(Loss) income from discontinued operations	$	(200,000)	$	(134,000)

Note 4: Special Purpose Acquisition Company ("SPAC") Sponsorship

On April 29, 2021, we announced the Company's sponsorship, through our wholly-owned subsidiary, ShiftPixy Investments, Inc. ("Investments"), of four SPACs. Each SPAC was seeking to raise approximately $150 million in capital investment, through an IPO, to acquire companies in the light industrial, healthcare and technology segments of the staffing industry, as well as one or more insurance entities. On March 18, 2022, the IPO registration statements related to three of the SPACs we had sponsored, Vital Human Capital, Inc. ("Vital"), TechStackery, Inc. ("TechStackery"), and Firemark Global Capital, Inc. ("Firemark"), were withdrawn. With the withdrawal of these IPO registrations, the Company recorded approximately $38.0 million of deferred costs against Non-controlling interest.

The registration statement and prospectus covering the IPO of IHC was declared effective by the SEC on October 19, 2021, and IHC Units, consisting of one share of common stock and an accompanying warrant to purchase one share of IHC common stock, began trading on the New York Stock Exchange (“NYSE”) on October 20, 2021. The IHC IPO closed on October 22, 2021, raising gross proceeds for IHC of $115 million. In connection with the IHC IPO, we purchased, through the Company's

18

Table of Contents

wholly-owned subsidiary, 4,639,000 placement warrants at a price of $1.00 per warrant, for an aggregate purchase price of$4,639,000.

Following the closing of the IPO, the sum of $116,725,000 was placed in a trust account (the “Trust Account”), and was invested in U.S. government securities within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the "ICA"), with a maturity of 185 days or less, or in any open-ended investment company that holds itself out as a money market fund investing solely in U.S. Treasuries and meeting certain conditions under Rule 2a-7 of the ICA, as determined by the Company, until the earlier of: (i) the completion of the IBC and (ii) the distribution of the funds in the Trust Account to the Company’s shareholders, as described below. The $116,725,000 consisted of the $115,000,000 of gross proceeds from the sale of the IHC Units in the IPO and $1,725,000 funded by the Company, as the corporate parent of the Sponsor, representing guaranteed interest for future redemptions and calculated as one year's interest at 1.5%. With the completion of the IPO, the Company recorded approximately $9.5 million of deferred costs in APIC, and $0.3 million of offering costs paid on behalf of IHC. During Fiscal 2022, IHC incurred approximately $3.5 million in offering costs. No other offering costs have been incurred during the period for the withdrawn SPACs. The Trust Account generated interest and dividend income for the three month ended November 30, 2022 and November 30, 2021 of approximately $0.9 million and $3,000, respectively. After completion of its IPO, IHC sought to acquire companies in the light industrial segment of the staffing industry.

Upon the completion of IHC's IPO, through the Company's wholly-owned subsidiary, we owned approximately 15% of its issued and outstanding stock. Furthermore, we anticipated that IHC would operate as a separately managed, publicly traded entity following the completion of its IBCs. The operations of IHC have been consolidated in the accompanying condensed financial statements for the reasons set forth above in Note 2, Summary of Significant Accounting Policies.

On October 14, 2022, the stockholders of IHC approved the proposed action to file an amended and restated certificate of incorporation to extend the date by which the Company has to consummate a Business Combination from October 22, 2022, to April 22, 2023, or a such earlier date as determined by the board of directors. The Company accordingly filed the Amendment with the Secretary of State of Delaware. In connection with the meeting, however, shareholders holding 11,251,347 Public Shares exercised their right to redeem their shares for a pro rata portion of the funds in the Trust Account. leaving 248,653 of the Company’s remaining Public Shares outstanding and the Trust Account substantially below the $5,000,001 minimum net tangible asset amount required by IHC's Amended and Restated Certificate of Incorporation to be available upon consummation of such Business Combination. IHC's efforts to secure the decisions of some shareholders to reverse their redemptions were unsuccessful, and IHC accordingly declined to fund the extension, cancelled the Amendment as filed with the Secretary of State of Delaware, and proceeded to cease operations, dissolve and unwind. The board of directors of IHC accordingly adopted resolutions to liquidate, dissolve and unwind the entity. Since IHC was dissolved on November 14, 2022, and since the Trust released all the redemption funds to shareholders on December 2, 2022, effectively liquidating the Trust, we will evaluate the impact including potential de-consolidation of its operations during the wind up period in Fiscal 2023. The Class A common shares subject to redemption is classified as a current liability.

Note 5: Deferred Offering Costs - SPACs

During the fiscal year ending August 31, 2021, the Company incurred professional fees related to the filing of registration statements for the IPOs of four SPACs. The Company also transferred certain Founder Shares of those SPACs to a third party which created a non-controlling interest in those entities. These Founder Shares of common stock were transferred to the SPACs’ underwriter representative (the “Representative”) at below fair market value, resulting in compensation and therefore deferred offering costs for the SPACs, and the creation of a non-controlling interest. The non-controlling interest is recorded on the condensed balance sheets and the statements of stockholders' deficit.

As of August 31, 2021, Deferred offering costs - SPACs totaled $48,261,000, consisting of $789,000 of legal and accounting fees related to the SPACs’ IPOs and $47,472,000 related to the non-controlling interest consolidated subsidiaries. As of November 30, 2022. there were no deferred offering costs.

The non-controlling interest – deferred offering costs represents the estimated value of the portion of the Company's Founder Shares in each of the following SPACs that we received as a result of the Company's sponsorship, and which we transferred to the Representative on April 22, 2021, at a price below the fair market value of the shares, as follows: (i) 2,000,000 shares of IHC common stock; (ii) 2,000,000 shares of TechStackery common stock; (iii) 2,000,000 shares of Vital common stock; and (iv) 4,000,000 shares of Firemark common stock. We estimate the total value of the 10,000,000 shares transferred, which represents deferred compensation to the Representative, to be $47,472,000, or $4.7472 per share. We arrived at this valuation by reference to similar SPAC IPO transactions, as set forth below:

1.Consistent with most SPAC IPOs, the market price of units (consisting of some combination of common stock and warrants) sold to the public in a SPAC IPO is $10 per unit.

19

Table of Contents

2.We have valued the warrant portion of each Unit at $0.75 per share. Deducting this value from the Unit yields a value of $9.25 per share of common stock at the time of the IPO, which we have applied to the value of each of the Founder Shares that we issued to the Representative.

3.We have applied a further discount of 48.8%, which is a blended discount designed to reflect the following contingencies and uncertainties: (a) 20% probability that the SPAC IPOs are never consummated; (b) 20% probability that none of the Company's sponsored SPACs successfully complete their IBC; and (c) 21% additional discounts to account for future sponsor and Representative concessions, as well as the possibility of decrease in the value of the common stock of each SPAC.

One of the Company's sponsored SPACs, IHC, completed its IPO on October 22, 2021, resulting in the recognition of approximately $13 million of offering costs, including $9.8 million that had been deferred as of August 31, 2022. No offering costs were incurred for TechStackery, Vital, or Firemark as of November 30, 2022, as these company's registration statements were withdrawn.

As discussed in Note 4, Special Purpose Acquisition Company ("SPAC") Sponsorship, the registration statements on Form S-1 previously filed with the SEC relating to three of its Sponsored SPACs — Vital, TechStackery, and Firemark have been withdrawn. The abandonment of these SPAC IPOs resulted in our recognition of approximately $38.5 million of deferred offering costs against $38 million in non-controlling interest and $0.5 million in the other expenses in the condensed consolidated statements of operations.

Note 6: Going Concern

The accompanying unaudited condensed financial statements have been prepared in conformity with GAAP, which contemplate continuation of the Company as a going concern. As of November 30, 2022, the Company had cash of $0.9 million and a working capital deficit of $32.0 million. During this period, the Company used approximately $3.7 million of cash from its continuing operations and incurred recurring losses, resulting in an accumulated deficit of $198.1 million. As of November 30, 2022, the Company is delinquent with respect to remitting payroll tax payments to the IRS. The Company has been in communication with the IRS regarding amounts owing in relation to credits due. In addition, some clients have filed suits against the Company, demanding that the Company take action to seek additional ERTC tax credits for the subject periods. Until the matter is concluded and the taxes are paid, the IRS could, subject to its standard processes and the Company’s rights to respond, implement collection actions, including such actions as levying against Company bank accounts, to recover the amounts that it calculates to be due and owing.

Historically, the Company's principal source of financing has come through the sale of the Company's common stock, including in certain instances, warrants and issuance of convertible notes. In September 2022, we raised approximately $5.0 million ($4.4 million, net of costs) in connection with the underwriting of a private placement offering. See Note 7, stockholders' deficit.

The recurring losses, negative working capital and cash used in the Company’s operations are indicators of substantial doubt as to the Company’s ability to continue as a going concern for at least one year from issuance of these financial statements. The Company's plans and expectations for the next twelve months include raising additional capital to help fund expansion of our operations and strengthening of the Company's sales force strategy by focusing on staffing services as the Company's key driver to improve the Company's margin and the continued support and functionality improvement of the Company's information technology (“IT”) and HRIS platform. This expanded go-to-market strategy will focus on building a national account portfolio managed by a newly-formed regional team of senior sales executives singularly focused on sustained quarterly revenue growth and gross profit margin expansion. We expect to continue to invest in the Company's HRIS platform, ShiftPixy Labs, and other growth initiatives, all of which have required and will continue to require significant cash expenditures.

The Company also expects its ShiftPixy Labs growth initiative to generate cash flow once launched, by functioning as an incubator of food service and restaurant concepts through collaboration and partnerships with local innovative chefs. If successful, the Company believes that this initiative will produce businesses that provide recurring revenue through direct sales, as well as through utilization of the ShiftPixy Ecosystem, HRIS platform, and other human capital services that the Company provides. To the extent that this business model is successful and can be replicated in other locations, the Company believes that it has the potential to contribute significant revenue to ShiftPixy in the future. The Company may also take equity stakes in various branded restaurants that it develops and operates with its partners through ShiftPixy Labs. Such ownership interests will be held to the extent that it is consistent with the Company’s continued existence as an operating company, and to the extent that the Company believes such ownership interests have the potential to create value for its shareholders.

The Company expects to engage in additional sales of its securities during this fiscal year either through registered public offerings or private placements, the proceeds of which the Company intends to use to fund its operations and growth initiatives. The Company’s management believes that its current cash position, along with its anticipated revenue growth and proceeds

20

Table of Contents

from future sales of its securities, when combined with prudent expense management, will alleviate substantial doubt about its ability to continue as a going concern and to fund its operations for at least one year from the date these financials are available (especially when considering the absence of any funded debt outstanding on its balance sheet). If these sources do not provide the capital necessary to fund the Company’s operations during the next twelve months, it may need to curtail certain aspects of its operations or expansion activities, consider the sale of additional assets, or consider other means of financing. The Company can give no assurance that it will be successful in implementing its business plan and obtaining financing on advantageous terms, or that any such additional financing will be available. If the Company is not successful on obtaining the necessary financing, we do not currently have the cash resources to meet our operating commitments for the next twelve months. These consolidated financial statements do not include any adjustments for this uncertainty.

Note 7: Stockholders’ Deficit

Preferred Stock

In September 2016, the founding shareholders of the Company were granted options to acquire preferred stock of the Company (the “Preferred Options”). The number of Preferred Options granted was based upon the number of shares held at the time of the grant. These Preferred Options are nontransferable and forfeited upon the sale of the related founding shares of common stock held by the option holder. Upon the occurrence of certain specified events, such founding shareholders can exercise each Preferred Option to purchase one share of preferred stock of the Company at an exercise price of $0.0001 per share. The preferred stock underlying the Preferred Options does not include any rights to dividends or preference upon liquidation of the Company and is convertible into shares of the Company’s common stock on a one-for-one basis. Upon consummation of the Vensure Asset Sale in January 2020, a total of 24,634,560 Preferred Options became exercisable and exchangeable into an equal number of shares of the Company's common stock.

On June 4, 2020, Scott W. Absher, the Company’s Chief Executive Officer, exercised 12,500,000 Preferred Options to purchase 12,500,000 shares of the Company's preferred stock for an aggregate purchase price of $1,250. Immediately following the exercise of the Preferred Options, Mr. Absher elected to convert the 12,500,000 shares of preferred stock into 12,500,000 shares of common stock, which were subject to a 24-month lock-up period during which such shares could not be traded. Between July 20, 2020 and November 30, 2020, an additional 294,490 Preferred Options were exercised and converted into 294,490 shares of common stock, which were subject to a six-month lock up period at the time they were issued, during which such shares could not be traded on the open market. As of November 30, 2022, the restrictions on all of these shares have been lifted, rendering them freely tradable.

On October 22, 2021, the Company’s board of directors canceled 11,790,000 Preferred Options previously issued to its co-founder, J. Stephen Holmes. Accordingly, these Preferred Options are no longer exercisable. A total of 37,570 Preferred Options issued pursuant to the September 2016 grant and triggered by the Vensure Asset Sale remain unexercised.

The amount of Preferred Options, and the number of shares of preferred stock issuable upon exercise of such options, is based upon the number of shares of common stock held by the option holders at the time the Preferred Options were issued in September 2016. Accordingly, in order to confirm the original intent of the granting of up to 25,000,000 Preferred Options to Mr. Absher, it has always been the Company’s intent to adopt a second grant of an additional 12,500,000 Preferred Options to Mr. Absher, whereby each option permits the holder to acquire one share of the Company’s preferred stock for $0.0001 per share. On August 13, 2021, consistent with this intent, the Company granted 12,500,000 Preferred Options to Mr. Absher to purchase shares of Preferred Stock, par value $0.0001 for consideration of $0.0001 per share. Each Preferred Option is exercisable for a period of twenty-four months upon (i) the acquisition of a Controlling Interest (as defined below) in the Company by any single shareholder or group of shareholders acting in concert (other than Mr. Absher), or (ii) the announcement of (x) any proposed merger, consolidation, or business combination in which the Company’s Common Stock is changed or exchanged, or (y) any sale or distribution of at least 50% of the Company’s assets or earning power, other than through a reincorporation. Each share of Preferred Stock is convertible into Common Stock on a one-for-one basis. “Controlling Interest” means the ownership or control of outstanding voting shares of the Company sufficient to enable the acquiring person, directly or indirectly and individually or in concert with others, to exercise one-fifth or more of all the voting power of the Company in the election of directors or any other business matter on which shareholders have the right to vote under the Wyoming Business Corporation Act.

On July 14, 2022, the Board of the Company approved the issuance to the Company’s founder and principal shareholder, Scott Absher, of 12,500,000 shares of the Company’s Preferred Class A Stock ("Preferred Shares"), par value $0.0001 per share, in exchange for (a) the surrender by Mr. Absher of his options to acquire 12,500,000 Preferred Shares, which Preferred Options provide for exercise upon certain triggering events as described above, and as detailed in the Company's prior filings, and (b) the tender of payment by Mr. Absher of the sum of $5,000, representing four times the par value for such Preferred Shares. The Company evaluated the Preferred Shares on the same date using Level 2 inputs based on the closing market price of the Company’s common stock. The resulting allocated common share price was then discounted for a lack of marketability of

21

Table of Contents

shares, which yielded a fair value of $0.2322 per Preferred Share. The Company used the following assumptions to value the expense related to the Preferred Shares: (i) life of 10 years; (ii) risk free rate of 3.1%; (iii) volatility of 125.7%; (iv) exercise price of $0.0001 per share; and (v) a fair value of $0.3 per share of the Company’s common stock. These were recorded as compensation expense in the general and administrative expenses during the fiscal year August 31, 2022.

On September 1,, 2022, Mr. Absher converted 8,600,000 Preferred Shares to 8,600,000 shares of the Company’s common stock, par value $0.0001 per share. Pursuant to Rule 144, these 8,000,000 shares of common stock are subject to a six-month holding period during which they may not be sold in the marketplace. All of the 8,6,00,000 preferred shares were converted into common shares on September 1, 2022, after the Company's reverse stock split had taken effect.

On August 12, 2022, the Company entered into an agreement with Mr. Absher whereby he waived claims to certain unpaid compensation due to him through July 31, 2022, totaling $820,793, in exchange for an option to receive 4,100,000 shares of the Company's Preferred Class A Stock. The Company evaluated the Preferred Shares on the same date using Level 2 inputs based on the closing market price of the Company’s common stock. The resulting allocated common share price was then discounted for a lack of marketability of shares, which yielded a fair value of $0.2025 per Preferred Share. The Company used the following assumptions to value the expense related to the Preferred Shares: (i) life of 10 years; (ii) risk free rate of 3.0%; (iii) volatility of 125.7%; (iv) exercise price of $0.0001 per share; and (v) a fair value of $0.2 per share of the Company’s common stock. Pursuant to Rule 144, these 4,100,000, when converted into shares of common stock are subject to a six-month holding period during which they may not be sold in the marketplace. All of the 8,600,000 preferred shares were converted into common stock on September 1, 2022, after the Company's reverse stock split had taken effect. As of November 30, 2022, there were no preferred shares options or preferred shares outstanding. As a result of this transaction, the Company recorded a preferential dividend of 127,145,000 based upon the incremental value of the stock that was held prior to the reverse stock split and the date of preferred stock conversion to common stock. In addition, this had no effect on stockholders' deficit.

Prior to the shareholder vote to approve the reverse stock split, the Company on August 2, 2022, amended its Articles of Incorporation to hereby state that the preferred stock will not be split adjusted if the common stock reverse stock split is effectuated. The reverse stock split was subsequently approved by the shareholders, and effectively the terms and conditions of the preferred stock were “deemed modified” and treated as an extinguishment (in accordance with ASC 470-50 and ASC 260-10-S99-2 for the disproportionate value received (the carrying value compared to the fair value received).

Common Stock and Warrants

During the three months ended November 30, 2022, the Company closed the following transactions:

September 2022 Private Placement

On September 20, 2022, the Company entered into a securities purchase agreement (the “Purchase Agreement”) with a large institutional investor (the “Purchaser”) pursuant to which the Company sold to the Purchaser an aggregate of 416,667 shares (the “Shares”) of its common stock together with warrants (the “Warrants”) to purchase up to 833,334 shares of common stock (collectively, the “Offering”). Each share of common stock and two accompanying Warrants were sold together at a combined offering price of $12.00. The Warrants are exercisable for a period of seven years commencing upon issuance at an exercise price of $12.00, subject to adjustment. The Offering closed on September 23, 2022. The net gross proceeds to the Company from the Offering was $4,738,000.

In connection with the Purchase Agreement, the Company and the Purchaser entered into amendment No. 1 to warrants (the “Warrant Amendment”). Pursuant to the Warrant Amendment, the exercise price of (i) 25,233 warrants issued on September 3, 2021, and (ii) 98,969 warrants issued on January 28, 2022, was reduced to $0.01., As a result of the change in exercise price, the Company recorded an expense of $106,000. The incremental change in the fair market values was based upon the Black Scholes option pricing model with the following inputs. Risk free interest of 3.7%, expected volatility of 149.4%, dividend yield of 0% and expected term of 6.7 to 6.8 years.

A.G.P./Alliance Global Partners (the “Placement Agent”) acted as the exclusive placement agent in connection with the Offering pursuant to the terms of a placement agent agreement, dated September 20, 2022, between the Company and the Placement Agent (the “Placement Agent Agreement”). Pursuant to the Placement Agent Agreement, the Company paid the Placement Agent a fee equal to 7.0% of the aggregate gross proceeds from the Offering. In addition to the cash fee, the Company issued to the Placement Agent warrants to purchase up to 20,833 shares of common stock (5% of the number of shares sold in the Offering (the “Placement Agent Warrants”). The Placement Agent Warrants will be exercisable for a period commencing six months from issuance, will expire four years from the effectiveness of a registration statement for the resale of the underlying shares, and have an initial exercise price of $13.20 per share.

22

Table of Contents

On September 1, 2022, after the Company's reverse stock split had taken effect, Mr. Absher converted 8,600,000 of his shares of Preferred Class A Stock to 8,600,000 shares of our common stock, see Note 9.

The following table summarizes the changes in the Company’s common stock and Prefunded  Warrants from August 31, 2022 to November 30, 2022

	Number of shares	Weighted average remaining life (years)	Weighted average exercise price
Warrants outstanding, August 31, 2022	522,786	7.2	$	47.99
Issued	854,166	7.1	12.00
Cancelled	—	—	—
Exercised	(124,204)	0	—
Warrants outstanding, November 30, 2022	1,252,748	6.9	34.78
Warrants exercisable, November 30, 2022	50,173	3.0	$	459.36

The following table summarizes the Company’s warrants outstanding as of November 30, 2022 (Unaudited):

	Warrants Outstanding	Weighted average Life of Outstanding Warrants in years	Exercise price
September 2022 Common Warrants(1)	833,333	6.8	$	12.00
September 2022 Underwriter Warrants	20,833	4.3	$	13.20
July 2022 Common Warrants(2)	348,408	7.6	$	26.00
Sep 2021Underwriter Warrants	3,762	6.4	175.00
May 2021Underwriter Warrants	2,474	3.5	267.00
October 2020 Common Warrants	23,000	2.9	330.00
October 2020 Underwriter Warrants	2,000	2.9	330.00
May 2020 Common Warrants	12,776	2.5	540.00
May 2020 Underwriter Warrants	1,111	2.5	540.00
March 2020 Exchange Warrants	4,237	2.9	1,017.00
Amended March 2019 Warrants	663	1.3	4,000.00
March 2019 Services Warrants	34	1.3	7,000.00
June 2018 Warrants	63	1.0	4,000.00
June 2018 Services Warrants	54	1.0	9,960.00
	1,252,748	6.9	$	34.78

(1)The September 2022 Common Warrants are exercisable exercisable commencing March 23, 2023 (six months from the date of issuance) and will terminate March 23, 2030.

(2)The July 2022 Common Warrants are not exercisable until January 19, 2023.

Note 8: Stock Based Compensation

Employee Stock Option Plan Increase

In March 2017, the Company adopted its 2017 Stock Option/Stock Issuance Plan (the “Plan”). The Plan provides incentives to eligible employees, officers, directors and consultants in the form of incentive stock options (“ISOs”), non-qualified stock options (“NQs”), (each of which is exercisable into shares of common stock) (collectively, “Options”) or shares of common stock (“Share Grants”).

23

Table of Contents

On July 1, 2020, the Company's board of directors unanimously approved an increase in the number of shares of common stock issuable under the Plan from 250,000 to 3,000,000. On March 31, 2021, the Company’s shareholders approved the increase in the number of shares of common stock issuable under the Plan as well as any contingent grant awards under the Plan on or subsequent to July 1, 2020. On June 4, 2021, the Company filed a registration statement on Form S-8 with the SEC to register the issuance of up to an aggregate of 3,000,000 shares, par value $0.0001 per share, reserved for issuance under the Plan.

For all options granted prior to July 1, 2020, each option has a term of service vesting provision over a period of time as follows: 25% vest after a 12-month service period following the award, with the balance vesting in equal monthly installments over the succeeding 36 months. Options granted on or after July 1, 2020 typically vest over four years, with 25% of the grant vesting one year from the grant date, and the remainder in equal quarterly installments over the succeeding 12 quarters. All options granted to date have a stated ten-year term and, as of November 30, 2022, all options granted to date are exercisable.

Stock grants are issued at fair value, considered to be the market price on the grant date. The fair value of option awards is estimated on the grant date using the Black-Scholes stock option pricing model.

Following its adoption of ASU 2016-9, the Company elected to account for forfeitures under the Plan as they occur. Any compensation cost previously recognized for an unvested award that is forfeited because of a failure to satisfy a service condition is reversed in the period of the forfeiture.

Stock-based compensation expense was $255,000 and $408,000 for the three months ended November 30, 2022, and November 30, 2021, respectively.

The following table summarizes option activity during the three months ended November 30, 2022 (Unaudited):

	Options Outstanding and Exercisable
	Number of Options	Weighted Average Remaining Contractual Life	Weighted Average Exercise Price
		(In years)
Balance Outstanding, August 31, 2022	11,753	8.1	$	733.00
Granted
Exercised
Forfeited	(1,150)		217.00
Balance Outstanding at November 30, 2022	10,603	7.8	$	789.00

 

Options outstanding as of November 30, 2022 had an aggregate intrinsic value of $0. 

As of November 30, 2022, the total unrecognized deferred share-based compensation expected to be recognized over the remaining weighted average vesting periods of 1.8 years for outstanding grants was $1,458,000. Option vesting activity from August 31, 2022, through November 30, 2022 was as follows:

Options Vested	Number of Options	Weighted Remaining Contractual Life	Weighted Average Exercise Price
		(In years)
Balance, August 31, 2022	5,269	8.1	$	1,146.00
Vested	830	8.0	426.00
Exercised			—
Forfeited	(369)		286.00
Balance, November 30, 2022	5,730	7.6	$	1,101.00

The following table summarizes information about stock options outstanding and vested as of November 30, 2022: 

24

Table of Contents

	Options Outstanding				Options Vested
Exercise Prices	Number of Options Exercisable	Weighted Average Remaining Contractual Life	Weighted Average Exercise Price		Number of Options	Weighted Average Remaining Contractual Life	Weighted Average Exercise Price
		(In Years)				(In Years)
$0.50 - 10.00	10,241	7.8	$	438.00	5,375	7.8	$	467.00
$10.01 - $40.00	20	6.5	1,895.00		18	7.3	1,897.00
$40.01 - $80.00	121	6.3	5,121.00		116	6.6	5,120.00
$80.01 - $120.00	101	5.5	10,298.00		101	5.5	10,298.00
$120.01 - $160.00	109	4.6	15,584.00		109	4.6	15,584.00
$160.01 - $391.60	11	4.6	30,160.00		11	4.6	39,160.00
	10,603	7.6	$	789.00	5,730	7.6	$	1,101.00

 

Note 9: Related Parties and Certain Directors and Officers

Scott W. Absher, the Company's CEO and Chair of our Board, received compensation in the form of salary of $127,644 and $153,307 for the three months ending November 30, 2022 and November 30, 2021, respectively. In addition, for the three month period ending November 30, 2022, Mr. Absher has a deferred, unpaid compensation accrual in the amount of $58,832.

On September 1, 2022, after the Company's reverse stock split had taken effect, Mr. Absher converted 8,600,000 of his shares of Preferred Class A Stock to 8,600,000 shares of our common stock.The Company recorded a preferential dividend of 127,145,000 based upon the incremental value of the stock that was held prior to the reverse stock split and the date of preferred stock conversion to common stock.

Mr. Absher's annual salary compensation for calendar year 2023 has been set at $750,000.

J. Stephen Holmes

J. Stephen Holmes formerly served as a non-employee sales manager advisor to and was a significant shareholder of the Company. The Company incurred $750,000 in professional fees for services provided by Mr. Holmes during Fiscal 2021. For the three months ended November 30, 2021, Mr. Holmes was compensated $120,000 for his services.

On or about October 22, 2021, we severed all ties with Mr. Holmes, effective immediately, and cancelled Preferred Options that had previously been issued to him but had not been exercised. As a result of these actions, the Company no longer has any financial obligation to Mr. Holmes, and believes that he is no longer a significant shareholder of the Company. See Note 7, Stockholders Equity. Accordingly, for the three months ending November 30, 2022, Mr. Holmes received no compensation and provided no services.

Amanda Murphy

Amanda Murphy, the Company's COO and Director, received compensation for the 3 month period ending November 30, 2022, in the amount of $66,078, and for the three month period ending November 30, 2021, in the amount of $66,038. In addition, for the three month period ending November 30, 2022, Ms. Murphy has a deferred, unpaid compensation accrual in the amount of $58,967.

Domonic J. Carney

On May 24, 2022, Domonic J. Carney resigned as Chief Financial Officer and Treasurer of the Company, according to a Sabbatical Leave Agreement, effective immediately. As of November 30, 2022, $87,858 remains outstanding as Back Pay.

Related Persons to Scott Absher

Mark Absher, the brother of Scott Absher, was previously employed as our Registered In-House Counsel, Director and Secretary. Mr. Absher resigned from his positions with the Company on February 6, 2019. On November 18, 2021, Mr. Absher

25

Table of Contents

rejoined the Company as Deputy General Counsel – Special Projects, for an annual salary of $240,000. Mr. Absher's compensation for the three month period ending November 30, 2022, was $60,296, and his compensation for the three month period ending November 30, 2021 was $8,307.

David May, a member of our business development team, is the son-in-law of Scott Absher. Mr. May received compensation of approximately $149,000 in Fiscal 2022. Mr. May's compensation for the three month period ending November 30, 2022, was $37,319, and his salary and commission compensation for for the three month period ending November 30, 2021. was $42,857.

Jason Absher, a member of the Company's business development team, is the nephew of Scott Absher and the son of Mark Absher. Mr. Absher received compensation for the three month period ending November 30, 2022, in the amount of $30,017, and for the three month period ending November 30, 2021, in the amount of $30,000.

Phil Eastvold, the Executive Producer of ShiftPixy Labs, is the son-in-law of Scott Absher. Mr. Eastvold's compensation for the three month period ending November 30, 2022, was $56,083, and his compensation for the three month period ending November 30, 2021 was $56,038.

Connie Absher (the spouse of Scott Absher), Elizabeth Eastvold (the daughter of Scott Absher and spouse of Mr. Eastvold), and Hannah Woods (the daughter of Scott Absher), are also employed by the Company. These individuals, as a group, received aggregate compensation in the amount of $48,764 for the three month period ending November 30, 2022 and in the amount of $53,611 for the three month period ending November 30, 2021.

Note 10: Commitments

Operating Leases & License Agreements

Effective August 13, 2020, the Company entered into a non-cancelable seven-year lease for 13,246 square feet of office space located in Miami, Florida, to house its principal executive offices commencing October 2020, and continuing through September 2027. The lease contains escalation clauses relating to increases in real property taxes as well as certain maintenance costs. Monthly rent expense under this lease is approximately $57,000.

Effective October 1, 2020, the Company entered into a non-cancelable 64-month lease for 23,500 square feet of primarily industrial space located in Miami, Florida, to house ghost kitchens, production facilities, and certain marketing and technical functions, including those associated with ShiftPixy Labs. The lease contains escalation clauses relating to increases in real property taxes as well as certain maintenance costs. Monthly rent expense under this lease is approximately $34,000.

Effective June 7, 2021, the Company entered into a non-cancelable sublease agreement with Verifone, Inc. to sublease premises consisting of approximately 8,000 square feet of office space located in Miami, Florida, that the Company anticipates using for its sales and operations workforce. The lease has a term of three years expiring on May 31, 2024. The base rent is paid monthly and escalates annually pursuant to a schedule set forth in the sublease. Monthly rent expense under this lease is approximately $26,000.

Effective June 21, 2021, the Company entered into a non-cancelable 77-month lease for premises consisting of approximately 13,418 square feet of office space located in Sunrise, Florida, that the Company anticipates using primarily to house its operations personnel and other elements of its workforce. The Company lease had possession date of August 1, 2022. The base rent is paid monthly and escalates annually pursuant to a schedule set forth in the lease. Monthly rent expense under this lease is approximately $27,000.

Effective May 2, 2022, the Company entered into a non-cancelable 60-month operating lease, as constituted in an amendment to a prior lease, commencing on July 1, 2022, for office space in Irvine, California, which the Company anticipates using primarily to house its IT, operations personnel, and other elements of its workforce. The base rent is paid monthly and escalates annually according to a schedule outlined in the lease. The monthly rent expense under this lease is approximately $24,000. As an incentive, the landlord provided a rent abatement of 50% of the monthly rent for the first four months, with a right of recapture in the event of default.

On August 31, 2022, the Company decided to formally abandon the leases for its offices in the Courvoisier Center, including a sublease on the second floor with Verifone. The determination was based on its inability to utilize the premises as they were under extensive construction renovation by the landlord, resulting in a significant negative impact on the Company’s ability to conduct business and the health and well-being of the Company’s employees and guests. The Company formally notified the landlord of its intention to vacate the premises and has not been legally released from the Company's primary obligations under the leases. The Company received a formal complaint from the landlord, and the matter is in litigation. The Company intends to vigorously defend the lawsuit and counterclaim for relocation costs. See Note 11, Contingencies. As a result of the

26

Table of Contents

abandonment, the Company evaluated the Right-Of-Use ("ROU") Assets for impairment as of August 31, 2022, and recorded an impairment charge of $3.9, within the impairment loss line item for the year ended August 31, 2022, see 10-K for such information. Furthermore, the Company released the corresponding lease liability and evaluated the need for a loss contingency in accordance with ASC 450, recording a contingent liability of $3.8 in the accrued expenses of the consolidated balance sheets as of November 30, 2022 and August 31, 2022/.

The components of lease expense are as follows:

	Three Months Ended November 30, 2022
Operating Lease Cost	$	256,000

Future minimum lease and licensing payments under non-cancelable operating leases at November 30, 2022, are as follows:

	Minimum lease commitments
2023	$	919,000
2024	1,064,000
2025	1,099,000
2026	777,000
2027	568,000
Thereafter	351,000
Total minimum payments	$	4,778,000
Less: present value discount	621,000
Lease Liability	$	4,157,000
Weighted-average remaining lease term - operating leases (months)	72
Weighted-average discount rate	5.54		%

The current portion of the operating lease liability is included within our accounts payable and other accrued liabilities in our condensed consolidated balance sheets.

Special Purpose Acquisition Company Sponsorship

On April 29, 2021, the Company announced its sponsorship, through a wholly-owned subsidiary, of four SPAC IPOs. The Company purchased founder shares in each SPAC (the "Founder Shares"), through its wholly-owned subsidiary, for an aggregate purchase price of $25,000 per SPAC. The number of Founder Shares issued was determined based on the expectation that such Founder Shares would represent 15% of the outstanding shares of each SPAC after its IPO (excluding the private placement warrants described below and their underlying securities).

The registration statement and prospectus covering the IPO of IHC, was declared effective by the SEC on October 19, 2021, and IHC units (the “IHC Units”), consisting of one share of common stock and an accompanying warrant to purchase one share of IHC common stock, began trading on the NYSE on October 20, 2021. The IHC IPO closed on October 22, 2021, raising gross proceeds for IHC of $115 million. In connection with the IHC IPO, the Company purchased, through its wholly-owned subsidiary, 4,639,102 placement warrants at a price of $1.00 per warrant, for an aggregate purchase price of $4,639,102. Each private placement warrant is exercisable to purchase one whole share of common stock in IHC at $11.50 per share. The private placement warrants will be worthless to the extent that IHC does not complete an initial business combination.

The investment amounts set forth above do not include loans that the Company may extend to IHC in an amount not to exceed $500,000, in its role as sponsor. As of November 30, 2022, the Company had advanced, through its wholly owned subsidiary, an aggregate of approximately $861,000 to the SPACs for payment of various expenses in connection with the SPAC IPOs,

27

Table of Contents

principally consisting of SEC registration, legal and auditing fees. The Company previously disclosed that it anticipates that the SPAC will repay these advanced expenses from when its IBC is completed. As of November 30, 2022, the Company had an outstanding balance of $744,000 from the advances, which are considered uncollectible with the dissolution of IHC. The intercompany balances have been eliminated in consolidation.

Note 11: Contingencies

Certain conditions may exist as of the date the financial statements are issued, which may result in a loss to the Company, but which will be resolved only when one or more future events occur or fail to occur. The Company’s management assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment.

During the ordinary course of business, the Company is subject to various claims and litigation. Management believes that after consulting legal counsel the outcome of such claims or litigation will not have a material adverse effect on the Company’s financial position, results of operations or cash flow. Some of the matters are detailed below.

Kadima Litigation

The Company became engaged in a dispute with its former software developer, Kadima Ventures (“Kadima”), over incomplete but paid for software development work. In May 2016, the Company entered into a contract with Kadima for the development and deployment of user features that were proposed by Kadima for an original build cost of $2.2 million to complete. This proposal was later revised upward to approximately $7.2 million to add certain features to the original proposal. As of November 30, 2022, the Company has paid approximately $11.0 million to Kadima, but has never been provided access to the majority of the promised software. Kadima has refused to continue development work, denied access to developed software, and refused to surrender to the Company any software that it has developed unless the Company pays an additional $12.0 million above the $11.0 million already paid. In April 2019, Kadima filed a complaint against the Company in the Superior Court of the State of Arizona, Maricopa County, alleging claims for breach of contract, promissory estoppel and unjust enrichment, and seeking damages in excess of $11.0 million. The Company vigorously disputed and denied each of Kadima’s claims, including that it owes any sums to Kadima, and further asserted that it is entitled, at a minimum, to a refund of a substantial portion of the sums that it has already paid, along with the release of the software modules currently being withheld. Following trial of the case, the court, on November 23, 2022, entered a minute order, finding in favor of the Company and against Kadima in the amount of $5 million plus costs and fees. As noted in Note 12, Subsequent Events, the minute order was converted to a final judgement order, entered on January 4, 2023, in favor of the Company and against Kadima for $5 million in compensatory damages, plus an amount in excess of $1.8 million in pre-judgment interest, plus expert witness fees of $250,000, plus costs, plus post judgment interest.

Splond Litigation

On April 8, 2019, claimant, Corey Splond, filed a class action lawsuit, on behalf of himself and other similarly situated individuals in the Eighth Judicial District Court for the State of Nevada, Clark County, naming the Company and its client as defendants, and alleging violations of certain wage and hour laws. The Company denies any liability. Discovery is proceeding in the case, and no trial date has been set. Even if the plaintiff ultimately prevails, the potential damages recoverable will depend substantially upon whether the Court determines in the future that this lawsuit may appropriately be maintained as a class action. Further, in the event that the Court ultimately enters a judgment in favor of plaintiff, the Company believes that it would be contractually entitled to be indemnified by its client against at least a portion of any damage award.

Radaro Litigation

On July 9, 2020, the Company was served with a complaint filed by one of its former software vendors, Radaro Inc., in the United States District Court for the Central District of California, alleging damages arising from claims sounding in breach of contract and fraud. By Order filed October 21, 2020, the Court dismissed plaintiff’s claims for fraud and for punitive damages, with leave to replead. The Company denied plaintiff’s claims and defended the lawsuit vigorously. On October 31, 2022, the Company settled the claim with Radaro, the terms of which are confidential.

Everest Litigation

On December 18, 2020, the Company was served with a Complaint filed in the United States District Court for the Central District of California by its former workers’ compensation insurance carrier, Everest National Insurance Company. The Complaint asserts claims for breach of contract, alleging that the Company owes certain premium payments to plaintiff under a

28

Table of Contents

retrospective rated policy, and seeks damages of approximately $0.6 million, which demand has since increased to approximately $1.6 million. On February 5, 2021, the Company filed an Answer to Plaintiff’s Complaint denying its claims for relief, and also filed a cross-claim against the third party claims administrator, Gallagher Bassett Services, Inc., for claims sounding in breach of contract and negligence based upon its administration of claims arising under the policy. By order dated April 7, 2021, the Court dismissed the Company’s complaint against Gallagher Bassett without prejudice to re-filing in another forum. On May 17, 2021, the Company refiled its complaint against Gallagher Basset in the Circuit Court of Cook County, Illinois. Everest subsequently filed a complaint against Gallagher Bassett in New Jersey. Discovery is underway in the cases, and the California Court has set a trial date in the Everest case of August 8, 2023, while no trial date has been set in either of the related Illinois or New Jersey cases, which are in preliminary stages. Mediation in the matter was conducted on December 14, 2022, and the matter was kept open until further notice as the partied are seeking to settle the case.

Sunz Litigation

On March 19, 2021, the Company was served with a Complaint filed in the Circuit Court for the 11th Judicial Circuit, Manatee County, Florida, by its former workers’ compensation insurance carrier, Sunz Insurance Solutions, LLC. The Complaint asserts claims for breach of contract, alleging that the Company owes payments for loss reserve funds totaling approximately $10 million, which represents approximately 200% of the amount of incurred and unpaid claims. The Company denies plaintiff’s allegations and is defending the lawsuit vigorously. On May 12, 2021, the Company filed a motion to dismiss the complaint, and Sunz filed an amended complaint in response. Discovery is proceeding in the matter and no trial date has been set. On June 21, 2022, the Court granted Plaintiff’s partial motion for summary judgment, holding that Defendant is liable under the contract, but further finding that the amount of damages, if any, to which Plaintiff is entitled should be determined at trial. We believe that partial summary judgment was improvidently granted, and therefore appealed the Court’s Order by filing a petition for writ of certiorari with the Court of Appeal, which appeal is now pending. On or about November 14, 2022, a court granted Sunz’ motion for summary judgment on a contractual issue—holding that the Company waived claims regarding Sunz’ management of claims to the extent that the Company did not complain about such management within 6 months of the alleged mismanagement of the claims. This ruling may limit the scope of the Company’s counterclaim.

Vensure Litigation

On September 7, 2021, Shiftable HR Acquisition, LLC, a wholly-owned subsidiary of Vensure, filed a complaint against the Company in the Court of Chancery of the State of Delaware asserting claims arising from the Asset Purchase Agreement (the “APA”) governing the Vensure Asset Sale described above. The APA provided for Vensure to purchase, through its wholly-owned subsidiary, certain of the Company’s assets for total consideration of $19 million in cash, with $9.5 million to be paid at closing, and the remainder to be paid in 48 equal monthly installments (the “Installment Sum”). The Installment Sum was subject to certain adjustments to account for various post-closing payments made by the parties, and the APA provided for the following procedure to determine the final amount of the Installment Sum: (i) Within 90 days of the effective date, Vensure was required to provide the Company with a “Proposed Closing Statement”, which must detail any adjustments; (ii) Within 30 days of its receipt of Vensure’s Proposed Closing Statement, the Company had the right to challenge any of the proposed adjustments contained therein; and (iii) If the Company disputed Vensure’s Proposed Closing Statement, a 30-day period ensued for the parties to attempt to resolve the dispute, with the Company entitled to examine “such Books and Records of [Vensure] as relate to the specific items of dispute . . .”

Vensure resisted the Company’s repeated efforts to obtain the Proposed Closing Statement for over one year after the closing of the transaction. Finally, on March 12, 2021, under threat of legal action by the Company, Vensure provided its Proposed Closing Statement, in which it contended for the first time that it owes nothing to the Company, and that the Company actually owes Vensure the sum of $1.5 million. By letter dated April 6, 2021, the Company provided Vensure with its objections to the Proposed Closing Statement, which included Vensure’s gross overstatement of payments it purportedly made on the Company’s behalf, as well as its bad faith actions in obstructing the Company’s efforts to make these payments.

From April 2021 through August 2021, Vensure and the Company engaged in the “30-day negotiation period” referred to above, which was extended multiple times at Vensure’s request to provide Vensure an opportunity to provide evidence supporting its assertions. Over the course of these negotiations, Vensure withdrew its claim for approximately $1.5 million from the Company, and acknowledged that Vensure owed ShiftPixy some portion of the Installment Fund. Nevertheless, in early September 2021, without warning and contrary to the dispute resolution provisions of the APA, Vensure filed suit against the Company in Delaware Chancery Court for breach of contract and declaratory judgment, seeking unspecified damages. The Company vigorously disputes and denies each of Vensure’s claims. Accordingly, on November 4, 2021, the Company filed its Answer and Counterclaim to Vensure’s Complaint, in which it not only denied Vensure’s claims, but also asserted counterclaims for breach of contract and tortious interference with contract. The counterclaim seeks damages from Vensure

29

Table of Contents

totaling approximately $9.5 million – the full amount due under the APA - plus an award of attorneys’ fees and expenses. The case is proceeding, and no trial date has been set.

Courvoisier Centre Litigation

On August 24, 2022, the landlord of our headquarters offices, Courvoisier Centre, LLC, filed a complaint against the Company in the Eleventh Judicial Circuit Court (Miami-Dade County, Florida) alleging breach of the lease. We vacated the offices and ceased payments under the lease in July of 2022, after repeatedly complaining to the landlord regarding the impact of its extensive renovations of the campus and building in which the Company's offices were situated, citing substantial impairments to the Company's ability to conduct business as well as concerns regarding the health and well-being of the Company’s employees and guests, and the Landlord’s inability and refusal to provide any adequate relief. On or about October 10, 2022, we filed our answer to the complaint and the Company's counterclaim. The Company intends to vigorously defend the lawsuit and seek recovery for its costs of relocation.

Certified Tire Litigation

On June 29, 2020, the Company was served with a complaint filed by its former client, Certified Tire, in the Superior Court of the State of California, Orange County, naming the Company, two of its officers, and one of its former subsidiaries as defendants. The Complaint asserts multiple causes of action, all of which stem from the former client’s claim that the Company is obligated to reimburse it for sums it paid in settlement of a separate lawsuit brought by one of its employees pursuant to PAGA. This underlying lawsuit alleged the Company's former client was responsible for multiple violations of the California Labor Code. The Company and the officers named as defendants deny the former client’s allegations, and the Company is defending the lawsuit vigorously based primarily on the Company's belief that the alleged violations that gave rise to the underlying lawsuit were the responsibility of Certified Tire and not the Company. Discovery is currently proceeding, and trial is scheduled to commence on or after March 27, 2023. The Company’s dispositive motion for summary judgment was denied by the court because of its determination that factual disputes exist.

In Re John Stephen Holmes Bankruptcy Litigation

On November 8, 2022, the Chapter 7 trustee of the bankruptcy estate of John Stephen Holmes filed an action against the Company, asserting that the cancellation of Mr. Holmes' preferred options on October 22, 2021, violated the automatic stay applicable to Mr. Holmes' Chapter 7 proceedings. The matter is in the preliminary stages; as noted in Note 12, Subsequent Events, the Company has filed a motion to dismiss the complaint.

Nasdaq Listing Notifications

On April 4, 2022, we received a letter from the staff of the Listing Qualifications Department (the "Staff") of Nasdaq notifying us that for the previous 30 consecutive business days, the bid price for the Company's common stock had closed below the minimum $1.00 per share requirement for continued listing under Nasdaq's Listing Rule 5550(a)(2) (the "Minimum Bid Requirement"). Following the completion of the reverse split of the Company's r common stock, which became effective on September 1, 2022, on September 19, 2022, the Company received a letter from the staff of Nasdaq (the "Staff") notifying the Company that the Staff has determined that for the last 10 consecutive business days, from September 1 to September 16, 2022, the closing bid price of the Company’s common stock had been at $1.00 per share or greater and that accordingly, the Company has regained compliance with Listing Rule 5550(a)(2).

In addition, on April 21, 2022, ShiftPixy, Inc. (the “Company”) received a letter from the staff of the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”), which notified the Company that it did not comply with Nasdaq’s Listing Rule 5550(b)(1) that requires the Company to (i) maintain a minimum of $2,500,000 in stockholders’ equity for continued listing or (ii) meet the alternatives of minimum market value for listed securities or net income from continuing operations. On October 3, 2022, the Company received a letter from the Staff notifying the Company that the Staff has determined that the Company has regained compliance with Listing Rule 5550(b) in that, for the last 21 consecutive business days, from September 1 through September 30, 2022, the Company’s market value of listed securities has been above $35,000,000.

30

Table of Contents

Note 12: Subsequent Events

Management has evaluated events that have occurred subsequent to the date of these consolidated financial statements and has determined that, other than those listed below, no such reportable subsequent events exist through the date the financial statements were issued in accordance with FASB ASC Topic 855, "Subsequent Events."

IHC

IHC Trust released all the redemption funds to IHC shareholders on December 2, 2022, effectively liquidating the Trust.

In Re John Stephen Holmes Bankruptcy Litigation

On December 15, 2022, we filed a motion to dismiss the complaint filled by the bankruptcy trustee. No action has been taken on the motion.

Kadima Litigation

On January 4, 2023, the court in the Kadima litigation entered a formal order of judgment in favor of the Company and against Kadima for $5 million in compensatory damages, plus an amount in excess of $1.8 million in pre-judgment interest, plus expert witness fees of $250,000, plus costs, plus post judgment interest.

Changes in CFO Position

Effective December 16, 2022, Manny Rivera, resigned from his position as Acting Chief Financial Officer of the Company. Effective January 15, 2023, Douglas Beck, CPA assumed the position of Chief Financial Officer of the Company.

Nasdaq Letter of Reprimand

On January 17, 2023, the staff of the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) issued a Letter of Reprimand to the Company for the Company’s violation, as determined by Nasdaq, of Listing Rule 5635(d) (the “Rule”). The Staff determined that two transactions completed by the Company, on July 18, 2022, and September 20, 2022 (prior to and after the Company’s 1-for-100 reverse stock split), should be aggregated inasmuch as the transactions were with the same investor and deemed proximate in time and use of proceeds, and that, because the total shares issued in the transactions substantially exceeded 20% of the total shares outstanding and were issued at a price less than the Minimum Price, shareholder approval should have been secured prior to issuing shares in the September 20, 2022, transaction.

The Staff considered it appropriate, pursuant to Listing Rule 5810(c)(4), to close these matters with the issuance of a Letter of Reprimand as opposed to a delisting of the Company’s securities, noting that the Company (1) stated that any violation of the Listing Rules was inadvertent, (2) stated that it reasonably relied upon the expertise of its outside counsel and had no reason to believe counsel would omit consideration of any material issue and accordingly proceeded with closing, (3) noted that its substantial majority shareholder approved the September 20, 2022, transaction, (4) has committed to engage with Nasdaq prior to entering into transactions involving common investors if such transactions take place within six months from one another, and (5) has not demonstrated a prior pattern of non-compliance. The Company’s action in amending the warrants issued in September 2022 to extend the date of their initial exercise to 6 months from the date of their issuance (which has been completed as disclosed in the Company’s 8-K filed on December 2, 2022) was offered by the Company as a remedial measure.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

The following discussion of our financial condition and results of operations should be read in conjunction with our financial statements and the related notes, and other financial information included in this Quarterly Report, as well as the information contained in our Annual Report on Form 10-K and 10-K/A for the fiscal year ended August 31, 2022 (“Fiscal 2022”), filed with the SEC on December 13, 2022 and December 14, 2022, respectively.

CAUTIONARY STATEMENT REGARDING FORWARD LOOKING STATEMENTS AND INFORMATION

This Quarterly Report, the other reports, statements, and information that we have previously filed or that we may subsequently file with the SEC, and public announcements that we have previously made or may subsequently make, contain “forward-looking statements” within the meaning of the federal securities laws, including the Private Securities Litigation Reform Act of 1995, which statements involve substantial risks and uncertainties. Unless the context is otherwise, the forward-looking statements included or incorporated by reference in this Quarterly Report and those reports, statements, information and announcements address activities, events or developments that we expect or anticipate will or may occur in the future. Forward-looking statements generally relate to future events or our future financial or operating performance. In some cases, you can

31

Table of Contents

identify forward-looking statements because they contain words such as “may,” “might,” “will,” “should,” “expects,” “plans,” “anticipates,” “could,” “intends,” “target,” “projects,” “contemplates,” “believes,” “estimates,” “predicts,” “potential” or “continue” or the negative of these words or other similar terms or expressions that concern our expectations, strategy, plans or intentions. Forward-looking statements contained in this Quarterly Report include, but are not limited to, statements about:

• our future financial performance, including our revenue, costs of revenue and operating expenses;

• our ability to achieve and grow profitability;

• the sufficiency of our cash, cash equivalents and investments to meet our liquidity needs;

• our predictions about industry and market trends;

• our ability to expand successfully internationally;

• our ability to manage effectively our growth and future expenses, including our growth and expenses associated with our sponsorship of various special purpose acquisition companies;

• our estimated total addressable market;

• our ability to maintain, protect and enhance our intellectual property;

• our ability to comply with modified or new laws and regulations applying to our business;

• the attraction and retention of qualified employees and key personnel;

• the effect that the novel coronavirus disease (“COVID-19”) or other public health issues could have on our business, financial condition and the economy in general;

• our ability to be successful in defending litigation brought against us; and

• our ability to continue to meet the listing requirements of Nasdaq.

We caution you that the forward-looking statements highlighted above do not encompass all of the forward-looking statements made in this Quarterly Report.

We have based the forward-looking statements contained in this Quarterly Report primarily on our current expectations and projections about future events and trends that we believe may affect our business, financial condition, results of operations and prospects. The outcome of the events described in these forward-looking statements is subject to risks, uncertainties and other factors described in the section entitled “Risk Factors” in this report and in our Annual Report on Form 10-K and 10-K/A for Fiscal 2022, filed with the SEC on December 13, 2021 and on December 14, 2022, respectively, which is expressly incorporated herein by reference, and elsewhere in this Quarterly Report. Moreover, we operate in a very competitive and challenging environment. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all risks and uncertainties that could have an impact on the forward-looking statements contained in this Quarterly Report. We cannot assure you that the results, events and circumstances reflected in the forward-looking statements will be achieved or occur, and actual results, events or circumstances could differ materially from those described in the forward-looking statements.

The forward-looking statements made in this Quarterly Report relate only to events as of the date on which the statements are made. We undertake no obligation to update any forward-looking statements made herein to reflect events or circumstances after the date of this Quarterly Report or to reflect new information or the occurrence of unanticipated events, except as required by law. We may not actually achieve the plans, intentions or expectations disclosed in our forward-looking statements and you should not place undue reliance on our forward-looking statements. Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures, other strategic transactions or investments we may make or enter into.

The risks and uncertainties we currently face are not the only ones we face. New factors emerge from time to time, and it is not possible for us to predict which will arise. There may be additional risks not presently known to us or that we currently believe are immaterial to our business. In addition, we cannot assess the impact of each factor on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. Our business, operating results, liquidity and financial condition could be materially affected in an adverse manner as a result of these risks.

The industry and market data contained in this Quarterly Report are based either on our management’s own estimates or, where indicated, independent industry publications, reports by governmental agencies or market research firms or other published

32

Table of Contents

independent sources and, in each case, are believed by our management to be reasonable estimates. However, industry and market data are subject to change and cannot always be verified with complete certainty due to limits on the availability and reliability of raw data, the voluntary nature of the data gathering process and other limitations and uncertainties inherent in any statistical survey of market shares. We have not independently verified market and industry data from third-party sources. In addition, consumption patterns and customer preferences can and do change. As a result, you should be aware that market share, ranking and other similar data set forth herein, and estimates and beliefs based on such data, may not be verifiable or reliable.

The ShiftPixy logo and other trademarks or service marks of ShiftPixy, Inc. appearing in this Quarterly Report on Form 10-Q are the property of ShiftPixy, Inc. This Form 10-Q also includes trademarks, trade names and service marks that are the property of other organizations. Solely for convenience, trademarks and trade names referred to in this Form 10-Q appear without the ® and ™ symbols, but those references are not intended to indicate, in any way, that we will not assert, to the fullest extent under applicable law, our rights, or that the applicable owner will not assert its rights, to these trademarks and trade names.

Overview

Our current business, and the primary source of our revenues to date, has been providing human resources, employment compliance, employment related insurance, payroll, and operational employment services solutions for our business clients using a comprehensive HRIS platform under a human capital fee-based business model. We have developed a comprehensive human resources information system or HRIS platform designed to provide real-time, agile business intelligence information for our clients as well as an employment marketplace designed to match client opportunities with a large workforce under a digital umbrella. Our market focus is to use this traditional approach, coupled with developed technology, to address underserved markets containing predominately lower wage employees with high turnover, beginning with light industrial, services, and food and hospitality markets. We provide human resources, employment compliance, insurance-related, payroll, and operational employment services solutions for our clients and shift work or gig opportunities for worksite employees (WSEs or shifters). As consideration for providing these services, we receive administrative or processing fees, typically as a percentage of a client’s gross payroll, process and file payroll taxes and payroll tax returns, provide workers’ compensation insurance, and provide employee benefits. We have built a substantial business on a recurring revenue model since our inception in 2015. For the three months ended November 30, 2022 and November 30, 2021, we processed approximately $11.7 million and $14.1 million of payroll billings, respectively, our primary operating metric, and incurred approximately $5.4 million and $8.7 million in operating losses for the three months ended November 30, 2022 and November 31, 2021, respectively. Our loses were driven primarily by substantial investments in our technology platform, our SPAC sponsorships and our ShiftPixy Labs growth initiative, as well as by necessary upgrades to our back-office operations to facilitate servicing a large WSE base under a traditional staffing model.

For most of the fiscal year ending August 31, 2022, and continuing into the first quarter of 2023 ending November 30, 2022, our primary focus was on clients in the restaurant and hospitality industries, (market segments typically characterized by high employee turnover and low pay rates), and healthcare industries typically employing specialized personnel that command higher pay rates. We believe that these industries are better served by our HRIS platform and related mobile application, which provide payroll and human resources tracking for our clients, and which we believe result in lower operating costs, improved customer experience and revenue growth acceleration. California continued to be our largest market during the three months ending November 30, 2022, accounting for approximately 48.78% of our gross billings. Washington and New Mexico represented our other significant markets during the first quarter of 2023 ending November 30, 2022, representing approximately 22.43% of our total gross billings. (Our other locations did not contribute revenue to a material degree.) All of our clients enter into client services agreements ("CSAs") with us or one of our wholly owned subsidiaries.

Our business focus during the fiscal year ending August 31, 2022, and continuing into the three months ending November 30, 2022, was to complete our HRIS platform and to expand that platform to position the Company for rapid billings growth as well as to expand our product offerings to increase our monetization of our payroll billings. Now we feel that our HRIS platform is at completion stage and our IT development cost has started to stabilize with a significant cost reduction year over year, we are focused in the maintenance and minor functionality improvements to keep our technology at a top level of excellence in functionality. To that end, we identified and began to execute on various growth strategies, and expect that our execution of these strategies, if successful, will yield significant customer growth driven by widespread adoption of our technology

33

Table of Contents

offerings, which we believe represents a substantial value proposition to our clients as a valuable source of agile human capital business intelligence.

Our revenues for the first quarter of 2023 ending November 30, 2022, consisted of: i) staffing solutions revenues equal to gross billings for staffing solutions clients; and ii) EAS solutions revenues which consist of administrative fees calculated as a percentage of gross payroll processed, payroll taxes due on WSEs billed to the client and remitted to the taxation authority, and workers’ compensation premiums billed to the client for which we facilitate coverage for our clients. Our costs of revenues for EAS solutions revenues consist of the accrued and paid payroll taxes and our costs to provide the workers’ compensation coverage and administration related services, including premiums and loss reserves. For staffing solutions revenues, our cost of revenues also included the gross payroll paid to staffing solutions employees. A significant portion of our liabilities is for our projected workers’ compensation claims, carried as liabilities. We provided a self-funded workers’ compensation policy up to $500,000 and purchased reinsurance for claims in excess of that limit through February 28, 2021, after which we changed to a direct cost premium only workers’ compensation program.

We believe that our customer value proposition is to provide a combination of overall net cost savings to our clients, for which they are willing to pay increased administrative fees, as follows:

•Payroll tax compliance and management services;

•Governmental HR compliance services, such as compliance with the Affordable Care Act (“ACA”);

•Reduced client workers’ compensation premiums or enhanced coverage; and

•Access to an employee pool of potential applicants to reduce turnover costs.

We have invested heavily in a robust, cloud-based HRIS platform (the ShiftPixy “Ecosystem”) in order to:

•Reduce WSE management costs;

•Automate new WSE and client onboarding; and

•Provide value-added services for our business clients resulting in additional revenue streams to the Company.

Our cloud-based HRIS platform captures, holds, and processes HR and payroll information for clients and WSEs through an easy-to-use customized front-end interface coupled with a secure, remotely hosted database. The HRIS platform can be accessed by either a desktop computer or an easy to use smartphone application designed with legally binding HR workflows in mind. Once fully implemented, we expect to reduce the time, expense, and error rate for on-boarding WSEs into our ecosystem. This allows our HRIS platform to serve as a “gig” marketplace for WSEs and clients and for client businesses to better manage their human capital needs.

We see our technology platform as a key competitive advantage and differentiator to our competitors and one that will allow us to expand our human capital business beyond our current focus of low-wage employees and healthcare workers. We believe that providing this baseline business, coupled with a technology solution to address additional concerns such as employee scheduling and turnover, will provide a unique, cost effective solution to the HR compliance, staffing, and scheduling problems that these businesses face. We are completing additional features that we expect to generate additional revenue streams, enhance and expand our product offering, increase our client customer and WSE counts, and increase our revenues and profit per existing WSE.

COVID-19 Pandemic Impact

The COVID-19 pandemic continues to provide both business setbacks and business opportunities. Our growth trajectory has been muted by the economic impacts of the COVID-19 pandemic on our core business clients, primarily restaurants and nurse staffing organizations supplying health services not related to COVID-19. However, many of our clients have, with the benefit of Payroll Protection Plan loans ("PPP Loans") under the CARES Act and with adjustments to business offerings to accommodate the impact of the virus and the related government response thereto, learned to respond to and in some cases grow despite the pandemic. Thus far, the impact of the variants of the disease have been largely inconsequential. However, if the disease or its variants further impose on the health of residents of states wherein we have a significant presence, the effects thereof, including the government response thereto, could have a material impact on our revenues.

Significant Developments in the Three Months Ended November 30, 2022.

34

Table of Contents

Financing Activities

September 2022 Private Placement

On September 20, 2022, the Company entered into a securities purchase agreement (the “Purchase Agreement”) with a large institutional investor (the “Purchaser”) pursuant to which the Company sold to the Purchaser an aggregate of 416,667 shares (the “Shares”) of its common stock together with warrants (the “Warrants”) to purchase up to 833,334 shares of common stock (collectively, the “Offering”). Each share of common stock and two accompanying Warrants were sold together at a combined offering price of $12.00. The Warrants are exercisable for a period of seven years commencing upon issuance at an exercise price of $12.00, subject to adjustment. The Offering closed on September 23, 2022. The gross proceeds to the Company from the Offering were approximately $5 million.

In connection with the Purchase Agreement, the Company and the Purchaser entered into amendment No. 1 to warrants (the “Warrant Amendment”). Pursuant to the Warrant Amendment, the exercise price of (i) 25,233 warrants issued on September 3, 2021, and (ii) 98,969 warrants issued on January 28, 2022, was reduced to $0.01.

A.G.P./Alliance Global Partners (the “Placement Agent”) acted as the exclusive placement agent in connection with the Offering pursuant to the terms of a placement agent agreement, dated September 20, 2022, between the Company and the Placement Agent (the “Placement Agent Agreement”). Pursuant to the Placement Agent Agreement, the Company paid the Placement Agent a fee equal to 7.0% of the aggregate gross proceeds from the Offering. In addition to the cash fee, the Company issued to the Placement Agent warrants to purchase up to 20,833 shares of common stock (5% of the number of shares sold in the Offering (the “Placement Agent Warrants”)). The Placement Agent Warrants will be exercisable for a period commencing six months from issuance, will expire four years from the effectiveness of a registration statement for the resale of the underlying shares, and have an initial exercise price of $13.20 per share.

Growth Initiatives

During the first quarter of Fiscal 2023, we concluded activities associated with our SPAC-related growth initiative, and we continued to execute on our other primary growth initiative, which is designed to leverage our technology solution, knowledge, and expertise to provide for significant revenue growth for the human capital management services we provide to our clients.

Transformative Sales Growth Strategy

In second half of Fiscal 2022, ShiftPixy activated an agile business development plan for rapid organic growth starting in the first quarter of Fiscal 2023, focused on building scalable long-term revenue creation with a goal to become the market leader in U.S. contingent labor through increasingly diverse service offerings. By helping Fortune 1000 companies rethink human capital, ShiftPixy’s novel technology and proprietary sourcing tools are designed to disrupt not only traditional thinking about staffing, but also provide a cure to toxic employee turnover and thus provide labor cost certainty.

This new and compelling go-to-market strategy is prepared to leverage the recently expanded staffing platform on the ShiftPixy Human Resources Information System (“HRIS”) that offers clients an industry-leading digital and mobile technology to handle the duties and demands of human capital management at significant scale. An enhanced value proposition will offer clients automation, acceleration, liberation, and some indemnification, which we believe will drive growth and deliver value to stakeholders while also increasing our market share. Successful execution of this sales growth plan will leave ShiftPixy strategically positioned for secular growth in the $123 billion temporary and contract employment staffing market in the U.S.

The Company’s transformative sales growth strategy will capitalize on several economic developments in attractive vertical markets including retail, skilled trades, logistics, manufacturing, healthcare, and hospitality. A sustained surge in e-commerce is driving the need for supply chain expansions that require additional warehouses and the labor necessary to expedite delivery and returns. Likewise, a re-focus on domestic manufacturing capacity expansion for critical technology and an acute labor supply gap is leading to a surge in demand for ShiftPixy’s contingent and flexible skilled labor pool. Additional tailwinds supporting our growth strategy include positive demographic trends as the labor market reprioritizes flexibility, control, and access to job opportunities anywhere and anytime.

ShiftPixy’s business development plan offers immediate solutions to critical workflow challenges for human capital acquisition, talent management, labor force retention, worker supply chain disruptions, and runaway hiring costs. ShiftPixy’s continuous improvement of its client and candidate experience elevates engagement and satisfaction for neglected contingent and temporary workers. The completion of the Company’s current sales growth strategy is expected to create one of the largest employers in the U.S. in 2023 and build the fastest growing flexible labor force to meet the demands of a fast-changing human capital market while ushering significant enterprise value creation and recurring revenue growth for our shareholders.

35

Table of Contents

ShiftPixy Labs

On July 29, 2020, we announced the launch of ShiftPixy Labs, which includes the development of ghost kitchens in conjunction with our wholly-owned subsidiary, ShiftPixy Ghost Kitchens, Inc. Through this initiative, we intend to bring various food delivery concepts to market that will combine with our HRIS platform to create an easily replicated, comprehensive food preparation and delivery solution. The initial phase of this initiative is being implemented in our dedicated kitchen facility located in close proximity to our Miami headquarters, which we are already showcasing through the distribution of video programming on social media produced and distributed by our wholly-owned subsidiary, ShiftPixy Productions, Inc. If successful, we intend to replicate this initiative in similarly constructed facilities throughout the United States and in selected international locations. We also intend to provide similar services via mobile kitchen concepts, all of which will be heavily reliant on our HRIS platform and which we believe will capitalize on trends observed during the COVID-19 pandemic toward providing customers with a higher quality prepared food delivery product that is more responsive to their needs.

The idea of ShiftPixy Labs, originated from discussions with our restaurant clients, combined with our observations of industry trends that appear to have accelerated during the pandemic. Beginning in Calendar 2020, we recognized a significant uptick in the use of mobile applications to order take-out food either for individual pickup or third-party delivery, which grew even more dramatically as the pandemic took hold. Not surprisingly, the establishment of fulfillment kitchens for third party delivery also spread rapidly during this time period, initially among national fast food franchise chains but then among smaller QSRs.

We believe that the restaurant industry is in the midst of a food fulfillment paradigm shift that will ultimately result in the widespread use of “ghost kitchens” in a shared environment. Similar to shared office work locations, a shared kitchen can provide significant cost efficiencies and savings compared to the cost of operating multiple retail restaurant locations. Coupled with ShiftPixy’s technology stack, which includes order delivery and dispatch, we believe that the ghost kitchen solutions that emerge from ShiftPixy Labs will provide a robust and effective delivery order fulfillment option for our clients.

We have also observed the growing impact of social media platforms over the past five years, a trend which has accelerated through the pandemic. As this trend has gained steam, many social media influencers have successfully capitalized on their popularity by establishing new business concepts in a variety of industries, including within the QSR space. Some of these QSRs are identified as “virtual” restaurants with delivery-only service fulfilled by centralized ghost kitchens. We intend to capitalize on this trend by creating an extensive social media presence for ShiftPixy Labs.

Many restaurant entrepreneurs have also become successful during the pandemic by moving outside through the use of mobile food trucks, which can be used as a launching point for restaurants and ultimately expanded to traditional indoor dining locations. We have researched this phenomenon and, coupled with our experience in the restaurant industry, believe a significant business opportunity exists to assist with the fulfillment of new restaurant ideas and rapidly expand those ideas across a broad geographic footprint utilizing centralized ghost kitchen fulfillment centers. Again, we believe that ShiftPixy Labs will provide solutions that will facilitate the rapid growth of these new businesses, through a combination of centralized ghost kitchens and an available pool of human capital resources provided through our HRIS platform, as well as though other business assistance provided by our management team.

During Fiscal 2021, we established an industrial facility in Miami that we expect to be fully completed and operational during Fiscal 2023. During Fiscal 2022 we equipped this facility with ten standardized kitchen stations in both single and double kitchen configurations built within standard cargo container shells and order a food truck for mobile operation. We expect this facility, upon completion, to function as a state-of-the-art ghost kitchen space that will be used to incubate restaurant ideas through collaboration and partnerships with local innovative chefs, resulting in sound businesses that provide recurring revenue to us in a variety of ways, both through direct sales and utilization of the ShiftPixy Ecosystem, our HRIS platform, and other human capital services that we provide. To the extent that this business model is successful and can be replicated in other locations, it has the potential to contribute significant revenue to us in the future.

We may also take equity stakes in various branded restaurants that we develop and operate with our partners through ShiftPixy Labs. Such ownership interests will be held to the extent that it is consistent with our continued existence as an operating company, and to the extent that we believe such ownership interests have the potential to create significant value for our shareholders.

Workers’ Compensation Insurance

During Fiscal 2021, the Company made a strategic decision to change its approach to securing workers’ compensation coverage for our clients. This was primarily due to rapidly increasing loss development factors stemming in part from the COVID-19

36

Table of Contents

pandemic. The combination of increased claims from WSEs, the inability of WSEs to obtain employment quickly and return to work after injury claims, and increasing loss development factor rates from our insurance and reinsurance carriers resulted in significantly larger potential loss exposures, claims payments, and additional expense accruals. Starting on January 1, 2021, we began to migrate our clients to our new direct cost program, which we believe significantly limits our claims exposure. Effective March 1, 2021, all of our clients had migrated to the direct cost program.

For the first quarter of Fiscal 2023, included in our cost of sales was approximately $200,000 of expense for claims estimate increases relating to loss reserves activity for the legacy Sunz and Everest programs. These claims estimates are the subject of ongoing litigation with our former workers’ compensation insurance providers, Sunz and Everest, as described in Note 11, Contingencies, above. We are currently re-evaluating our workers’ compensation liability estimates under our legacy Sunz and Everest programs.

Vensure Asset Sale Note Receivable Reconciliation

On January 3, 2020, we entered into an asset purchase agreement with Shiftable HR Acquisition, LLC, a wholly-owned subsidiary of Vensure, pursuant to which we assigned client contracts representing approximately 88% of our quarterly revenue as of November 30, 2019, including 100% of our existing PEO business effective as of December 31, 2019, and we transferred $1.6 million of working capital assets, including cash balances and certain operating assets associated with the assigned client contracts included in the agreement. Gross proceeds from the Asset Sale were $19.2 million, of which $9.7 million was received at closing and $9.5 million was embodied in the Note Receivable described above, to be paid out in equal monthly payments for the next four years after certain transaction conditions were met. During our third quarter of Fiscal 2022, we recorded an asset impairment to adjust the net realizable value of the long-term note receivable to zero. As of November 30, 2022, Vensure and the Company were engaged in litigation regarding the amount owed to the Company pursuant to the Note Receivable, as described in Note 11, Contingencies, above.

•Served approximately 68 clients and an average of 2,000 WSEs for the period ending November 30, 2022 vs. 72 clients and an average of 3,000 WSEs for the same period ending November 30, 2021.

•We processed approximately $11.7 million of gross payroll billings from continuing operations for the three months ended November 30, 2022, representing a decrease of 24.1% when compared to the three months ended November 30, 2021, due to the loss of a few clients during such period  Our continuing operations mix remained consistent for the three months ended November 30, 2022, when compared to the three months ended November 30, 2021, primarily consisting of QSR or quick service restaurant , WSEs. (For further information, please refer to the “Non-GAAP Financial Measures” section below.)

•Our revenues decreased 3.7 million for the three months ended November 30, 2022, compared to the same period in Fiscal 2021, primarily due to the loss of a few clients during the second half of Fiscal 2022, for which the full impact is reflected during the first quarterly reporting of Fiscal 2023.

•Our gross margin was 8% for the three months ended November 30, 2022, and 8% over the same period in Fiscal 2022, remaining consistent for both periods.

•Our operating loss for the three months ended November 30, 2022 decreased approximately $3.4 million compared to the same period in Fiscal 2022. The decrease is due to cost reductions of $1.6 million in payroll expenses and the reduction or approximately $1.1 million in software development costs net by the increase of approximately $-0.2 million in interest and penalties on outstanding payroll liabilities due.

Our financial performance for the three months ended November 30, 2022, compared to the three months ended November 30, 2021, included the significant items set forth herein below.

Results of Operations

The following table summarizes the condensed consolidated results of our operations for the three months ended November 30, 2022, and November 30, 2021.

37

Table of Contents

	For the Three Months Ended
	November 30, 2022		November 30, 2021
Revenues (See Note 2)	$	5,266,000	$	8,940,000
Cost of revenue	4,845,000		8,245,000
Gross profit  (loss)	421,000		695,000
Operating expenses:
Salaries, wages, and payroll taxes	2,259,000		3,890,000
Stock-based compensation – general and administrative
Commissions	10,000		27,000
Professional fees	1,195,000		1,737,000
Software development	60,000		1,161,000
Depreciation and amortization	149,000		123,000
General and administrative	1,971,000		2,340,000
Total operating expenses	5,644,000		9,278,000
Operating Loss	(5,223,000)		(8,583,000)
Other (expense) income:
Interest expense	—		(1,000)
Other income	—		—
Expensed SPAC offering costs	—		—
Total other expense	—		4,000
Loss from continuing operations	(5,223,000)		(8,579,000)
Total (loss) income from discontinued operations, net of tax	(200,000)		(134,000)
Net loss	$	(5,423,000)	$	(8,713,000)
Preferred stock preferential dividend	(127,145,000)		—
Net loss attributable to common shareholders	$	(132,568,000)	$	(8,713,000)
Net loss attributable to common shareholders
Continuing operations	$	(13.88)	$	(24.00)
Discontinued operations	(0.02)		—
Net  loss per common share – Basic and diluted	$	(13.90)	$	(24.00)
Weighted average common shares outstanding – Basic and diluted	9,533,982		359,452

We report our revenues as gross billings, net of related direct labor costs for our EAS/HCM clients and revenues without reduction of labor costs for staffing services clients.

The following table presents certain information related to our gross profit components (unaudited):

38

Table of Contents

	For the Three Months Ended
	November 30, 2022			November 30, 2021
Gross Billings for HCM	$	11.7		$	14.1
Gross Wages for HCM	$	(10.3)		$	(12.3)
Total Net Revenue for HCM	$	1.4		1.8
Revenue for Staffing	3.8			7.1
Total Net Revenues (in millions)	$	5.3		$	8.9
Increase (Decrease), Quarter over Quarter (in millions)	(3.6)			6.4
Percentage Increase (Decrease), Quarter over Quarter	(40.4)		%	257.2		%
Cost of Revenues (in millions)	$	4.8		$	8.2
Increase (Decrease), Quarter over Quarter (in millions)	(3.4)			6.30
Percentage Increase (Decrease), Quarter over Quarter	(41.5)		%	314.3		%
Gross Profit (in millions)	$	0.4		$	0.7
Increase (Decrease), Quarter over Quarter (in millions)	(0.3)			0.2
Percentage Increase (Decrease), Quarter over Quarter	(42.9)		%	35.5		%
Gross Profit Percentage of Revenues	7.5		%	7.8		%

Three months ended November 30, 2022

Net revenue for our HCM services excludes the payroll cost component of gross billings. With respect to staffing services, employer payroll taxes, employee benefit programs, and workers’ compensation insurance, we believe that we are the primary obligor, and we have latitude in establishing price, selecting suppliers, and determining the service specifications. As such, the billings for those components are included as revenue. Revenues are recognized ratably over the payroll period as WSEs perform their services at the client worksite. See also non-GAAP Financial Measures below.

Net Revenue decreased approximately $3.7 million from $8.9 million for the three months ended November 30, 2022 to $5.3 million for the three months ended November 30, 2022. The decrease is based on the loss of a few clients during the third quarterly reporting of Fiscal 2022, for which the full impact of the loss of this revenue is being reflected in the first quarterly reporting of Fiscal 2023. Average WSEs decreased by approximately $1,000 for the thee months ending November 30, 2022.

Net revenue per WSE remained consistent for the three month period ended November 30, 2022 compared to the same period in FY 2022.

For the three months ended November 30, 2022, our revenue associated with administrative fees decreased by $0.2 million,, our tax revenues by $0.5 million , workers’ compensation revenue by $0.1 million, for our administrative fees by $0.3 million and our tax revenue by $0.7 million , compared to the same period in Fiscal 2022. The decrease is consistent with our billed wages decrease for the three months ended November 30, 2022, compared the same period in Fiscal 2022.

Cost of Revenues includes our costs associated with employer taxes, workers’ compensation insurance premiums, and the gross wages paid for our staffing clients. Cost of revenues for the three months ended November 30, 2022, decreased by $3.4 million to $4.8 millions from $8.2 million for the same period in Fiscal 2022. The decrease is correlated with the decrease in our net revenues, respectively.

The contributors to the decrease in cost of revenue for the three months ended November 30, 2022, are; a decrease of $3.4 million in gross wages related primarily to $2.8 million decrease in gross wages and $0.5 million decrease in taxes, respectively.

39

Table of Contents

Gross Profit for the three months ended November 30, 2022 decreased by $0.3 million, compared to the same period in Fiscal 2022.

The decrease for the three months ended November 30, 2022 was primarily driven by the decrease in net revenues, consistent with our $5.1 million decrease in gross billings compared to the same period in Fiscal 2022.

Operating expenses for the three months ended November 30, 2022, decreased by $3.6 million to $5.6 million from $9.3 million, compared to the same period in Fiscal 2022. The decrease in operating expenses for the three months ended November 30, 2022 is primarily due to a decrease of approximately $1.6 million in payroll related expenses due to the reduction in employees, $0.5 million in professional fees, due the ceased operations of our sponsored SPACs and,$1.1 million in software development cost, based on the elimination of external IT consultants as our application was substantially completed during the third quarterly reporting of Fiscal 2022, net by the increased costs of $0.2 million in interest and penalties on payroll liabilities due.

The following table presents certain information related to our operating expenses (unaudited):

	For the Three months Ended
	November 30, 2022		November 30, 2021
Operating expenses:
Salaries, wages, and payroll taxes	$	2,259,000	$	3,890,000
Commissions	10,000		27,000
Professional fees	1,195,000		1,737,000
Software development	60,000		1,161,000
Depreciation and amortization	149,000		123,000
General and administrative	1,971,000		2,340,000
Total operating expenses	$	5,644,000	$	9,278,000

Operating expenses decreased for the three months ended November 30, 2022 by $3.6 million, compared with the same period of Fiscal 2022. The components of operating expenses changed as follows:

Salaries, wages and payroll taxes decreased for the three months ended November 30, 2022, by approximately $1.6 million, in comparison to the same period in Fiscal 2022. The decrease is primarily attributable to the significant reduction in employees in the executive, operations, and software development ranks of our business. Our corporate employee count decreased from 85 employees as of November 30, 2021, to 65 employees as of November 30, 2022.

Professional fees consists of legal fees, accounting and public company costs, board fees, and consulting fees. Professional fees for the three months ended November 30, 2022, decreased by $0.5 million , compared to the same period in Fiscal 2022. The decrease is primarily attributable to our termination of our sponsorship of IHC's IBC-related activities, net by our legal fees related to our current active litigation.

Software development consists of costs associated with research and development outsourced to third parties. Software development costs decreased by $1.1 million ,, for the three months ended November 30, 2022, respectively, compared to the same period in Fiscal 2022. The decrease is based on our substantial completion of our application during our third quarterly reporting of Fiscal 2022 and the strategic decision to hold our IT development outsourcing, focusing on the use of internal resources for the maintenance and non significant application improvements.

General and administrative expenses consist of office rent and related overhead, software licenses, insurance, penalties, business taxes, stock based compensation, travel and entertainment, and other general business expenses. General and administrative expenses for the three months ended November 30, 2022, decrease by $0.4 million, compared with the same period of Fiscal 2022. The decrease was a result of reduced directors and insurance premiums due to less coverage from failed SPAC. Non-cash cash stock compensation expense decrease by $0.2 million and an increase of $0.2 million in general and administrative expenses primarily due to interest and penalties related to the outstanding payroll taxes liabilities.

Net loss for the three months ended November 30, 2022, decreased by $3.3 million, from $8.71 million to $5.4 million, compared to the same period in Fiscal 2022. The decrease is mainly driven by the reduction in the costs described above, net by

40

Table of Contents

the interest and dividends received from the Trust account and the gain from the renegotiation our D&O insurance for our sponsored SPAC.

Loss from continuing operations for the three months ended November 30, 2022, decreased by $3.3 million and was describe above.

Loss from discontinued operations. For the three months ended November 30, 2022, we recorded a loss primarily based upon our reassessment of our workers' compensation claims reserve associated with the clients that we transferred to Vensure in connection with the Vensure Asset Sale. For the three months ended November 30, 2022, the loss from discontinued operations increased $0.1 million, compared with the same period in Fiscal 2022. The negligible increase for the three months ended November 30, 2022, is due to the reassessment of claims liability for the period.

Liquidity and Capital Resources

As of November 30, 2022, the Company had cash of $0.9 million and a working capital deficit of $32.0 million. During this same period, the Company used approximately $3.7 million of cash from its continuing operations and incurred recurring losses, resulting in an accumulated deficit of $198.1 million as of November 30, 2022.

On September 20, 2022, the Company entered into a securities purchase agreement (the “Purchase Agreement”) with a large institutional investor (the “Purchaser”) pursuant to which the Company sold to the Purchaser an aggregate of 416,667 shares (the “Shares”) of its common stock together with warrants (the “Warrants”) to purchase up to 833,334 shares of common stock (collectively, the “Offering”). Each share of common stock and two accompanying Warrants were sold together at a combined offering price of $12.00. The Warrants are exercisable for a period of seven years commencing upon issuance at an exercise price of $12.00, subject to adjustment. The Offering closed on September 23, 2022. The net gross proceeds to the Company from the Offering was $4,738,000 .

The recurring losses, negative working capital and cash used in the Company’s operations are indicators of substantial doubt as to the Company’s ability to continue as a going concern for at least one year from issuance of these financial statements. For a discussion of our liquidity and capital resources, see Note 6, Going Concern, to the Notes to the Condensed Consolidated Financial Statements in “Part I, Item 1. Condensed Consolidated Financial Statements” of this Quarterly Report.

Non-GAAP Financial Measures

In addition to financial measures presented in accordance with GAAP, we monitor other non-GAAP measures that we use to manage our business, make planning decisions and allocate resources. These key financial measures provide an additional view of our operational performance over the long term and provide useful information that we use to maintain and grow our business. The presentation of these non-GAAP financial measures is used to enhance the understanding of certain aspects of our financial performance. They are not meant to be considered in isolation, superior to, or as a substitute for the directly comparable financial measures presented in accordance with GAAP.

Our revenue recognition policy differs for our EAS/HCM and staffing clients and is dependent on the respective CSA applicable to each client. During Fiscal 2021, some of our EAS clients migrated to a staffing CSA. Our policy is to report revenues as gross billings, net of related direct labor costs, for our EAS/HCM clients, and revenues without reduction for labor costs for staffing clients. For the three months ended November 30, 2022, our gross billings from HCM and staffing services totaled approximately $11.7 million and $3.8 million (total of $15.5 million), representing 75% and 25% of our gross revenue, respectively. For the three months ended November 30, 2021, our gross billings from HCM and staffing services totaled approximately $14.1 million and $7.1 million (total of $21.2 million), representing 66.4% and 33.6% of our gross revenue, respectively.

Gross billings represent billings to our business clients and include WSE gross wages, employer payroll taxes, and workers’ compensation premiums as well as administrative fees for our value-added services and other charges for workforce management support. Gross billings for our HCM services are a non-GAAP measurement that we believe to represent a key revenue-based operating metric, along with number of WSEs and number of clients. Active WSEs are defined as employees on our HRIS platform that have provided services for at least one of our clients for any reported period. Our primary profitability metrics are gross profit, and our primary driver of gross profit is administrative fees.

41

Table of Contents

Reconciliation of GAAP to Non-GAAP Measure

Gross Billings to Net Revenues

The following table presents a reconciliation of our Gross Billings (unaudited) to Revenues:

	For the Three Months Ended November 30,
($ in millions)	2022		2021
Gross Billings	$	11.7	$	14.1
Less: Adjustment to Gross Billings	$	10.3	$	12.3
Revenues	$	1.4	$	1.8

The following table provides the key revenue and our primary gross profit driver used by management (unaudited).

	For the Three Months Ended November 30,
	2022			2021
Administrative Fees (in millions)	$	0.3		$	0.5
Increase (Decrease), Quarter over Quarter (in millions)	$	(0.2)		$	0.1
Percentage Increase (Decrease), Quarter over Quarter	(38.2)		%	34.9		%
Administrative Fee % of Gross Billings	1.8		%	2.2		%
Average WSEs (unaudited)	2,000			3,000
Average Gross Billings per Average WSE	$	8,049		$	7,066

Average Active WSEs totaled approximately 2,000, decreased for the three months ended November 30, 2022 as compared to 3,000 WSE for three months ending November 30, 2021 was due the decrease in rnet revenue. was due to loss of client.s

Material Commitments

We do not have any contractual obligations for ongoing capital expenditures at this time. We do, however, purchase equipment and software necessary to conduct our operations on an as needed basis.

Contingencies

For a discussion of contingencies, see Note 11, Contingencies, to the Notes to the Condensed Consolidated Financial Statements in “Part I, Item 1. Condensed Consolidated Financial Statements ” of this Quarterly Report.

New and Recently Adopted Accounting Standards

For a listing of our new and recently adopted accounting standards, see Note 2, Summary of Significant Accounting Policies, to the Notes to the Condensed Consolidated Financial Statements in “Part I, Item 1. Condensed Consolidated Financial Statements ” of this Quarterly Report.

Item 3. Quantitative and Qualitative Disclosures about Market Risk

Not required for smaller reporting companies.

42

Table of Contents

Item 4. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures

We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in the Company’s reports filed under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to management, including the Chief Executive Officer (Principal Executive Officer) and the Chief Financial Officer (Principal Financial Officer), to allow for timely decisions regarding required disclosure. In designing and evaluating disclosure controls and procedures, the Company recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

The Company carried out an evaluation under the supervision and with the participation of management, including the Principal Executive Officer and Principal Financial Officer, of the effectiveness of its disclosure controls and procedures at November 30, 2022, as defined in Rule 13a -15(e) and Rule 15d -15(e) under the Exchange Act. This evaluation was carried out under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, at November 30, 2022, our disclosure controls and procedures were not effective due to material weaknesses in internal control over financial reporting related to the lack of adequate accounting and finance personnel, as further discussed in our Annual Report on Form 10-K for the year ended August 31, 2022, and which the Company determined continued to exist as of November 30, 2022.

Changes in Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting that occurred during the three months ended November 30, 2022, that have materially affected, or are reasonably likely to materially affect, the Company’s internal controls over financial reporting.

43

Table of Contents

PART II — OTHER INFORMATION

Item 1. Legal Proceedings.

The Company is a party to various legal actions, in addition to the contingencies noted in item 11, above, arising in the ordinary course of business which, in the opinion of the Company, are not material in that management either expects that the Company will be successful on the merits of the pending cases or that any liabilities resulting from such cases will be immaterial or substantially covered by insurance. While it is impossible to estimate with certainty the ultimate legal and financial liability with respect to these actions, management believes that the aggregate amount of such liabilities will not be material to the results of operations, financial position or cash flows of the Company. There have been no material developments to the litigation disclosed in our Annual Report on Form 10-K and 10-K/A for Fiscal 2022, filed with the SEC on December 12, 2021 and on December 13, 2022, respectively, except as noted in Note 11 Contingencies to the accompanying financial statements.

Item 1A. Risk Factors.

You should carefully review and consider the information regarding certain factors that could materially affect our business, financial condition or future results set forth under Part I, Item 1A, Risk Factors, contained in our Annual Report on Form 10-K for Fiscal 2022, as filed with the SEC on December 12, 2021, which is expressly incorporated herein by reference.There have been no material changes from the risk factors disclosed in our Annual Report on Form 10-K and 10-K/A for Fiscal 2022, filed with the SEC on December 12, 2022 and December 13, 2022, respectively.

In addition, we note that our President, CEO and director, Scott W. Absher, currently owns approximately 89% of the issued and outstanding shares of the Company’s Common Stock; accordingly, he may be deemed to control the Company as a result of his voting power and otherwise has significant influence over the voting matters of the shareholders of the Company’s Common Stock, including but not limited to the power to elect directors and approve other actions that require stockholder approval. Notwithstanding Mr. Absher's share ownership percentage, no action has been taken to seek the Controlled Company Exemption available under Nasdaq Listing Rule 5615(c)(2). If the Company were to seek Controlled Company status, (a) we would not be required to comply with certain governance requirements set forth in the listing standards, including requiring a majority of independent Directors on our Board, the determination of the compensation of our executive officers solely by independent Directors, and the recommendation of nominees for Director solely by independent Directors, and (b) as a result, the Company’s stockholders would not have certain of the same protections as a stockholder of other publicly-traded companies, and the market price of the Company’s common stock could be adversely affected. The concentration of ownership with respect to the Company’s common stock also results in there being a limited trading volume, which may make it more difficult for stockholders to sell their shares and increase the price volatility of the Company’s common stock.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

None.

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Mine Safety Disclosures.

Not applicable.

Item 5. Other Information.

Not applicable.

Item 6. Exhibits.

(a) Exhibits.

Exhibit No.	Document Description
31.1	CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

44

Table of Contents

31.2	CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002.
32.1*	CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002.
32.2*	CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002.
Exhibit 101	Interactive data files formatted in XBRL (eXtensible Business Reporting Language): (i) the Condensed Consolidated Balance Sheets, (ii) the Condensed Consolidated Statements of Operations, (iii) the Condensed Consolidated Statements of Cash Flows, and (iv) the Notes to the Condensed Consolidated Financial Statements.
101.INS	XBRL Instance Document
101.SCH	XBRL Taxonomy Extension Schema Document
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document
101.LAB	XBRL Taxonomy Extension Label Linkbase Document
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document

* This exhibit shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 of the Securities Exchange Act of 1934, whether made before or after the date hereof and irrespective of any general incorporation language in any filings.

45

Table of Contents

SIGNATURES

Pursuant to the the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	ShiftPixy, Inc., a Wyoming corporation
DATE: January 23, 2023	By:	/s/ Scott W. Absher
		Scott W. Absher
		Principal Executive Officer
DATE: January 23, 2023	By:	/s/ Douglas Beck
		Douglas Beck
		Principal Financial Officer

46

EX-31.1

EXHIBIT 31.1

CERTIFICATION

I, Scott W. Absher, certify that:

1.	I have reviewed this report on Form 10-Q of ShiftPixy, Inc.;
2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.	The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)	designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)	designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)	evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)	disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's first quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent function):

a)	all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b)	any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

	ShiftPixy, Inc.
DATE: January 23, 2023	By:	/s/ Scott W. Absher
		Scott W. Absher
		Chief Executive Officer

EX-31.2

EXHIBIT 31.2

CERTIFICATION

I, Douglas Beck, CPA, certify that:

1.	I have reviewed this report on Form 10-Q of ShiftPixy, Inc.;
2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.	The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)	designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)	designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)	evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)	disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's first fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent function):

a)	all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b)	any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

DATE: January 23, 2023	By:	/s/ Douglas Beck
		Douglas Beck, CPA
		Chief Financial Officer

EX-32.1

EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to 18 U.S.C. § 1350, as adopted pursuant to Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned hereby certifies that the Quarterly Report on Form 10-Q for the period ended November 30,2022, of ShiftPixy, Inc. (the "Company") fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 and that the information contained in such Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

	ShiftPixy, Inc.
DATE: January 23, 2023	By:	/s/ Scott W. Absher
		Scott W. Absher
		Chief Executive Officer

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to ShiftPixy, Inc., and will be retained by ShiftPixy, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

EX-32.2

EXHIBIT 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to 18 U.S.C. § 1350, as adopted pursuant to Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned hereby certifies that the Quarterly Report on Form 10-Q for the period ended November 30, 2022, of ShiftPixy, Inc. (the "Company") fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 and that the information contained in such Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

DATE: January 23, 2023	By:	/s/ Douglas Beck
		Douglas Beck, CPA
		Chief Financial Officer

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to ShiftPixy, Inc. and will be retained by ShiftPixy, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

XML

Cover - shares	3 Months Ended
	Nov. 30, 2022	Jan. 19, 2023
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Nov. 30, 2022
Document Transition Report	false
Entity File Number	001-37954
Entity Registrant Name	SHIFTPIXY, INC.
Entity Incorporation, State or Country Code	WY
Entity Tax Identification Number	47-4211438
Entity Address, Address Line One	13450 W Sunrise Blvd
Entity Address, Address Line Two	Suite 650
Entity Address, City or Town	Sunrise
Entity Address, State or Province	FL
Entity Address, Postal Zip Code	33323
City Area Code	888
Local Phone Number	798-9100
Title of 12(b) Security	Common Stock, par value $0.0001 per share
Trading Symbol	PIXY
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Emerging Growth Company	true
Entity Small Business	true
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		9,671,196
Entity Central Index Key	0001675634
Amendment Flag	false
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2023
Current Fiscal Year End Date	--08-31

XML

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Nov. 30, 2022	Aug. 31, 2022
Current assets
Cash	$ 864	$ 618
Accounts receivable	238	279
Unbilled accounts receivable	2,706	2,105
Prepaid expenses	480	696
Other current assets	288	187
Cash and marketable securities held in Trust Account (See Notes 2 and 4)	117,770	116,969
Total current assets	122,346	120,854
Fixed assets, net	3,020	2,769
Right-of -use operating lease	3,965	4,076
Deposits and other assets	920	919
Total assets	130,251	128,618
Current liabilities
Accounts payable and other accrued liabilities	15,827	17,122
Payroll related liabilities	18,766	16,055
Accrued workers’ compensation costs	575	567
Current liabilities of discontinued operations	1,438	1,362
Class A common shares of SPAC mandatory redeemable 11,500,000 shares as of November 30, 2022 and August 31, 2022 (See Notes 2 and 4)	117,770	116,969
Total current liabilities	154,376	152,075
Non-current liabilities
Operating lease liability, non-current	3,453	3,541
Accrued workers’ compensation costs	1,196	1,227
Non-current liabilities of discontinued operations	3,394	3,269
Total liabilities	162,419	160,112
Commitments and contingencies
Stockholders’ deficit
Preferred stock, 50,000,000 authorized shares; $0.0001 par value: 0 and 8,600,000 shares issued and outstanding as of November 30, 2022 and August 31, 2022.	0	1
Common stock, 750,000,000 authorized shares; $0.0001 par value; 9,671,196 and 513,349 shares issued as of November 30, 2022 and August 31, 2022.	1	0
Additional paid-in capital	156,485	151,736
Accumulated deficit	(198,148)	(192,725)
Total ShiftPixy, Inc. Stockholders' deficit	(41,662)	(40,988)
Non-controlling interest in consolidated subsidiary (See Note 5)	9,494	9,494
Total stockholders' deficit	(32,168)	(31,494)
Total liabilities and stockholders' deficit	$ 130,251	$ 128,618

XML

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Nov. 30, 2022	Aug. 31, 2022
LIABILITIES AND STOCKHOLDERS' DEFICIT
Class A common shares of SPAC mandatory redeemable (in shares)	11,500,000	11,500,000
Stockholders’ deficit
Preferred stock, shares authorized (in shares)	50,000,000	50,000,000
Preferred stock, par or stated value per share (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares issued (in shares)	0	8,600,000
Preferred stock, shares outstanding (in shares)	0	8,600,000
Common stock, shares authorized (in shares)	750,000,000	750,000,000
Common stock, par or stated value per share (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares issued (in shares)	9,671,196	513,349

XML

Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended
	Nov. 30, 2022	Nov. 30, 2021
Income Statement [Abstract]
Revenues (See Note 2)	$ 5,266	$ 8,940
Cost of revenue	4,845	8,245
Gross profit	421	695
Operating expenses:
Salaries, wages, and payroll taxes	2,259	3,890
Commissions	10	27
Professional fees	1,195	1,737
Software development	60	1,161
Depreciation and amortization	149	123
General and administrative	1,971	2,340
Total operating expenses	5,644	9,278
Operating Loss	(5,223)	(8,583)
Other (expense) income:
Interest expense	0	(1)
Other income	0	5
Total other expense	0	4
Loss from continuing operations	(5,223)	(8,579)
Loss from discontinued operations, net of tax	(200)	(134)
Net loss	(5,423)	(8,713)
Preferred stock preferential dividend	(127,145)	0
Net loss attributable to ShiftPixy, Inc. shareholders	$ (132,568)	$ (8,713)
Net loss  per share, Basic and diluted
Continuing operations, basic (in dollars per share)	$ (13.88)	$ (24.00)
Continuing operations, diluted (in dollars per share)	(13.88)	(24.00)
Discontinued operations, basic (in dollars per share)	(0.02)	0
Discontinued operations, diluted (in dollars per share)	(0.02)	0
Net loss per common share, basic (in dollars per share)	(13.90)	(24.00)
Net loss per common share, diluted (in dollars per share)	$ (13.90)	$ (24.00)
Weighted average common shares outstanding, basic (in shares)	9,533,982	359,452
Weighted average common shares outstanding, diluted (in shares)	9,533,982	359,452

XML

Condensed Consolidated Statements of Stockholders' Deficit - USD ($) $ in Thousands	Total	Warrants	Private Placement	Parent	Parent Warrants	Parent Private Placement	Preferred Stock Issued	Common Stock Issued	Common Stock Issued Warrants	Common Stock Issued Private Placement	Additional Paid-In Capital	Additional Paid-In Capital Warrants	Additional Paid-In Capital Private Placement	Accumulated Deficit	Noncontrolling interest
Beginning balance (in shares) at Aug. 31, 2021							0
Beginning balance at Aug. 31, 2021	$ 40,920			$ (6,552)			$ 0	$ 0			$ 142,786			$ (149,338)	$ 47,472
Beginning balance (in shares) at Aug. 31, 2021								258,631
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued for convertible securities (in shares)									28,500
Common stock issued for convertible securities		$ 4,183			$ 4,183							$ 4,183
Stock-based compensation expense	408			408							408
Remeasurement of IHC temporary equity	(13,270)			(13,270)							(13,270)
Net loss	(8,713)			(8,713)										(8,713)
Ending balance (in shares) at Nov. 30, 2021							0
Ending balance (in shares) at Nov. 30, 2021								287,131
Ending balance at Nov. 30, 2021	$ 30,389			(17,083)			$ 0	$ 0			140,968			(158,051)	47,472
Beginning balance (in shares) at Aug. 31, 2022	8,600,000						8,600,000
Beginning balance at Aug. 31, 2022	$ (31,494)			(40,988)			$ 1	$ 0			151,736			(192,725)	9,494
Beginning balance (in shares) at Aug. 31, 2022	513,349							513,349
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Fair Market value increase of preferred stock prior to reverse stock split	$ 127,145			127,145							127,145
Preferential dividend of preferred stock	(127,145)			(127,145)							(127,145)
Common stock issued for convertible securities (in shares)							(8,600,000)	8,600,000	124,204
Common stock issued for convertible securities	0	$ 1		0	$ 1		$ (1)	$ 1				$ 1
Common stock issued, net of offering costs (in shares)										416,667
Common stock issued, net of offering costs			$ 4,387			$ 4,387							$ 4,387
Stock-based compensation expense	255			255							255
Additional Shares issued due to reverse stock split (in shares)								16,976
Net loss	$ (5,423)			(5,423)										(5,423)
Ending balance (in shares) at Nov. 30, 2022	0						0
Ending balance (in shares) at Nov. 30, 2022	9,671,196							9,671,196
Ending balance at Nov. 30, 2022	$ (32,168)			$ (41,662)			$ 0	$ 1			$ 156,485			$ (198,148)	$ 9,494

XML

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Nov. 30, 2022	Nov. 30, 2021
OPERATING ACTIVITIES
Net loss	$ (5,423)	$ (8,713)
Loss from discontinued operations	(200)	(134)
Net loss from continuing operations	(5,223)	(8,579)
Adjustments to reconcile net loss from continuing operations to net cash used in continuing operating activities:
Depreciation and amortization	149	123
Stock-based compensation	255	408
Warrant modification expense	106	0
Amortization of operating lease	23	0
Changes in operating assets and liabilities:
Accounts receivable	41	98
Unbilled accounts receivable	(601)	41
Prepaid expenses and other current assets	115	(366)
Deposits – workers’ compensation	0	200
Deposits and other assets	(1)	(73)
Accounts payable and other accrued liabilities	(1,295)	1,116
Payroll related liabilities	2,711	743
Accrued workers’ compensation costs	(23)	(384)
Total Adjustments	1,480	1,906
Net cash used in continuing operating activities	(3,743)	(6,673)
Net cash provided by (used in) discontinued operating activities	1	(1)
Net cash used in operating activities	(3,742)	(6,674)
INVESTING ACTIVITIES
Investment of IHC IPO proceeds into Trust Account	0	(116,725)
Purchase of fixed assets	(400)	(349)
Net cash used in investing activities	(400)	(117,074)
FINANCING ACTIVITIES
Deferred offering costs	0	(3,502)
Proceeds from initial public offering of IHC	0	116,725
Proceeds from prefunded warrant exercises	1	0
Proceeds from private placement, net of offering costs	0	4,183
Proceeds from private placement prefunded warrants, net of offering costs	4,387	6,861
Net cash provided by financing activities	4,388	124,267
Net increase in cash	246	519
Cash - Beginning of Period	618	1,199
Cash -End of Period	864	1,718
Supplemental Disclosure of Cash Flows Information:
Cash paid for interest	0	1
Cash paid for income taxes	0	0
Non-cash Investing and Financing Activities:
Deferred Offering costs SPACs	0	9,464
Increase in Marketable securities in trust account and Class A mandatory redeemable common shares	801	13,270
Transfer of preferred shares to common shares	$ 1

XML

Nature of Operations

3 Months Ended

Nov. 30, 2022

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Nature of Operations

Nature of Operations

ShiftPixy, Inc. (the "Company") was incorporated on June 3, 2015, in the State of Wyoming. The Company is a specialized Human Capital service provider that provides solutions for large, contingent, part-time workforce demands, primarily in the restaurant and hospitality service trades. The Company’s historic focus has been on the quick service restaurant industry in Southern California, but the Company has expanded into other geographic areas and industries that employ temporary or part-time labor sources, notably including the healthcare industry.

The Company functions as an employment administrative services (“EAS”) provider primarily through its wholly-owned subsidiary, ReThink Human Capital Management, Inc. (“HCM”), as well as a staffing provider through another of its wholly-owned subsidiaries, ShiftPixy Staffing, Inc. (“Staffing”). These subsidiaries provide a variety of services to our clients (as a co-employer through HCM and a direct employer through Staffing), including the following: administrative services, payroll processing, human resources consulting, and workers’ compensation administration and coverage (as permitted and/or required by state law). The Company has built a human resources information systems (“HRIS”) platform to assist in customer acquisition that simplifies the onboarding of new clients into the Company’s closed proprietary operating and processing information system (the “ShiftPixy Ecosystem”). We expect this HRIS platform to facilitate additional value-added services in future reporting periods.

In January 2020, the Company sold the assets of Shift Human Capital Management Inc. (“SHCM”), a wholly-owned subsidiary of the Company, pursuant to which the Company assigned the majority of the Company’s billable clients at the time of the sale to a third party for cash. The continuing impact of this transaction on the Company’s financial statements is described below in Note 3, Discontinued Operations.

Effective August 31, 2022, the Company filed articles of amendment to the Company’s articles of incorporation to effect a one-for-one hundred (1:100) reverse split of the Company’s issued and outstanding shares of Common Stock. The reverse split became effective on Nasdaq September 1, 2022. All share related numbers in this Report on Form 10-Q give effect to this reverse split.

XML

Summary of Significant Accounting Policies

3 Months Ended

Nov. 30, 2022

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

Summary of Significant Accounting Policies

Basis of Presentation

The accompanying condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and the rules of the Securities and Exchange Commission (“SEC”) applicable to interim reports of companies filing as a small reporting company. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for fair presentation have been included. The results of condensed operations for the three months ended November 30, 2022 are not necessarily indicative of the results that may be expected for the full year ending August 31, 2023.

For further information, refer to the consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K and 10-K/A for the fiscal year ended August 31, 2022 (“Fiscal 2022”), filed with the SEC on December 13, 2022 and December 14, 2022, respectively.

Principles of Consolidation

The condensed consolidated financial statements include the accounts of ShiftPixy, Inc., and its wholly-owned subsidiaries. The condensed consolidated financial statements also include the accounts of (a) Industrial Human Capital, Inc. ("IHC"), which is a special purpose acquisition company, or "SPAC", for which we serve as the financial sponsor (as described below), and which is deemed to be controlled by us as a result of the Company's 15% equity ownership stake, the overlap of three of our executive officers as executive officers of IHC, and significant influence that we currently exercise over the funding and acquisition of

new operations for an initial business combination ("IBC"). (See Note 2, Variable Interest Entity). All intercompany balances have been eliminated in consolidation.

Use of Estimates

The preparation of financial statements in conformity with GAAP requires the Company to make estimates and assumptions that affect certain reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include:

•Assumption as a going concern; management assumes that the Company will continue as a going concern , which contemplates continuity of operations, realization of assets and liquidation of all liabilities in the normal course of business;

•Liability for legal contingencies;

•Useful lives of property and equipment;

•Deferred income taxes and related valuation allowance;

•Valuation of illiquid non-controlling interest in SPAC shares transferred; and

•Projected development of workers’ compensation claims.

These significant accounting estimates or assumptions bear the risk of change due to the fact that there are uncertainties attached to these estimates or assumptions are difficult to measure of value.

Management regularly reviews the key factors and assumptions to develop the estimates utilizing currently available information, changes in facts and circumstances, historical experience, and reasonable assumptions. After such valuation, if deemed appropriate, those estimates are adjusted accordingly.

Revenue and Direct Cost Recognition

For the year ended August 31, 2021 ("Fiscal 2021"), we adopted Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (Topic 606), using the modified retrospective approach. Under this method, the guidance is applied only to the most current period presented in the financial statements. ASU No. 2014-09 outlines a single comprehensive revenue recognition model for revenue arising from contracts with customers and superseded most of the previous revenue recognition guidance, including industry-specific guidance. Under ASU No. 2014-09, an entity recognizes revenue for the transfer of promised goods or services to customers in an amount that reflects the consideration for which the entity expects to be entitled in exchange for those goods or services. The Company's revenue recognition policies remained substantially unchanged as a result of the adoption of ASU No. 2014-09 and the Company did not have any significant changes in the Company's business processes or systems.

The Company’s revenues are primarily disaggregated into fees for providing staffing solutions and EAS/HCM services. The Company enters into contracts with its clients for Staffing or EAS based on a stated rate and price in the contract. Contracts generally have a term of 12 months, however are cancellable at any time by either party with 30 days’ written notice. The performance obligations in the agreements are generally combined into one performance obligation, as they are considered a series of distinct services, and are satisfied over time because the client simultaneously receives and consumes the benefits provided as the Company performs the services. Payments for the Company’s services are typically made in advance of, or at the time that the services are provided. The Company does not have significant financing components or significant payment terms for its customers and consequently has no material credit losses. The Company uses the output method based on a stated rate and price over the payroll processed to recognize revenue, as the value to the client of the goods or services transferred to date appropriately depicts the Company's performance towards complete satisfaction of the performance obligation.

Staffing Solutions

The Company records gross billings as revenues for its staffing solutions clients. The Company is primarily responsible for fulfilling the staffing solutions services and has discretion in establishing price. The Company includes the payroll costs in

revenues with a corresponding increase to cost of revenues for payroll costs associated with these services. As a result, we are the principal in this arrangement for revenue recognition purposes.

EAS Solutions

EAS solutions revenue is primarily derived from the Company’s gross billings, which are based on (i) the payroll cost of the Company’s worksite employees (“WSEs”) and (ii) a mark-up computed as a percentage of payroll costs for payroll taxes and workers’ compensation premiums.

Gross billings are invoiced to each EAS client concurrently with each periodic payroll of the Company’s WSEs, which coincides with the services provided and which is typically a fixed percentage of the payroll processed. Revenues, which exclude the payroll cost component of gross billings and therefore consist solely of markup, are recognized ratably over the payroll period as WSEs perform their services at the client worksite. Although the Company assumes responsibility for processing and remitting payroll and payroll related obligations, it does not assume employment-related responsibilities such as determining the amount of the payroll and related payroll obligations. As a result, the Company records revenue on a “net” basis in this arrangement for revenue recognition purposes. Revenues that have been recognized but not invoiced for EAS clients are included in unbilled accounts receivable on the Company’s consolidated balance sheets and were $2,706,000 and $2,105,000, as of November 30, 2022 and August 31, 2022, respectively.

Consistent with the Company’s revenue recognition policy for EAS clients, direct costs do not include the payroll cost of its WSEs. The cost of revenue associated with the Company’s revenue generating activities is primarily comprised of all other costs related to its WSEs, such as the employer portion of payroll-related taxes, employee benefit plan premiums and workers’ compensation insurance costs.

The fees collected from the worksite employers for benefits (i.e. zero-margin benefits pass-through), workers’ compensation and state unemployment taxes are presented in revenues and the associated costs of benefits, workers’ compensation and state unemployment taxes are included in operating expenses for EAS clients, as the Company does retain risk and acts as a principal with respect to this aspect of the arrangement. With respect to these fees, the Company is primarily responsible for fulfilling the service and has discretion in establishing price.

Disaggregation of Revenue

The Company’s primary revenue streams include HCM and staffing services. The Company’s disaggregated revenues for the three months ended November 30, 2022 and November 30, 2021, respectively, were as follows:

	For the Three Months Ended
Revenue (in millions):	November 30, 2022		November 30, 2021
	(Unaudited)
HCM1	$	1.5	$	1.8
Staffing	3.8		7.1
	$	5.3	$	8.9

1 HCM revenue is presented net, $11.7 million gross billings less WSE payroll costs of $10.3 million for the three months ended November 30, 2022 and $14.1 million gross billings less WSE payroll costs of $12.3 million for the three months ended November 30, 2021.

During Fiscal 2021 the Company announced the launch of ShiftPixy Labs. ShiftPixy Labs generated no revenue for any periods presented in these financial statements.

For the three months ended November 30, 2022 and November 30, 2021, respectively, the following geographical regions represented more than 10% of total revenues:

	For the Three Months Ended
Region:	November 30, 2022		November 30, 2021
	(Unaudited)
California	48.8	%	53.7	%
Washington	12.2	%	13.3	%
New Mexico	10.2	%	6.73

Incremental Cost of Obtaining a Contract

Pursuant to the “practical expedients” provided under ASU No 2014-09, the Company expenses sales commissions when incurred because the terms of its contracts are cancellable by either party upon 30 days' notice. These costs are recorded in commissions in the Company’s condensed consolidated statements of operations.

Segment Reporting

Prior to August 31, 2021, the Company operated as one reportable segment under ASC 280, Segment Reporting. The chief operating decision maker regularly reviews the financial information of the Company at a consolidated level in deciding how to allocate resources and in assessing performance. During Fiscal 2021, the Company entered into new business lines and geographic areas that, to date, are not material. However, with the migration to Staffing during the fiscal quarter ending May 31, 2021, the Company is beginning to manage the business on a segmented basis and therefore intends to report such information once systems and processes are updated accordingly. Reporting and monitoring activities on a segment basis will allow the chief operating decision maker to evaluate operating performance more effectively.

Cash and Cash Equivalents

The Company considers all highly liquid investments with an original maturity of three months or less when purchased as cash equivalents. The Company had no cash equivalent as of November 30, 2022 and August 31, 2022.

Marketable Securities Held in Trust Account

As of November 30, 2022 and August 31, 2022, substantially all of the assets held in the Trust Account were invested in U.S. Treasury securities with maturities of 180 days or less. These funds are restricted for use and may only be used for purposes of completing an initial business combination ("IBC") or redemption of the public common shares of IHC. In December 2022, the Company distributed $117,574,000 to the shareholder's of IHC.

Concentration of Credit Risk

The Company maintains cash with a commercial bank, which is insured by the Federal Deposit Insurance Corporation (“FDIC”). At various times, the Company has deposits in this financial institution in excess of the amount insured by the FDIC. The Company has not experienced any losses related to these balances and believes its credit risk to be minimal. As of November 30, 2022 and August 31, 2022, there was $463,000 and $615,000, respectively, of cash on deposit in excess of the amounts insured by the FDIC.

For the three months ended November 30, 2022, three individual clients represented more than 10% of revenues. However, seven clients represented 88% of total accounts receivable as of November 30, 2022. For the three months ended November 30, 2021, no individual client represented more than 10% of revenues and three clients represented 98% of total accounts receivable.

Fixed Assets

Fixed assets are recorded at cost, less accumulated depreciation and amortization. Expenditures for major additions and improvements are capitalized and minor replacements, maintenance, and repairs are charged to expense as incurred. When fixed assets are retired or otherwise disposed of, the cost and accumulated depreciation are removed from the accounts and any resulting gain or loss is included in the results of operations for the respective period. Leasehold improvements are amortized over the shorter of the useful life or the initial lease term.

Fixed assets are recorded at cost and are depreciated over the estimated useful lives of the related assets using the straight-line method. The estimated useful lives of property and equipment for purposes of computing depreciation are as follows:

Equipment:	5 years
Furniture & Fixtures:	5 - 7 years
Leasehold improvements	Shorter of useful life or the remaining lease term, typically 5 years

Depreciation and amortization expense is included on the condensed consolidated statements of operations.

Computer Software Development

Software development costs relate primarily to software coding, systems interfaces and testing of the Company’s proprietary employer information systems and are accounted for in accordance with ASC 350-40, Internal Use Software.

Internal software development costs are capitalized from the time the internal use software is considered probable of completion until the software is ready for use. Business analysis, system evaluation and software maintenance costs are expensed as incurred. The capitalized computer software development costs are reported under the section fixed assets, net in the consolidated balance sheets and are amortized using the straight-line method over the estimated useful life of the software, generally three to five years from when the asset is placed in service.

The Company determined that there were no material capitalized internal software development costs for the three months ended November 30, 2022. All capitalized software recorded was purchased from third party vendors. Capitalized software development costs are amortized using the straight-line method over the estimated useful life of the software, generally three to five years from when the asset is placed in service.

The Company incurred research and development costs of $0.7 million for the three months ended November 30, 2022. During the three months ended November 30, 2021 the Company incurred research and development costs of approximately $2.2 million. All costs were related to internally developed or externally contracted software and related technology for the Company’s HRIS platform and related mobile application. In addition, no software costs were capitalized for the three months ended November 30, 2022 and November 30, 2021, respectively.

Lease Recognition

In February 2016, the FASB established Topic 842, Leases, by issuing ASU No. 2016-02 (“ASC 842”), which required lessees to recognize leases on-balance sheet and disclose key information about leasing arrangements. Topic 842 was subsequently amended by ASU No. 2018-01, Land Easement Practical Expedient for Transition to Topic 842; ASU No. 2018-10, Codification Improvements to Topic 842, Leases; and ASU No. 2018-11, Targeted Improvements. The standard established a right-of-use model (“ROU”) that required a lessee to recognize an ROU asset and lease liability on the balance sheet for all leases with a term longer than 12 months. Leases are classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the condensed consolidated statement of operations.

The Company adopted the standard on December 1, 2021 with an effective date of September 1, 2021. A modified retrospective transition approach was required, applying the standard to all leases existing at the date of initial application. An entity could choose to use either (1) the effective date of the standard or (2) the beginning of the earliest comparative period presented in the financial statements as its date of initial application. If an entity chose the second option, the transition requirements for existing leases also applied to leases entered into between the date of initial application and the effective date. The entity had to also recast its comparative period financial statements and provide the disclosures required by the standard for the comparative periods. The Company elected to use the effective date as its date of initial application. Consequently, financial information was not updated and the disclosures required under the standard were not provided for dates and periods prior to September 1, 2021.

The standard provided a number of optional practical expedients as part of transition accounting. The Company elected the “package of practical expedients”, which allowed the Company to avoid reassessing its prior conclusions about lease identification, lease classification and initial direct costs under the standard. The Company did not elect the use-of-hindsight or the practical expedient pertaining to land easements as these were not applicable to the Company.

The standard had a material effect on the Company’s Condensed Consolidated Financial Statements. The most significant changes related to (1) the recognition of ROU assets and lease liabilities on the Condensed Consolidated Balance Sheet for the Company's office equipment and real estate operating leases and (2) providing significant disclosures about the Company’s leasing activities.

Upon adoption, the Company recognized additional operating liabilities of approximately $7.7 million, with corresponding ROU operating lease asset, based on the present value of the remaining minimum rental payments under current leasing standards for existing operating leases. The Company determined if an arrangement was a lease at inception. The Company used an incremental borrowing rate based on the information available at the commencement date of the lease to determine the present value of lease payments. In determining the ROU asset and lease liability at lease inception, the lease terms could include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term.

The standard also provided practical expedients for an entity’s ongoing accounting for leases. The Company elected the short-term lease recognition exemption for office equipment leases. For those current and prospective leases that qualify as short-term, the Company will not recognize ROU assets or lease liabilities. The Company also elected the practical expedient to not separate lease and non-lease components for all of its real estate leases.

Impairment and Disposal of Long-Lived Assets

The Company periodically evaluates its long-lived assets for impairment in accordance with ASC 360-10, Property, Plant, and Equipment. ASC 360-10 requires that an impairment loss be recognized for assets to be disposed of or held-for-use when the carrying amount of an asset is deemed not to be recoverable. If events or circumstances were to indicate that any of the Company's long-lived assets might be impaired, the Company would assess recoverability based on the estimated undiscounted future cash flows to be generated from the applicable asset. In addition, the Company may record an impairment loss to the extent that the carrying value of the asset exceeds the fair value of the asset. Fair value is generally determined using an estimate of discounted future net cash flows from operating activities or upon disposal of the asset. There were no indicators noted of impairments during the three months ended November 30, 2022 and November 30, 2021, respectively.

Workers’ Compensation

Everest Program

Until July 2018, a portion of the Company’s workers’ compensation risk was covered by a retrospective rated policy through Everest National Insurance Company, which calculates the final policy premium based on the Company’s loss experience during the term of the policy and the stipulated formula set forth in the policy. The Company funds the policy premium based on standard premium rates on a monthly basis and based on the gross payroll applicable to workers covered by the policy. During the policy term and thereafter, periodic adjustments may involve either a return of previously paid premiums or a payment of additional premiums by the Company or a combination of both. If the Company’s losses under that policy exceed the expected losses under that policy, then the Company could receive a demand for additional premium payments. The Company is currently engaged in litigation regarding such a demand for additional premium payments, which we believe to be without merit, as discussed at Note 11, Contingencies, Everest Litigation, below.

Sunz Program

From July 2018 through February 28, 2021, the Company’s workers’ compensation program for its WSEs was provided primarily through an arrangement with United Wisconsin Insurance Company and administered by Sunz Insurance Solutions, LLC (“Sunz”). Under this program, the Company has financial responsibility for the first $0.5 million of claims per occurrence. The Company provides and maintains a loss fund that is earmarked to pay claims and claims related expenses. The workers’ compensation insurance carrier establishes monthly funding requirements comprised of premium costs and funds to be set aside for payment of future claims (“claim loss funds”). The level of claim loss funds is primarily based upon anticipated WSE payroll levels and expected workers’ compensation loss rates, as determined by the insurance carrier. Monies funded into the program for incurred claims expected to be paid within one year are recorded as Deposit - workers’ compensation, a short-term asset, while the remainder of claim funds are included in Deposit- workers’ compensation, a long-term asset in our condensed consolidated balance sheets. The Company is currently engaged in litigation regarding demands by Sunz for additional claims loss funds, which we believe to be without merit, as discussed at Note 11, Contingencies, Sunz Litigation, below.

Under the Everest and Sunz programs, the Company utilized a third party to estimate its loss development rate, which was based primarily upon the nature of WSEs’ job responsibilities, the location of WSEs, the historical frequency and severity of workers’ compensation claims, and an estimate of future cost trends. Each reporting period, changes in the assumptions resulting from changes in actual claims experience and other trends are incorporated into its workers’ compensation claims cost estimates.

There were no workers compensation deposits related to theses programs as of November 30, 2022 and as of August 31, 2022, respectively..

Current Program

Effective March 1, 2021, the Company migrated its clients to a guaranteed cost program. Under this program, the Company’s financial responsibility is limited to the cost of the workers’ compensation premium. The Company funds the workers’ compensation premium based on standard premium rates on a monthly basis and based on the gross payroll applicable to workers covered by the policy. Any final adjustments to the premiums are based on the final audited exposure multiplied by the applicable rates, classifications, experience modifications and any other associated rating criteria.

The Company’s estimate of incurred claim costs expected to be paid within one year is included in short-term liabilities, while its estimate of incurred claim costs expected to be paid beyond one year is included in long-term liabilities on its consolidated balance sheets. As of November 30, 2022 and August 31, 2022, the Company had short term accrued workers’ compensation costs of $0.6 million and $0.6 million, and long term accrued workers’ compensation costs of $1.2 million and $1.2 million, respectively.

The Company retained workers’ compensation asset reserves and workers’ compensation related liabilities for former WSEs of clients transferred to Shiftable HR Acquisition, LLC, a wholly-owned subsidiary of Vensure Employer Services, Inc. (“Vensure”), in connection with the Vensure Asset Sale described in Note 3, Discontinued Operations, below. As of November 30, 2022, the retained workers’ compensation assets and liabilities are presented as a discontinued operation net asset or liability. As of November 30, 2022, the Company had $1.4 million in short term liabilities, and $3.4 million in long term liabilities. The Company had no related worker's compensation assets as of November 30, 2022 and August 31, 2022, respectively.

Because the Company bears the financial responsibility for claims up to the level noted above, such claims, which are the primary component of its workers’ compensation costs, are recorded in the period incurred. Workers’ compensation insurance includes ongoing health care and indemnity coverage whereby claims are paid over numerous years following the date of injury. Accordingly, the accrual of related incurred costs in each reporting period includes estimates, which take into account the ongoing development of claims and therefore requires a significant level of judgment. In estimating ultimate loss rates, the Company utilizes historical loss experience, exposure data, and actuarial judgment, together with a range of inputs that are primarily based upon the WSE’s job responsibilities, their location, the historical frequency and severity of workers’ compensation claims, and an estimate of future cost trends. For each reporting period, changes in the actuarial assumptions resulting from changes in actual claims experience and other trends are incorporated into the Company’s workers’ compensation claims cost estimates. The estimated incurred claims are based upon: (i) the level of claims processed during each quarter; (ii) estimated completion rates based upon recent claim development patterns under the plan; and (iii) the number of participants in the plan.

The Company has had very limited and immaterial COVID-19 related claims between March 2020 through the date of this Quarterly Report, although there is a possibility of additional workers’ compensation claims being made by furloughed WSEs as a result of the employment downturn caused by the pandemic. On May 4, 2020, the State of California indicated that workers who become ill with COVID-19 would have a potential claim against workers’ compensation insurance for their illnesses. There is a possibility that additional workers’ compensation claims could be made by employees required to work by their employers during the COVID-19 pandemic, which could have a material impact on the Company's workers’ compensation liability estimates. While the Company has not seen significant additional expenses as a result of any such potential claims to date, which would include claims for reporting periods after November 30, 2022, we continue to monitor closely all workers’ compensation claims made as the COVID-19 pandemic continues.

Fair Value of Financial Instruments

ASC 820, Fair Value Measurement, requires entities to disclose the fair value of financial instruments, both assets and liabilities recognized and not recognized on the balance sheet, for which it is practical to estimate fair value. ASC 820 defines fair value of a financial instrument as the amount at which the instrument could be exchanged in a current transaction between willing parties. As of November 30, 2022 and August 31, 2022, the carrying value of certain financial instruments (cash, accounts receivable and payable) approximated fair value due to the short-term nature of the instruments. Notes Receivable is valued at the Company's estimate of expected collections value as described below and in Note 3, Discontinued Operations.

The Company measures fair value under a framework that utilizes a hierarchy prioritizing the inputs to relevant valuation techniques. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or

liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of inputs used in measuring fair value are:

•Level 1: Inputs to the valuation methodology are unadjusted quoted prices for identical assets or liabilities in active markets that the Company has the ability to access.

•Level 2: Inputs to the valuation methodology include:

◦Quoted prices for similar assets or liabilities in active markets;

◦Quoted prices for identical or similar assets or liabilities in inactive markets;

◦Inputs other than quoted prices that are observable for the asset or liability;

◦Inputs that are derived principally from or corroborated by observable market data by correlation or other means; and

◦If the asset or liability has a specified (contractual) term, the Level 2 input must be observable for substantially the full term of the asset or liability.

•Level 3: Inputs to the valuation methodology are unobservable and significant to the fair value measurement.

Funds held in trust represent U.S. treasury bills that were purchased with funds raised through the initial public offering of IHC. The funds raised from SPACs are held in trust accounts that are restricted for use and may only be used for purposes of completing an IBC or redemption of the public shares of common stock of the SPACs as set forth in their respective trust agreements. The funds held in trust are included within Level 1 of the fair value hierarchy and included in Cash and marketable securities held in Trust Account in the accompanying condensed consolidated balance sheets.

The Company did not have other Level 1 or Level 2 assets or liabilities at November 30, 2022 or August 31, 2022. We recorded the fair value of the SPAC founder shares that the Company transferred to the underwriters using non-recurring Level 3 assumptions, including quoted asset prices for SPAC shares and warrants and estimates of the likelihood of the IPOs and IBCs of the Company's sponsored SPACs being consummated. See also Note 4, Special Purpose Acquisition company (SPAC) and Note 5, Deferred Offering Costs – SPACS, below.

When the Company changes its valuation inputs for measuring financial assets and liabilities at fair value, either due to changes in current market conditions or other factors, it could be required to transfer those assets or liabilities to another level in the hierarchy based on the new inputs used. The Company recognizes these transfers at the end of the reporting period that the transfers occur. The development and determination of the unobservable inputs for Level 3 fair value measurements and the fair value calculations are the responsibility of the Company’s chief financial officer and are approved by the chief executive officer. There were no transfers out of Level 3 for the three months ended November 30, 2022.

Advertising Costs

The Company expenses all advertising as incurred. The Company incurred advertising costs totaling $0.7 million for the three months ended November 30, 2022 and $1.4 million for the three months ended November 30, 2021, respectively.

Income Taxes

The Company accounts for income taxes pursuant to ASC 740, Income Taxes. Under ASC 740, deferred income taxes are provided on a liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss carryforwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. The provision for income taxes represents the tax expense for the period, if any, and the change during the period in deferred tax assets and liabilities. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. ASC 740 also provides criteria for the recognition, measurement, presentation and disclosure of uncertain tax positions. Under ASC 740, the impact of an uncertain tax position on the income tax return may

only be recognized at the largest amount that is more-likely-than-not to be sustained upon audit by the relevant taxing authority. A full valuation allowance was recorded as of November 20, 2022 and August 31, 2022, respectively,

Earnings (Loss) Per Share

The Company utilizes ASC 260, Earnings per Share. Basic Net Income (Net Loss) per common share is computed by dividing Net Income (Net Loss) attributable to common shareholders by the weighted-average number of shares of common stock outstanding during the reporting period. Common stock outstanding for purposes of Net Income (Net Loss) per share calculations include unexercised Preferred Options and unexercised prefunded warrants, as described in Note 7, Stockholders' Equity, below. Diluted earnings (loss) per share is computed similar to basic earnings (loss) per share except that the denominator is increased to include additional common stock equivalents available upon exercise of stock options and warrants using the treasury stock method. Dilutive common stock equivalents include the dilutive effect of in-the-money stock equivalents, which are calculated based on the average share price for each period using the treasury stock method, excluding any common stock equivalents if their effect would be anti-dilutive. In periods in which a net loss has been incurred, all potentially dilutive common stock shares are considered anti-dilutive and thus are excluded from the calculation. Securities that are excluded from the calculation of weighted average dilutive common stock, because their inclusion would have been antidilutive, are:

For the Three Months Ended	November 30, 2022	November 30, 2021
	(Unaudited) )	(Unaudited)
Options (See Note 8)	10,603	4,023
Warrants (See Note 7)	1,252,748	174,918
Total potentially dilutive shares	1,263,351	178,941

For the table above, “Options” represent all options granted under the Company’s 2017 Stock Option/Stock Issuance Plan (the "Plan"), as described in Note 8, Stock Based Compensation, below.

Stock-Based Compensation

As of November 30, 2022, the Company had one stock-based compensation plan under which the Company may issue awards, as described in Note 8, Stock Based Compensation, below. The Company accounts for the Plan under the recognition and measurement principles of ASC 718, Compensation-Stock Compensation, which requires all stock-based payments to employees, including grants of employee stock options, to be recognized in the condensed consolidated statements of operations at their fair values.

The grant date fair value is determined using the Black-Scholes-Merton (“Black-Scholes”) pricing model. For all employee stock options, the Company recognizes expense on an accelerated basis over the employee’s requisite service period (generally the vesting period of the equity grant).

The Company’s option pricing model requires the input of highly subjective assumptions, including the expected stock price volatility and expected term. The expected volatility is based on the historical volatility of the Company’s common stock since the Company's initial public offering. Any changes in these highly subjective assumptions significantly impact stock-based compensation expense.

The Company elects to account for forfeitures as they occur. As such, compensation cost previously recognized for an unvested award that is forfeited because of the failure to satisfy a service condition is revised in the period of forfeiture.

The methods and assumptions used in the determination of the fair value of stock-based awards are consistent with those described in the Company's Annual Report on Form 10-K and 10-K/A for Fiscal 2022, filed with the SEC on December 3, 2021 and on February 28, 2022, respectively, which includes a detailed description of the Company's stock-based compensation awards, including information related to vesting terms, service and performance conditions, payout percentages, and process for estimating the fair value of stock options granted.

Financial Instruments-Credit Losses

In June 2016, the FASB issued ASU 2016-13, “Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” (“ASU 2016-13”). This standard requires an impairment model (known as the current expected credit loss (“CECL”) model) that is based on expected losses rather than incurred losses. Under the new guidance, each reporting entity should estimate an allowance for expected credit losses, which is intended to result in more timely

recognition of losses. This model replaces multiple existing impairment models in current U.S. GAAP, which generally requires a loss to be incurred before it is recognized. The new standard applies to trade receivables arising from revenue transactions such as contract assets and accounts receivable. Under ASC 606, revenue is recognized when, among other criteria, it is probable that an entity will collect the consideration it is entitled to when goods or services are transferred to a customer. When trade receivables are recorded, they become subject to the CECL model and estimates of expected credit losses on trade receivables over their contractual life will be required to be recorded at inception based on historical information, current conditions, and reasonable and supportable forecasts. This guidance is effective for smaller reporting companies for annual periods beginning after December 15, 2022, including the interim periods in the year. Early adoption is permitted. The Company will adopt the guidance when it becomes effective.

Recent Accounting Standards

As of November 30,2022, there were no new accounting standards that would need to be disclosed.

Variable Interest Entity

The Company has been involved in the formation of various entities considered to be Variable Interest Entities (“VIEs”). The Company evaluates the consolidation of these entities as required pursuant to ASC Topic 810 relating to the consolidation of VIEs. These VIEs are SPACs.

The Company’s determination of whether it is the primary beneficiary of a VIE is based in part on an assessment of whether or not the Company and its related parties are exposed to the majority of the risks and rewards of the entity. Typically, the Company is entitled to substantially all or a portion of the economics of these VIEs. The Company is the primary beneficiary of the VIE entities.

During the Fiscal 2022, the Company's sponsored SPAC, IHC, completed its IPO, selling 11,500,000 units (the "IHC Units") pursuant to a registration statement and prospectus, as described below. The IPO closed on October 22, 2021, raising gross proceeds of $115 million. These proceeds were deposited in a trust account established for the benefit of the IHC public shareholders and, along with an additional $1.7 million deposited in trust by the Company reserved for interest payments for future possible redemptions by IHC stockholders, are included in Cash and marketable securities held in Trust Account in the accompanying condensed consolidated balance sheet at November 30, 2022. These proceeds are invested only in U.S. treasury securities in accordance with the governing documents of IHC.

Each IHC Unit had an offering price of $10.00 and consisted of one share of IHC common stock and one redeemable warrant. Each warrant entitles the holder thereof to purchase one share of IHC common stock at a price of $11.50 per share. The IHC public stockholders have a right to redeem all or a portion of their shares of IHC common stock upon the completion of its IBC, subject to certain limitations. Under the terms of the registration statement and prospectus, IHC is required to consummate its IBC within 12 months of the completion of the IPO. If IHC is unable to meet this deadline, IHC could request an extension. If no extension is granted, then IHC will redeem 100% of the public shares of common stock outstanding for cash, subject to applicable law and certain conditions. In December 2022, the Company distributed $117,574,000 to the shareholders of IHC as described below and in Note 12, Subsequent Events.

In connection with the IPO, we purchased, through the Company's wholly-owned subsidiary, ShiftPixy Investments, Inc. ("Investments" or the "Sponsor"), 4,639,102 private placement warrants ("Placement Warrants") at a price of $1.00 per warrant, for an aggregate purchase price of $4,639,102, and we currently own 2,110,000 Founder Shares of IHC common stock, representing approximately 15% of the issued and outstanding common stock of IHC. Before the closing of the IPO, the Sponsor transferred 15,000 Founder Shares to IHC's independent directors, reducing its shareholdings from 2,125,000 to 2,110,000. Each Placement Warrant is identical to the warrants sold in the IPO, except as described in the IPO registration statement and prospectus. Following the completion of the IHC IPO, we determined that IHC is a Variable Interest Entity ("VIE") in which we have a variable interest because IHC does not have enough equity at risk to finance its activities without additional subordinated financial support. We have also determined that IHC's public stockholders do not have substantive rights, and their equity interest constitutes temporary equity, outside of permanent equity, in accordance with ASC 480-10-S99-3A. As such, we have concluded that we are currently the primary beneficiary of IHC as a VIE, as we have the right to receive benefits or the obligation to absorb losses of the entity, as well as the power to direct a majority of the activities that significantly impact IHC's economic performance. Since we are the primary beneficiary, IHC is consolidated into the Company condensed consolidated financial statements.

Shares Subject to Possible Redemption

The Company accounts for its common stock holdings in its sponsored SPACs (which are consolidated in the Company condensed consolidated financial statements) that are subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Shares of common stock subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable shares of common stock (including shares of common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, shares of common stock are classified as shareholders’ equity. Each sponsored SPAC's shares of common stock feature certain redemption rights that are considered to be outside of the SPAC's control and subject to occurrence of uncertain future events. Accordingly, as of November 30, 2022, shares of common stock subject to possible redemption are presented as temporary equity, outside of the shareholders’ equity section of the Company’s condensed consolidated balance sheets.

The Company recognizes changes in redemption value of these shares immediately as they occur and adjusts the carrying value of redeemable shares of common stock to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of the redeemable common stock are affected by charges against additional paid in capital and accumulated deficit. As of November 30, 2022, the carrying amount of the sponsored SPAC shares of IHC common stock subject to redemption was recorded at their redemption value of $117.8 million. The remeasurement of the redemption value of the redeemable shares of common stock is recorded in equity. The remeasurement in equity comprised of offering cost incurred in connection with the sale of public shares of the SPACs was $13 million, consisting of approximately $9.5 million of offering costs related to the Founder Shares transferred to the SPACs’ underwriter representative as described in Note 5, Deferred Offering Costs, and $3.5 million in other offering costs related to the IPO paid at closing in cash. The Company accounts for the warrants as equity-classified.

XML

Discontinued Operations

3 Months Ended

Nov. 30, 2022

Discontinued Operations and Disposal Groups [Abstract]

Discontinued Operations

Discontinued Operations

On January 3, 2020, the Company executed an asset purchase agreement assigning client contracts comprising approximately 88% of its quarterly revenue through the date of the transaction, including 100% of its existing professional employer organization (“PEO”) business effective as of December 31, 2019, and transferring $1.5 million of working capital assets, including cash balances and certain operating assets associated with the assigned client contracts included in the agreement, to a wholly owned subsidiary of Vensure (the “Vensure Asset Sale”). Gross proceeds from the Vensure Asset Sale were $19.2 million, of which $9.7 million was received at closing and $9.5 million was scheduled to be paid out in equal monthly payments over the four years following the closing of the transaction (the “Note Receivable”), subject to adjustments for working capital and customer retention (as measured by a gross wage guarantee included in the governing agreement), over the twelve month period following the Vensure Asset Sale.

For Fiscal 2020, the Company estimated the value of the Note Receivable at fair value as discussed in Note 2, Summary of Significant Accounting Policies, above. For the period ended November 30, 2022, the Company recorded the Note Receivable based on the Company's estimate of expected collections which, in turn, was based on additional information obtained through discussions with Vensure and evaluation of the Company's records. On March 12, 2021, the Company received correspondence from Vensure proposing approximately $10.7 million of working capital adjustments under the terms of the Vensure Asset Sale agreement which, if accepted, would have had the impact of eliminating any sums owed to the Company under the Note Receivable. As indicated in the reconciliation table below, the Company has recorded $2.6 million of working capital adjustments, subject to final review and acceptance, and has provided for an additional reserve of $2.9 million for potential claims. By letter dated April 6, 2021, the Company disputed Vensure’s proposed adjustments and maintains that the amount Vensure owes the Company pursuant to the Note Receivable is as much as $9.5 million. The Company assessed the collectibility of this note during the reporting of its Fiscal Year End of August 31, 2022, and determined that it was probable that all contractually required payments will not be collected and recorded a reserve on collectibility of approximately $4.0 million. The disputes between the Company and Vensure regarding working capital adjustments under the Vensure Asset Sale agreement are currently the subject of litigation pending in the Delaware Chancery Court, as discussed at at Note 11, Contingencies, Vensure Litigation, below.

The following reconciliation of the gross proceeds to the net proceeds from the Vensure Asset Sale is presented in the condensed consolidated balance sheets for the period ended November 30, 2022 and August 31, 2022.

	As of
	November 30, 2022 (Unaudited)		August 31, 2022
Gross proceeds	$	19,166,000	$	19,166,000
Cash received at closing – asset sale	(9,500,000)		(9,500,000)
Cash received at closing – working capital	(166,000)		(166,000)
Gross note receivable	$	9,500,000	$	9,500,000
Less:  Transaction reconciliation – estimated working capital adjustments	(2,604,000)		(2,604,000)
Adjusted Note Receivable	6,896,000		6,896,000
Reserve for estimated potential claims	(2,892,000)		(2,892,000)
Reserve for potential collectability concerns	$	(4,004,000)	$	(4,004,000)
Long-term note receivable, estimated net realizable value	$	—	$	—

As of November 30, 2022 and August 31, 2022, as discussed above the Notes Receivables asset has been impairment to adjust the net realizable value of the long-term note receivable to zero.

The Vensure Asset Sale generated a gain of $15.6 million for during the fiscal year end August 31, 2020. The Company expected a minimal tax impact from the Vensure Asset Sale as it utilized its net operating losses accumulated since inception to offset the gain resulting from discontinued operations tax provision with a corresponding offset to the valuation allowance.

The Vensure Asset Sale met the criteria of discontinued operations set forth in ASC 205 and as such the Company has reclassified its discontinued operations for all periods presented and has excluded the results of its discontinued operations from continuing operations for all periods presented.

The terms of the Vensure Asset Sale call for adjustments to the Note Receivable either for: (i) working capital adjustments or (ii) in the event that the gross wages of the business transferred is less than the required amount.

(i) Working capital adjustments: Through November 30, 2022, the Company has identified $2.6 million of likely working capital adjustments, including $0.1 million related to lower net assets transferred at closing, and $2.5 million of cash remitted to the Company’s bank accounts, net of cash remitted to Vensure’s bank accounts. Under the terms of the Vensure Asset Sale, a reconciliation of the working capital was to have been completed by April 15, 2020. Due to operational difficulties and quarantined staff caused by the outbreak of COVID-19, Vensure requested a postponement of the working capital reconciliation that was due in Fiscal 2020. Although Vensure provided the Company with its working capital reconciliation on March 12, 2021, it failed to provide adequate documentation to support its calculations. Accordingly, the working capital adjustment recorded as of November 30, 2022, represents the Company’s estimate of the reconciliation adjustment by using Vensure’s claims and the limited supporting information Vensure provided as a starting point, and then making adjustments for amounts in dispute based upon the Company's internal records and best estimates. There is no assurance that the working capital change identified as of November 30, 2022, represents the final working capital adjustment.

(ii) Gross billings adjustment: Under the terms of the Vensure Asset Sale, the proceeds of the transaction are reduced if the actual gross wages of customers transferred for Calendar 2020 are less than 90% of those customers’ Calendar 2019 gross wages. The Company has prepared an estimate of the Calendar 2020 gross wages based on a combination of factors including reports of actual transferred client billings in early Calendar 2020, actual gross wages of continuing customers of the Company, publicly available unemployment reports for the Southern California markets and the relevant COVID-19 impacts on employment levels, and other information. Based on the information available, the Company estimated that it would receive additional consideration below the required threshold and reduced the contingent consideration by $1.4 million. Vensure has not identified any such adjustments to date. Based on the information available, the Company reclassified the previously recorded gross wages claim to a general potential claims reserve during Fiscal 2021. No additional adjustment was made during the period ended November 30, 2022.

The carrying amounts of the classes of assets and liabilities from the Vensure Asset Sale included in discontinued operations are as follows:

	As of
	November 30, 2022		August 31, 2022
	(Unaudited)
Deposits – workers’ compensation	—		—
Total current assets	—		—
Deposits – workers’ compensation	—		—
Total assets	$	—	$	—
Accrued workers’ compensation cost	1,438,000		1,362,000
Total current liabilities	1,438,000		1,362,000
Accrued workers’ compensation cost	3,394,000		3,269,000
Total liabilities	4,832,000		4,631,000
Net liability	$	(4,832,000)	$	(4,631,000)

Reported results for the discontinued operations by period were as follows:

	For the Three Months Ended
	November 30, 2022		November 30, 2021
	(Unaudited)
Revenues	$	—	$	—
Cost of revenue	200,000		134,000
Gross profit (loss)	(200,000)		(134,000)
Total operating expenses	—		—
(Loss) income from discontinued operations	$	(200,000)	$	(134,000)

XML

Special Purpose Acquisition Company ("SPAC") Sponsorship

3 Months Ended

Nov. 30, 2022

Investments in and Advances to Affiliates [Abstract]

Special Purpose Acquisition Company ("SPAC") Sponsorship

Special Purpose Acquisition Company ("SPAC") Sponsorship

On April 29, 2021, we announced the Company's sponsorship, through our wholly-owned subsidiary, ShiftPixy Investments, Inc. ("Investments"), of four SPACs. Each SPAC was seeking to raise approximately $150 million in capital investment, through an IPO, to acquire companies in the light industrial, healthcare and technology segments of the staffing industry, as well as one or more insurance entities. On March 18, 2022, the IPO registration statements related to three of the SPACs we had sponsored, Vital Human Capital, Inc. ("Vital"), TechStackery, Inc. ("TechStackery"), and Firemark Global Capital, Inc. ("Firemark"), were withdrawn. With the withdrawal of these IPO registrations, the Company recorded approximately $38.0 million of deferred costs against Non-controlling interest.

The registration statement and prospectus covering the IPO of IHC was declared effective by the SEC on October 19, 2021, and IHC Units, consisting of one share of common stock and an accompanying warrant to purchase one share of IHC common stock, began trading on the New York Stock Exchange (“NYSE”) on October 20, 2021. The IHC IPO closed on October 22, 2021, raising gross proceeds for IHC of $115 million. In connection with the IHC IPO, we purchased, through the Company's

wholly-owned subsidiary, 4,639,000 placement warrants at a price of $1.00 per warrant, for an aggregate purchase price of$4,639,000.

Following the closing of the IPO, the sum of $116,725,000 was placed in a trust account (the “Trust Account”), and was invested in U.S. government securities within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the "ICA"), with a maturity of 185 days or less, or in any open-ended investment company that holds itself out as a money market fund investing solely in U.S. Treasuries and meeting certain conditions under Rule 2a-7 of the ICA, as determined by the Company, until the earlier of: (i) the completion of the IBC and (ii) the distribution of the funds in the Trust Account to the Company’s shareholders, as described below. The $116,725,000 consisted of the $115,000,000 of gross proceeds from the sale of the IHC Units in the IPO and $1,725,000 funded by the Company, as the corporate parent of the Sponsor, representing guaranteed interest for future redemptions and calculated as one year's interest at 1.5%. With the completion of the IPO, the Company recorded approximately $9.5 million of deferred costs in APIC, and $0.3 million of offering costs paid on behalf of IHC. During Fiscal 2022, IHC incurred approximately $3.5 million in offering costs. No other offering costs have been incurred during the period for the withdrawn SPACs. The Trust Account generated interest and dividend income for the three month ended November 30, 2022 and November 30, 2021 of approximately $0.9 million and $3,000, respectively. After completion of its IPO, IHC sought to acquire companies in the light industrial segment of the staffing industry.

Upon the completion of IHC's IPO, through the Company's wholly-owned subsidiary, we owned approximately 15% of its issued and outstanding stock. Furthermore, we anticipated that IHC would operate as a separately managed, publicly traded entity following the completion of its IBCs. The operations of IHC have been consolidated in the accompanying condensed financial statements for the reasons set forth above in Note 2, Summary of Significant Accounting Policies.

On October 14, 2022, the stockholders of IHC approved the proposed action to file an amended and restated certificate of incorporation to extend the date by which the Company has to consummate a Business Combination from October 22, 2022, to April 22, 2023, or a such earlier date as determined by the board of directors. The Company accordingly filed the Amendment with the Secretary of State of Delaware. In connection with the meeting, however, shareholders holding 11,251,347 Public Shares exercised their right to redeem their shares for a pro rata portion of the funds in the Trust Account. leaving 248,653 of the Company’s remaining Public Shares outstanding and the Trust Account substantially below the $5,000,001 minimum net tangible asset amount required by IHC's Amended and Restated Certificate of Incorporation to be available upon consummation of such Business Combination. IHC's efforts to secure the decisions of some shareholders to reverse their redemptions were unsuccessful, and IHC accordingly declined to fund the extension, cancelled the Amendment as filed with the Secretary of State of Delaware, and proceeded to cease operations, dissolve and unwind. The board of directors of IHC accordingly adopted resolutions to liquidate, dissolve and unwind the entity. Since IHC was dissolved on November 14, 2022, and since the Trust released all the redemption funds to shareholders on December 2, 2022, effectively liquidating the Trust, we will evaluate the impact including potential de-consolidation of its operations during the wind up period in Fiscal 2023. The Class A common shares subject to redemption is classified as a current liability.

XML

Deferred Offering Costs - SPACs

3 Months Ended

Nov. 30, 2022

Noncontrolling Interest [Abstract]

Deferred Offering Costs - SPACs

Deferred Offering Costs - SPACs

During the fiscal year ending August 31, 2021, the Company incurred professional fees related to the filing of registration statements for the IPOs of four SPACs. The Company also transferred certain Founder Shares of those SPACs to a third party which created a non-controlling interest in those entities. These Founder Shares of common stock were transferred to the SPACs’ underwriter representative (the “Representative”) at below fair market value, resulting in compensation and therefore deferred offering costs for the SPACs, and the creation of a non-controlling interest. The non-controlling interest is recorded on the condensed balance sheets and the statements of stockholders' deficit.

As of August 31, 2021, Deferred offering costs - SPACs totaled $48,261,000, consisting of $789,000 of legal and accounting fees related to the SPACs’ IPOs and $47,472,000 related to the non-controlling interest consolidated subsidiaries. As of November 30, 2022. there were no deferred offering costs.

The non-controlling interest – deferred offering costs represents the estimated value of the portion of the Company's Founder Shares in each of the following SPACs that we received as a result of the Company's sponsorship, and which we transferred to the Representative on April 22, 2021, at a price below the fair market value of the shares, as follows: (i) 2,000,000 shares of IHC common stock; (ii) 2,000,000 shares of TechStackery common stock; (iii) 2,000,000 shares of Vital common stock; and (iv) 4,000,000 shares of Firemark common stock. We estimate the total value of the 10,000,000 shares transferred, which represents deferred compensation to the Representative, to be $47,472,000, or $4.7472 per share. We arrived at this valuation by reference to similar SPAC IPO transactions, as set forth below:

1.Consistent with most SPAC IPOs, the market price of units (consisting of some combination of common stock and warrants) sold to the public in a SPAC IPO is $10 per unit.

2.We have valued the warrant portion of each Unit at $0.75 per share. Deducting this value from the Unit yields a value of $9.25 per share of common stock at the time of the IPO, which we have applied to the value of each of the Founder Shares that we issued to the Representative.

3.We have applied a further discount of 48.8%, which is a blended discount designed to reflect the following contingencies and uncertainties: (a) 20% probability that the SPAC IPOs are never consummated; (b) 20% probability that none of the Company's sponsored SPACs successfully complete their IBC; and (c) 21% additional discounts to account for future sponsor and Representative concessions, as well as the possibility of decrease in the value of the common stock of each SPAC.

One of the Company's sponsored SPACs, IHC, completed its IPO on October 22, 2021, resulting in the recognition of approximately $13 million of offering costs, including $9.8 million that had been deferred as of August 31, 2022. No offering costs were incurred for TechStackery, Vital, or Firemark as of November 30, 2022, as these company's registration statements were withdrawn.

As discussed in Note 4, Special Purpose Acquisition Company ("SPAC") Sponsorship, the registration statements on Form S-1 previously filed with the SEC relating to three of its Sponsored SPACs — Vital, TechStackery, and Firemark have been withdrawn. The abandonment of these SPAC IPOs resulted in our recognition of approximately $38.5 million of deferred offering costs against $38 million in non-controlling interest and $0.5 million in the other expenses in the condensed consolidated statements of operations.

XML

Going Concern

3 Months Ended

Nov. 30, 2022

Risks and Uncertainties [Abstract]

Going Concern

Going Concern

The accompanying unaudited condensed financial statements have been prepared in conformity with GAAP, which contemplate continuation of the Company as a going concern. As of November 30, 2022, the Company had cash of $0.9 million and a working capital deficit of $32.0 million. During this period, the Company used approximately $3.7 million of cash from its continuing operations and incurred recurring losses, resulting in an accumulated deficit of $198.1 million. As of November 30, 2022, the Company is delinquent with respect to remitting payroll tax payments to the IRS. The Company has been in communication with the IRS regarding amounts owing in relation to credits due. In addition, some clients have filed suits against the Company, demanding that the Company take action to seek additional ERTC tax credits for the subject periods. Until the matter is concluded and the taxes are paid, the IRS could, subject to its standard processes and the Company’s rights to respond, implement collection actions, including such actions as levying against Company bank accounts, to recover the amounts that it calculates to be due and owing.

Historically, the Company's principal source of financing has come through the sale of the Company's common stock, including in certain instances, warrants and issuance of convertible notes. In September 2022, we raised approximately $5.0 million ($4.4 million, net of costs) in connection with the underwriting of a private placement offering. See Note 7, stockholders' deficit.

The recurring losses, negative working capital and cash used in the Company’s operations are indicators of substantial doubt as to the Company’s ability to continue as a going concern for at least one year from issuance of these financial statements. The Company's plans and expectations for the next twelve months include raising additional capital to help fund expansion of our operations and strengthening of the Company's sales force strategy by focusing on staffing services as the Company's key driver to improve the Company's margin and the continued support and functionality improvement of the Company's information technology (“IT”) and HRIS platform. This expanded go-to-market strategy will focus on building a national account portfolio managed by a newly-formed regional team of senior sales executives singularly focused on sustained quarterly revenue growth and gross profit margin expansion. We expect to continue to invest in the Company's HRIS platform, ShiftPixy Labs, and other growth initiatives, all of which have required and will continue to require significant cash expenditures.

The Company also expects its ShiftPixy Labs growth initiative to generate cash flow once launched, by functioning as an incubator of food service and restaurant concepts through collaboration and partnerships with local innovative chefs. If successful, the Company believes that this initiative will produce businesses that provide recurring revenue through direct sales, as well as through utilization of the ShiftPixy Ecosystem, HRIS platform, and other human capital services that the Company provides. To the extent that this business model is successful and can be replicated in other locations, the Company believes that it has the potential to contribute significant revenue to ShiftPixy in the future. The Company may also take equity stakes in various branded restaurants that it develops and operates with its partners through ShiftPixy Labs. Such ownership interests will be held to the extent that it is consistent with the Company’s continued existence as an operating company, and to the extent that the Company believes such ownership interests have the potential to create value for its shareholders.

The Company expects to engage in additional sales of its securities during this fiscal year either through registered public offerings or private placements, the proceeds of which the Company intends to use to fund its operations and growth initiatives. The Company’s management believes that its current cash position, along with its anticipated revenue growth and proceeds

from future sales of its securities, when combined with prudent expense management, will alleviate substantial doubt about its ability to continue as a going concern and to fund its operations for at least one year from the date these financials are available (especially when considering the absence of any funded debt outstanding on its balance sheet). If these sources do not provide the capital necessary to fund the Company’s operations during the next twelve months, it may need to curtail certain aspects of its operations or expansion activities, consider the sale of additional assets, or consider other means of financing. The Company can give no assurance that it will be successful in implementing its business plan and obtaining financing on advantageous terms, or that any such additional financing will be available. If the Company is not successful on obtaining the necessary financing, we do not currently have the cash resources to meet our operating commitments for the next twelve months. These consolidated financial statements do not include any adjustments for this uncertainty.

XML

Stockholders' Deficit

3 Months Ended

Nov. 30, 2022

Equity [Abstract]

Stockholders' Deficit

Stockholders’ Deficit

Preferred Stock

In September 2016, the founding shareholders of the Company were granted options to acquire preferred stock of the Company (the “Preferred Options”). The number of Preferred Options granted was based upon the number of shares held at the time of the grant. These Preferred Options are nontransferable and forfeited upon the sale of the related founding shares of common stock held by the option holder. Upon the occurrence of certain specified events, such founding shareholders can exercise each Preferred Option to purchase one share of preferred stock of the Company at an exercise price of $0.0001 per share. The preferred stock underlying the Preferred Options does not include any rights to dividends or preference upon liquidation of the Company and is convertible into shares of the Company’s common stock on a one-for-one basis. Upon consummation of the Vensure Asset Sale in January 2020, a total of 24,634,560 Preferred Options became exercisable and exchangeable into an equal number of shares of the Company's common stock.

On June 4, 2020, Scott W. Absher, the Company’s Chief Executive Officer, exercised 12,500,000 Preferred Options to purchase 12,500,000 shares of the Company's preferred stock for an aggregate purchase price of $1,250. Immediately following the exercise of the Preferred Options, Mr. Absher elected to convert the 12,500,000 shares of preferred stock into 12,500,000 shares of common stock, which were subject to a 24-month lock-up period during which such shares could not be traded. Between July 20, 2020 and November 30, 2020, an additional 294,490 Preferred Options were exercised and converted into 294,490 shares of common stock, which were subject to a six-month lock up period at the time they were issued, during which such shares could not be traded on the open market. As of November 30, 2022, the restrictions on all of these shares have been lifted, rendering them freely tradable.

On October 22, 2021, the Company’s board of directors canceled 11,790,000 Preferred Options previously issued to its co-founder, J. Stephen Holmes. Accordingly, these Preferred Options are no longer exercisable. A total of 37,570 Preferred Options issued pursuant to the September 2016 grant and triggered by the Vensure Asset Sale remain unexercised.

The amount of Preferred Options, and the number of shares of preferred stock issuable upon exercise of such options, is based upon the number of shares of common stock held by the option holders at the time the Preferred Options were issued in September 2016. Accordingly, in order to confirm the original intent of the granting of up to 25,000,000 Preferred Options to Mr. Absher, it has always been the Company’s intent to adopt a second grant of an additional 12,500,000 Preferred Options to Mr. Absher, whereby each option permits the holder to acquire one share of the Company’s preferred stock for $0.0001 per share. On August 13, 2021, consistent with this intent, the Company granted 12,500,000 Preferred Options to Mr. Absher to purchase shares of Preferred Stock, par value $0.0001 for consideration of $0.0001 per share. Each Preferred Option is exercisable for a period of twenty-four months upon (i) the acquisition of a Controlling Interest (as defined below) in the Company by any single shareholder or group of shareholders acting in concert (other than Mr. Absher), or (ii) the announcement of (x) any proposed merger, consolidation, or business combination in which the Company’s Common Stock is changed or exchanged, or (y) any sale or distribution of at least 50% of the Company’s assets or earning power, other than through a reincorporation. Each share of Preferred Stock is convertible into Common Stock on a one-for-one basis. “Controlling Interest” means the ownership or control of outstanding voting shares of the Company sufficient to enable the acquiring person, directly or indirectly and individually or in concert with others, to exercise one-fifth or more of all the voting power of the Company in the election of directors or any other business matter on which shareholders have the right to vote under the Wyoming Business Corporation Act.

On July 14, 2022, the Board of the Company approved the issuance to the Company’s founder and principal shareholder, Scott Absher, of 12,500,000 shares of the Company’s Preferred Class A Stock ("Preferred Shares"), par value $0.0001 per share, in exchange for (a) the surrender by Mr. Absher of his options to acquire 12,500,000 Preferred Shares, which Preferred Options provide for exercise upon certain triggering events as described above, and as detailed in the Company's prior filings, and (b) the tender of payment by Mr. Absher of the sum of $5,000, representing four times the par value for such Preferred Shares. The Company evaluated the Preferred Shares on the same date using Level 2 inputs based on the closing market price of the Company’s common stock. The resulting allocated common share price was then discounted for a lack of marketability of

shares, which yielded a fair value of $0.2322 per Preferred Share. The Company used the following assumptions to value the expense related to the Preferred Shares: (i) life of 10 years; (ii) risk free rate of 3.1%; (iii) volatility of 125.7%; (iv) exercise price of $0.0001 per share; and (v) a fair value of $0.3 per share of the Company’s common stock. These were recorded as compensation expense in the general and administrative expenses during the fiscal year August 31, 2022.

On September 1,, 2022, Mr. Absher converted 8,600,000 Preferred Shares to 8,600,000 shares of the Company’s common stock, par value $0.0001 per share. Pursuant to Rule 144, these 8,000,000 shares of common stock are subject to a six-month holding period during which they may not be sold in the marketplace. All of the 8,6,00,000 preferred shares were converted into common shares on September 1, 2022, after the Company's reverse stock split had taken effect.

On August 12, 2022, the Company entered into an agreement with Mr. Absher whereby he waived claims to certain unpaid compensation due to him through July 31, 2022, totaling $820,793, in exchange for an option to receive 4,100,000 shares of the Company's Preferred Class A Stock. The Company evaluated the Preferred Shares on the same date using Level 2 inputs based on the closing market price of the Company’s common stock. The resulting allocated common share price was then discounted for a lack of marketability of shares, which yielded a fair value of $0.2025 per Preferred Share. The Company used the following assumptions to value the expense related to the Preferred Shares: (i) life of 10 years; (ii) risk free rate of 3.0%; (iii) volatility of 125.7%; (iv) exercise price of $0.0001 per share; and (v) a fair value of $0.2 per share of the Company’s common stock. Pursuant to Rule 144, these 4,100,000, when converted into shares of common stock are subject to a six-month holding period during which they may not be sold in the marketplace. All of the 8,600,000 preferred shares were converted into common stock on September 1, 2022, after the Company's reverse stock split had taken effect. As of November 30, 2022, there were no preferred shares options or preferred shares outstanding. As a result of this transaction, the Company recorded a preferential dividend of 127,145,000 based upon the incremental value of the stock that was held prior to the reverse stock split and the date of preferred stock conversion to common stock. In addition, this had no effect on stockholders' deficit.

Prior to the shareholder vote to approve the reverse stock split, the Company on August 2, 2022, amended its Articles of Incorporation to hereby state that the preferred stock will not be split adjusted if the common stock reverse stock split is effectuated. The reverse stock split was subsequently approved by the shareholders, and effectively the terms and conditions of the preferred stock were “deemed modified” and treated as an extinguishment (in accordance with ASC 470-50 and ASC 260-10-S99-2 for the disproportionate value received (the carrying value compared to the fair value received).

Common Stock and Warrants

During the three months ended November 30, 2022, the Company closed the following transactions:

September 2022 Private Placement

On September 20, 2022, the Company entered into a securities purchase agreement (the “Purchase Agreement”) with a large institutional investor (the “Purchaser”) pursuant to which the Company sold to the Purchaser an aggregate of 416,667 shares (the “Shares”) of its common stock together with warrants (the “Warrants”) to purchase up to 833,334 shares of common stock (collectively, the “Offering”). Each share of common stock and two accompanying Warrants were sold together at a combined offering price of $12.00. The Warrants are exercisable for a period of seven years commencing upon issuance at an exercise price of $12.00, subject to adjustment. The Offering closed on September 23, 2022. The net gross proceeds to the Company from the Offering was $4,738,000.

In connection with the Purchase Agreement, the Company and the Purchaser entered into amendment No. 1 to warrants (the “Warrant Amendment”). Pursuant to the Warrant Amendment, the exercise price of (i) 25,233 warrants issued on September 3, 2021, and (ii) 98,969 warrants issued on January 28, 2022, was reduced to $0.01., As a result of the change in exercise price, the Company recorded an expense of $106,000. The incremental change in the fair market values was based upon the Black Scholes option pricing model with the following inputs. Risk free interest of 3.7%, expected volatility of 149.4%, dividend yield of 0% and expected term of 6.7 to 6.8 years.

A.G.P./Alliance Global Partners (the “Placement Agent”) acted as the exclusive placement agent in connection with the Offering pursuant to the terms of a placement agent agreement, dated September 20, 2022, between the Company and the Placement Agent (the “Placement Agent Agreement”). Pursuant to the Placement Agent Agreement, the Company paid the Placement Agent a fee equal to 7.0% of the aggregate gross proceeds from the Offering. In addition to the cash fee, the Company issued to the Placement Agent warrants to purchase up to 20,833 shares of common stock (5% of the number of shares sold in the Offering (the “Placement Agent Warrants”). The Placement Agent Warrants will be exercisable for a period commencing six months from issuance, will expire four years from the effectiveness of a registration statement for the resale of the underlying shares, and have an initial exercise price of $13.20 per share.

On September 1, 2022, after the Company's reverse stock split had taken effect, Mr. Absher converted 8,600,000 of his shares of Preferred Class A Stock to 8,600,000 shares of our common stock, see Note 9.

The following table summarizes the changes in the Company’s common stock and Prefunded  Warrants from August 31, 2022 to November 30, 2022

	Number of shares	Weighted average remaining life (years)	Weighted average exercise price
Warrants outstanding, August 31, 2022	522,786	7.2	$	47.99
Issued	854,166	7.1	12.00
Cancelled	—	—	—
Exercised	(124,204)	0	—
Warrants outstanding, November 30, 2022	1,252,748	6.9	34.78
Warrants exercisable, November 30, 2022	50,173	3.0	$	459.36

The following table summarizes the Company’s warrants outstanding as of November 30, 2022 (Unaudited):

	Warrants Outstanding	Weighted average Life of Outstanding Warrants in years	Exercise price
September 2022 Common Warrants(1)	833,333	6.8	$	12.00
September 2022 Underwriter Warrants	20,833	4.3	$	13.20
July 2022 Common Warrants(2)	348,408	7.6	$	26.00
Sep 2021Underwriter Warrants	3,762	6.4	175.00
May 2021Underwriter Warrants	2,474	3.5	267.00
October 2020 Common Warrants	23,000	2.9	330.00
October 2020 Underwriter Warrants	2,000	2.9	330.00
May 2020 Common Warrants	12,776	2.5	540.00
May 2020 Underwriter Warrants	1,111	2.5	540.00
March 2020 Exchange Warrants	4,237	2.9	1,017.00
Amended March 2019 Warrants	663	1.3	4,000.00
March 2019 Services Warrants	34	1.3	7,000.00
June 2018 Warrants	63	1.0	4,000.00
June 2018 Services Warrants	54	1.0	9,960.00
	1,252,748	6.9	$	34.78

(1)The September 2022 Common Warrants are exercisable exercisable commencing March 23, 2023 (six months from the date of issuance) and will terminate March 23, 2030.

(2)The July 2022 Common Warrants are not exercisable until January 19, 2023.

XML

Stock Based Compensation

3 Months Ended

Nov. 30, 2022

Share-Based Payment Arrangement [Abstract]

Stock Based Compensation

Stock Based Compensation

Employee Stock Option Plan Increase

In March 2017, the Company adopted its 2017 Stock Option/Stock Issuance Plan (the “Plan”). The Plan provides incentives to eligible employees, officers, directors and consultants in the form of incentive stock options (“ISOs”), non-qualified stock options (“NQs”), (each of which is exercisable into shares of common stock) (collectively, “Options”) or shares of common stock (“Share Grants”).

On July 1, 2020, the Company's board of directors unanimously approved an increase in the number of shares of common stock issuable under the Plan from 250,000 to 3,000,000. On March 31, 2021, the Company’s shareholders approved the increase in the number of shares of common stock issuable under the Plan as well as any contingent grant awards under the Plan on or subsequent to July 1, 2020. On June 4, 2021, the Company filed a registration statement on Form S-8 with the SEC to register the issuance of up to an aggregate of 3,000,000 shares, par value $0.0001 per share, reserved for issuance under the Plan.

For all options granted prior to July 1, 2020, each option has a term of service vesting provision over a period of time as follows: 25% vest after a 12-month service period following the award, with the balance vesting in equal monthly installments over the succeeding 36 months. Options granted on or after July 1, 2020 typically vest over four years, with 25% of the grant vesting one year from the grant date, and the remainder in equal quarterly installments over the succeeding 12 quarters. All options granted to date have a stated ten-year term and, as of November 30, 2022, all options granted to date are exercisable.

Stock grants are issued at fair value, considered to be the market price on the grant date. The fair value of option awards is estimated on the grant date using the Black-Scholes stock option pricing model.

Following its adoption of ASU 2016-9, the Company elected to account for forfeitures under the Plan as they occur. Any compensation cost previously recognized for an unvested award that is forfeited because of a failure to satisfy a service condition is reversed in the period of the forfeiture.

Stock-based compensation expense was $255,000 and $408,000 for the three months ended November 30, 2022, and November 30, 2021, respectively.

The following table summarizes option activity during the three months ended November 30, 2022 (Unaudited):

	Options Outstanding and Exercisable
	Number of Options	Weighted Average Remaining Contractual Life	Weighted Average Exercise Price
		(In years)
Balance Outstanding, August 31, 2022	11,753	8.1	$	733.00
Granted
Exercised
Forfeited	(1,150)		217.00
Balance Outstanding at November 30, 2022	10,603	7.8	$	789.00

 

Options outstanding as of November 30, 2022 had an aggregate intrinsic value of $0. 

As of November 30, 2022, the total unrecognized deferred share-based compensation expected to be recognized over the remaining weighted average vesting periods of 1.8 years for outstanding grants was $1,458,000. Option vesting activity from August 31, 2022, through November 30, 2022 was as follows:

Options Vested	Number of Options	Weighted Remaining Contractual Life	Weighted Average Exercise Price
		(In years)
Balance, August 31, 2022	5,269	8.1	$	1,146.00
Vested	830	8.0	426.00
Exercised			—
Forfeited	(369)		286.00
Balance, November 30, 2022	5,730	7.6	$	1,101.00

The following table summarizes information about stock options outstanding and vested as of November 30, 2022: 

	Options Outstanding				Options Vested
Exercise Prices	Number of Options Exercisable	Weighted Average Remaining Contractual Life	Weighted Average Exercise Price		Number of Options	Weighted Average Remaining Contractual Life	Weighted Average Exercise Price
		(In Years)				(In Years)
$0.50 - 10.00	10,241	7.8	$	438.00	5,375	7.8	$	467.00
$10.01 - $40.00	20	6.5	1,895.00		18	7.3	1,897.00
$40.01 - $80.00	121	6.3	5,121.00		116	6.6	5,120.00
$80.01 - $120.00	101	5.5	10,298.00		101	5.5	10,298.00
$120.01 - $160.00	109	4.6	15,584.00		109	4.6	15,584.00
$160.01 - $391.60	11	4.6	30,160.00		11	4.6	39,160.00
	10,603	7.6	$	789.00	5,730	7.6	$	1,101.00

XML

Related Parties and Certain Directors and Officers

3 Months Ended

Nov. 30, 2022

Related Party Transactions [Abstract]

Related Parties and Certain Directors and Officers

Related Parties and Certain Directors and Officers

Scott W. Absher, the Company's CEO and Chair of our Board, received compensation in the form of salary of $127,644 and $153,307 for the three months ending November 30, 2022 and November 30, 2021, respectively. In addition, for the three month period ending November 30, 2022, Mr. Absher has a deferred, unpaid compensation accrual in the amount of $58,832.

On September 1, 2022, after the Company's reverse stock split had taken effect, Mr. Absher converted 8,600,000 of his shares of Preferred Class A Stock to 8,600,000 shares of our common stock.The Company recorded a preferential dividend of 127,145,000 based upon the incremental value of the stock that was held prior to the reverse stock split and the date of preferred stock conversion to common stock.

Mr. Absher's annual salary compensation for calendar year 2023 has been set at $750,000.

J. Stephen Holmes

J. Stephen Holmes formerly served as a non-employee sales manager advisor to and was a significant shareholder of the Company. The Company incurred $750,000 in professional fees for services provided by Mr. Holmes during Fiscal 2021. For the three months ended November 30, 2021, Mr. Holmes was compensated $120,000 for his services.

On or about October 22, 2021, we severed all ties with Mr. Holmes, effective immediately, and cancelled Preferred Options that had previously been issued to him but had not been exercised. As a result of these actions, the Company no longer has any financial obligation to Mr. Holmes, and believes that he is no longer a significant shareholder of the Company. See Note 7, Stockholders Equity. Accordingly, for the three months ending November 30, 2022, Mr. Holmes received no compensation and provided no services.

Amanda Murphy

Amanda Murphy, the Company's COO and Director, received compensation for the 3 month period ending November 30, 2022, in the amount of $66,078, and for the three month period ending November 30, 2021, in the amount of $66,038. In addition, for the three month period ending November 30, 2022, Ms. Murphy has a deferred, unpaid compensation accrual in the amount of $58,967.

Domonic J. Carney

On May 24, 2022, Domonic J. Carney resigned as Chief Financial Officer and Treasurer of the Company, according to a Sabbatical Leave Agreement, effective immediately. As of November 30, 2022, $87,858 remains outstanding as Back Pay.

Related Persons to Scott Absher

Mark Absher, the brother of Scott Absher, was previously employed as our Registered In-House Counsel, Director and Secretary. Mr. Absher resigned from his positions with the Company on February 6, 2019. On November 18, 2021, Mr. Absher

rejoined the Company as Deputy General Counsel – Special Projects, for an annual salary of $240,000. Mr. Absher's compensation for the three month period ending November 30, 2022, was $60,296, and his compensation for the three month period ending November 30, 2021 was $8,307.

David May, a member of our business development team, is the son-in-law of Scott Absher. Mr. May received compensation of approximately $149,000 in Fiscal 2022. Mr. May's compensation for the three month period ending November 30, 2022, was $37,319, and his salary and commission compensation for for the three month period ending November 30, 2021. was $42,857.

Jason Absher, a member of the Company's business development team, is the nephew of Scott Absher and the son of Mark Absher. Mr. Absher received compensation for the three month period ending November 30, 2022, in the amount of $30,017, and for the three month period ending November 30, 2021, in the amount of $30,000.

Phil Eastvold, the Executive Producer of ShiftPixy Labs, is the son-in-law of Scott Absher. Mr. Eastvold's compensation for the three month period ending November 30, 2022, was $56,083, and his compensation for the three month period ending November 30, 2021 was $56,038.

Connie Absher (the spouse of Scott Absher), Elizabeth Eastvold (the daughter of Scott Absher and spouse of Mr. Eastvold), and Hannah Woods (the daughter of Scott Absher), are also employed by the Company. These individuals, as a group, received aggregate compensation in the amount of $48,764 for the three month period ending November 30, 2022 and in the amount of $53,611 for the three month period ending November 30, 2021.

XML

Commitments

3 Months Ended

Nov. 30, 2022

Commitments and Contingencies Disclosure [Abstract]

Commitments

Commitments

Operating Leases & License Agreements

Effective August 13, 2020, the Company entered into a non-cancelable seven-year lease for 13,246 square feet of office space located in Miami, Florida, to house its principal executive offices commencing October 2020, and continuing through September 2027. The lease contains escalation clauses relating to increases in real property taxes as well as certain maintenance costs. Monthly rent expense under this lease is approximately $57,000.

Effective October 1, 2020, the Company entered into a non-cancelable 64-month lease for 23,500 square feet of primarily industrial space located in Miami, Florida, to house ghost kitchens, production facilities, and certain marketing and technical functions, including those associated with ShiftPixy Labs. The lease contains escalation clauses relating to increases in real property taxes as well as certain maintenance costs. Monthly rent expense under this lease is approximately $34,000.

Effective June 7, 2021, the Company entered into a non-cancelable sublease agreement with Verifone, Inc. to sublease premises consisting of approximately 8,000 square feet of office space located in Miami, Florida, that the Company anticipates using for its sales and operations workforce. The lease has a term of three years expiring on May 31, 2024. The base rent is paid monthly and escalates annually pursuant to a schedule set forth in the sublease. Monthly rent expense under this lease is approximately $26,000.

Effective June 21, 2021, the Company entered into a non-cancelable 77-month lease for premises consisting of approximately 13,418 square feet of office space located in Sunrise, Florida, that the Company anticipates using primarily to house its operations personnel and other elements of its workforce. The Company lease had possession date of August 1, 2022. The base rent is paid monthly and escalates annually pursuant to a schedule set forth in the lease. Monthly rent expense under this lease is approximately $27,000.

Effective May 2, 2022, the Company entered into a non-cancelable 60-month operating lease, as constituted in an amendment to a prior lease, commencing on July 1, 2022, for office space in Irvine, California, which the Company anticipates using primarily to house its IT, operations personnel, and other elements of its workforce. The base rent is paid monthly and escalates annually according to a schedule outlined in the lease. The monthly rent expense under this lease is approximately $24,000. As an incentive, the landlord provided a rent abatement of 50% of the monthly rent for the first four months, with a right of recapture in the event of default.

On August 31, 2022, the Company decided to formally abandon the leases for its offices in the Courvoisier Center, including a sublease on the second floor with Verifone. The determination was based on its inability to utilize the premises as they were under extensive construction renovation by the landlord, resulting in a significant negative impact on the Company’s ability to conduct business and the health and well-being of the Company’s employees and guests. The Company formally notified the landlord of its intention to vacate the premises and has not been legally released from the Company's primary obligations under the leases. The Company received a formal complaint from the landlord, and the matter is in litigation. The Company intends to vigorously defend the lawsuit and counterclaim for relocation costs. See Note 11, Contingencies. As a result of the

abandonment, the Company evaluated the Right-Of-Use ("ROU") Assets for impairment as of August 31, 2022, and recorded an impairment charge of $3.9, within the impairment loss line item for the year ended August 31, 2022, see 10-K for such information. Furthermore, the Company released the corresponding lease liability and evaluated the need for a loss contingency in accordance with ASC 450, recording a contingent liability of $3.8 in the accrued expenses of the consolidated balance sheets as of November 30, 2022 and August 31, 2022/.

The components of lease expense are as follows:

	Three Months Ended November 30, 2022
Operating Lease Cost	$	256,000

Future minimum lease and licensing payments under non-cancelable operating leases at November 30, 2022, are as follows:

	Minimum lease commitments
2023	$	919,000
2024	1,064,000
2025	1,099,000
2026	777,000
2027	568,000
Thereafter	351,000
Total minimum payments	$	4,778,000
Less: present value discount	621,000
Lease Liability	$	4,157,000
Weighted-average remaining lease term - operating leases (months)	72
Weighted-average discount rate	5.54		%

The current portion of the operating lease liability is included within our accounts payable and other accrued liabilities in our condensed consolidated balance sheets.

Special Purpose Acquisition Company Sponsorship

On April 29, 2021, the Company announced its sponsorship, through a wholly-owned subsidiary, of four SPAC IPOs. The Company purchased founder shares in each SPAC (the "Founder Shares"), through its wholly-owned subsidiary, for an aggregate purchase price of $25,000 per SPAC. The number of Founder Shares issued was determined based on the expectation that such Founder Shares would represent 15% of the outstanding shares of each SPAC after its IPO (excluding the private placement warrants described below and their underlying securities).

The registration statement and prospectus covering the IPO of IHC, was declared effective by the SEC on October 19, 2021, and IHC units (the “IHC Units”), consisting of one share of common stock and an accompanying warrant to purchase one share of IHC common stock, began trading on the NYSE on October 20, 2021. The IHC IPO closed on October 22, 2021, raising gross proceeds for IHC of $115 million. In connection with the IHC IPO, the Company purchased, through its wholly-owned subsidiary, 4,639,102 placement warrants at a price of $1.00 per warrant, for an aggregate purchase price of $4,639,102. Each private placement warrant is exercisable to purchase one whole share of common stock in IHC at $11.50 per share. The private placement warrants will be worthless to the extent that IHC does not complete an initial business combination.

The investment amounts set forth above do not include loans that the Company may extend to IHC in an amount not to exceed $500,000, in its role as sponsor. As of November 30, 2022, the Company had advanced, through its wholly owned subsidiary, an aggregate of approximately $861,000 to the SPACs for payment of various expenses in connection with the SPAC IPOs,

principally consisting of SEC registration, legal and auditing fees. The Company previously disclosed that it anticipates that the SPAC will repay these advanced expenses from when its IBC is completed. As of November 30, 2022, the Company had an outstanding balance of $744,000 from the advances, which are considered uncollectible with the dissolution of IHC. The intercompany balances have been eliminated in consolidation.

XML

Contingencies

3 Months Ended

Nov. 30, 2022

Commitments and Contingencies Disclosure [Abstract]

Contingencies

Contingencies

Certain conditions may exist as of the date the financial statements are issued, which may result in a loss to the Company, but which will be resolved only when one or more future events occur or fail to occur. The Company’s management assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment.

During the ordinary course of business, the Company is subject to various claims and litigation. Management believes that after consulting legal counsel the outcome of such claims or litigation will not have a material adverse effect on the Company’s financial position, results of operations or cash flow. Some of the matters are detailed below.

Kadima Litigation

The Company became engaged in a dispute with its former software developer, Kadima Ventures (“Kadima”), over incomplete but paid for software development work. In May 2016, the Company entered into a contract with Kadima for the development and deployment of user features that were proposed by Kadima for an original build cost of $2.2 million to complete. This proposal was later revised upward to approximately $7.2 million to add certain features to the original proposal. As of November 30, 2022, the Company has paid approximately $11.0 million to Kadima, but has never been provided access to the majority of the promised software. Kadima has refused to continue development work, denied access to developed software, and refused to surrender to the Company any software that it has developed unless the Company pays an additional $12.0 million above the $11.0 million already paid. In April 2019, Kadima filed a complaint against the Company in the Superior Court of the State of Arizona, Maricopa County, alleging claims for breach of contract, promissory estoppel and unjust enrichment, and seeking damages in excess of $11.0 million. The Company vigorously disputed and denied each of Kadima’s claims, including that it owes any sums to Kadima, and further asserted that it is entitled, at a minimum, to a refund of a substantial portion of the sums that it has already paid, along with the release of the software modules currently being withheld. Following trial of the case, the court, on November 23, 2022, entered a minute order, finding in favor of the Company and against Kadima in the amount of $5 million plus costs and fees. As noted in Note 12, Subsequent Events, the minute order was converted to a final judgement order, entered on January 4, 2023, in favor of the Company and against Kadima for $5 million in compensatory damages, plus an amount in excess of $1.8 million in pre-judgment interest, plus expert witness fees of $250,000, plus costs, plus post judgment interest.

Splond Litigation

On April 8, 2019, claimant, Corey Splond, filed a class action lawsuit, on behalf of himself and other similarly situated individuals in the Eighth Judicial District Court for the State of Nevada, Clark County, naming the Company and its client as defendants, and alleging violations of certain wage and hour laws. The Company denies any liability. Discovery is proceeding in the case, and no trial date has been set. Even if the plaintiff ultimately prevails, the potential damages recoverable will depend substantially upon whether the Court determines in the future that this lawsuit may appropriately be maintained as a class action. Further, in the event that the Court ultimately enters a judgment in favor of plaintiff, the Company believes that it would be contractually entitled to be indemnified by its client against at least a portion of any damage award.

Radaro Litigation

On July 9, 2020, the Company was served with a complaint filed by one of its former software vendors, Radaro Inc., in the United States District Court for the Central District of California, alleging damages arising from claims sounding in breach of contract and fraud. By Order filed October 21, 2020, the Court dismissed plaintiff’s claims for fraud and for punitive damages, with leave to replead. The Company denied plaintiff’s claims and defended the lawsuit vigorously. On October 31, 2022, the Company settled the claim with Radaro, the terms of which are confidential.

Everest Litigation

On December 18, 2020, the Company was served with a Complaint filed in the United States District Court for the Central District of California by its former workers’ compensation insurance carrier, Everest National Insurance Company. The Complaint asserts claims for breach of contract, alleging that the Company owes certain premium payments to plaintiff under a

retrospective rated policy, and seeks damages of approximately $0.6 million, which demand has since increased to approximately $1.6 million. On February 5, 2021, the Company filed an Answer to Plaintiff’s Complaint denying its claims for relief, and also filed a cross-claim against the third party claims administrator, Gallagher Bassett Services, Inc., for claims sounding in breach of contract and negligence based upon its administration of claims arising under the policy. By order dated April 7, 2021, the Court dismissed the Company’s complaint against Gallagher Bassett without prejudice to re-filing in another forum. On May 17, 2021, the Company refiled its complaint against Gallagher Basset in the Circuit Court of Cook County, Illinois. Everest subsequently filed a complaint against Gallagher Bassett in New Jersey. Discovery is underway in the cases, and the California Court has set a trial date in the Everest case of August 8, 2023, while no trial date has been set in either of the related Illinois or New Jersey cases, which are in preliminary stages. Mediation in the matter was conducted on December 14, 2022, and the matter was kept open until further notice as the partied are seeking to settle the case.

Sunz Litigation

On March 19, 2021, the Company was served with a Complaint filed in the Circuit Court for the 11th Judicial Circuit, Manatee County, Florida, by its former workers’ compensation insurance carrier, Sunz Insurance Solutions, LLC. The Complaint asserts claims for breach of contract, alleging that the Company owes payments for loss reserve funds totaling approximately $10 million, which represents approximately 200% of the amount of incurred and unpaid claims. The Company denies plaintiff’s allegations and is defending the lawsuit vigorously. On May 12, 2021, the Company filed a motion to dismiss the complaint, and Sunz filed an amended complaint in response. Discovery is proceeding in the matter and no trial date has been set. On June 21, 2022, the Court granted Plaintiff’s partial motion for summary judgment, holding that Defendant is liable under the contract, but further finding that the amount of damages, if any, to which Plaintiff is entitled should be determined at trial. We believe that partial summary judgment was improvidently granted, and therefore appealed the Court’s Order by filing a petition for writ of certiorari with the Court of Appeal, which appeal is now pending. On or about November 14, 2022, a court granted Sunz’ motion for summary judgment on a contractual issue—holding that the Company waived claims regarding Sunz’ management of claims to the extent that the Company did not complain about such management within 6 months of the alleged mismanagement of the claims. This ruling may limit the scope of the Company’s counterclaim.

Vensure Litigation

On September 7, 2021, Shiftable HR Acquisition, LLC, a wholly-owned subsidiary of Vensure, filed a complaint against the Company in the Court of Chancery of the State of Delaware asserting claims arising from the Asset Purchase Agreement (the “APA”) governing the Vensure Asset Sale described above. The APA provided for Vensure to purchase, through its wholly-owned subsidiary, certain of the Company’s assets for total consideration of $19 million in cash, with $9.5 million to be paid at closing, and the remainder to be paid in 48 equal monthly installments (the “Installment Sum”). The Installment Sum was subject to certain adjustments to account for various post-closing payments made by the parties, and the APA provided for the following procedure to determine the final amount of the Installment Sum: (i) Within 90 days of the effective date, Vensure was required to provide the Company with a “Proposed Closing Statement”, which must detail any adjustments; (ii) Within 30 days of its receipt of Vensure’s Proposed Closing Statement, the Company had the right to challenge any of the proposed adjustments contained therein; and (iii) If the Company disputed Vensure’s Proposed Closing Statement, a 30-day period ensued for the parties to attempt to resolve the dispute, with the Company entitled to examine “such Books and Records of [Vensure] as relate to the specific items of dispute . . .”

Vensure resisted the Company’s repeated efforts to obtain the Proposed Closing Statement for over one year after the closing of the transaction. Finally, on March 12, 2021, under threat of legal action by the Company, Vensure provided its Proposed Closing Statement, in which it contended for the first time that it owes nothing to the Company, and that the Company actually owes Vensure the sum of $1.5 million. By letter dated April 6, 2021, the Company provided Vensure with its objections to the Proposed Closing Statement, which included Vensure’s gross overstatement of payments it purportedly made on the Company’s behalf, as well as its bad faith actions in obstructing the Company’s efforts to make these payments.

From April 2021 through August 2021, Vensure and the Company engaged in the “30-day negotiation period” referred to above, which was extended multiple times at Vensure’s request to provide Vensure an opportunity to provide evidence supporting its assertions. Over the course of these negotiations, Vensure withdrew its claim for approximately $1.5 million from the Company, and acknowledged that Vensure owed ShiftPixy some portion of the Installment Fund. Nevertheless, in early September 2021, without warning and contrary to the dispute resolution provisions of the APA, Vensure filed suit against the Company in Delaware Chancery Court for breach of contract and declaratory judgment, seeking unspecified damages. The Company vigorously disputes and denies each of Vensure’s claims. Accordingly, on November 4, 2021, the Company filed its Answer and Counterclaim to Vensure’s Complaint, in which it not only denied Vensure’s claims, but also asserted counterclaims for breach of contract and tortious interference with contract. The counterclaim seeks damages from Vensure

totaling approximately $9.5 million – the full amount due under the APA - plus an award of attorneys’ fees and expenses. The case is proceeding, and no trial date has been set.

Courvoisier Centre Litigation

On August 24, 2022, the landlord of our headquarters offices, Courvoisier Centre, LLC, filed a complaint against the Company in the Eleventh Judicial Circuit Court (Miami-Dade County, Florida) alleging breach of the lease. We vacated the offices and ceased payments under the lease in July of 2022, after repeatedly complaining to the landlord regarding the impact of its extensive renovations of the campus and building in which the Company's offices were situated, citing substantial impairments to the Company's ability to conduct business as well as concerns regarding the health and well-being of the Company’s employees and guests, and the Landlord’s inability and refusal to provide any adequate relief. On or about October 10, 2022, we filed our answer to the complaint and the Company's counterclaim. The Company intends to vigorously defend the lawsuit and seek recovery for its costs of relocation.

Certified Tire Litigation

On June 29, 2020, the Company was served with a complaint filed by its former client, Certified Tire, in the Superior Court of the State of California, Orange County, naming the Company, two of its officers, and one of its former subsidiaries as defendants. The Complaint asserts multiple causes of action, all of which stem from the former client’s claim that the Company is obligated to reimburse it for sums it paid in settlement of a separate lawsuit brought by one of its employees pursuant to PAGA. This underlying lawsuit alleged the Company's former client was responsible for multiple violations of the California Labor Code. The Company and the officers named as defendants deny the former client’s allegations, and the Company is defending the lawsuit vigorously based primarily on the Company's belief that the alleged violations that gave rise to the underlying lawsuit were the responsibility of Certified Tire and not the Company. Discovery is currently proceeding, and trial is scheduled to commence on or after March 27, 2023. The Company’s dispositive motion for summary judgment was denied by the court because of its determination that factual disputes exist.

In Re John Stephen Holmes Bankruptcy Litigation

On November 8, 2022, the Chapter 7 trustee of the bankruptcy estate of John Stephen Holmes filed an action against the Company, asserting that the cancellation of Mr. Holmes' preferred options on October 22, 2021, violated the automatic stay applicable to Mr. Holmes' Chapter 7 proceedings. The matter is in the preliminary stages; as noted in Note 12, Subsequent Events, the Company has filed a motion to dismiss the complaint.

Nasdaq Listing Notifications

On April 4, 2022, we received a letter from the staff of the Listing Qualifications Department (the "Staff") of Nasdaq notifying us that for the previous 30 consecutive business days, the bid price for the Company's common stock had closed below the minimum $1.00 per share requirement for continued listing under Nasdaq's Listing Rule 5550(a)(2) (the "Minimum Bid Requirement"). Following the completion of the reverse split of the Company's r common stock, which became effective on September 1, 2022, on September 19, 2022, the Company received a letter from the staff of Nasdaq (the "Staff") notifying the Company that the Staff has determined that for the last 10 consecutive business days, from September 1 to September 16, 2022, the closing bid price of the Company’s common stock had been at $1.00 per share or greater and that accordingly, the Company has regained compliance with Listing Rule 5550(a)(2).

In addition, on April 21, 2022, ShiftPixy, Inc. (the “Company”) received a letter from the staff of the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”), which notified the Company that it did not comply with Nasdaq’s Listing Rule 5550(b)(1) that requires the Company to (i) maintain a minimum of $2,500,000 in stockholders’ equity for continued listing or (ii) meet the alternatives of minimum market value for listed securities or net income from continuing operations. On October 3, 2022, the Company received a letter from the Staff notifying the Company that the Staff has determined that the Company has regained compliance with Listing Rule 5550(b) in that, for the last 21 consecutive business days, from September 1 through September 30, 2022, the Company’s market value of listed securities has been above $35,000,000.

XML

Subsequent Events

3 Months Ended

Nov. 30, 2022

Subsequent Events [Abstract]

Subsequent Events

Subsequent Events

Management has evaluated events that have occurred subsequent to the date of these consolidated financial statements and has determined that, other than those listed below, no such reportable subsequent events exist through the date the financial statements were issued in accordance with FASB ASC Topic 855, "Subsequent Events."

IHC

IHC Trust released all the redemption funds to IHC shareholders on December 2, 2022, effectively liquidating the Trust.

In Re John Stephen Holmes Bankruptcy Litigation

On December 15, 2022, we filed a motion to dismiss the complaint filled by the bankruptcy trustee. No action has been taken on the motion.

Kadima Litigation

On January 4, 2023, the court in the Kadima litigation entered a formal order of judgment in favor of the Company and against Kadima for $5 million in compensatory damages, plus an amount in excess of $1.8 million in pre-judgment interest, plus expert witness fees of $250,000, plus costs, plus post judgment interest.

Changes in CFO Position

Effective December 16, 2022, Manny Rivera, resigned from his position as Acting Chief Financial Officer of the Company. Effective January 15, 2023, Douglas Beck, CPA assumed the position of Chief Financial Officer of the Company.

Nasdaq Letter of Reprimand

On January 17, 2023, the staff of the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) issued a Letter of Reprimand to the Company for the Company’s violation, as determined by Nasdaq, of Listing Rule 5635(d) (the “Rule”). The Staff determined that two transactions completed by the Company, on July 18, 2022, and September 20, 2022 (prior to and after the Company’s 1-for-100 reverse stock split), should be aggregated inasmuch as the transactions were with the same investor and deemed proximate in time and use of proceeds, and that, because the total shares issued in the transactions substantially exceeded 20% of the total shares outstanding and were issued at a price less than the Minimum Price, shareholder approval should have been secured prior to issuing shares in the September 20, 2022, transaction.

The Staff considered it appropriate, pursuant to Listing Rule 5810(c)(4), to close these matters with the issuance of a Letter of Reprimand as opposed to a delisting of the Company’s securities, noting that the Company (1) stated that any violation of the Listing Rules was inadvertent, (2) stated that it reasonably relied upon the expertise of its outside counsel and had no reason to believe counsel would omit consideration of any material issue and accordingly proceeded with closing, (3) noted that its substantial majority shareholder approved the September 20, 2022, transaction, (4) has committed to engage with Nasdaq prior to entering into transactions involving common investors if such transactions take place within six months from one another, and (5) has not demonstrated a prior pattern of non-compliance. The Company’s action in amending the warrants issued in September 2022 to extend the date of their initial exercise to 6 months from the date of their issuance (which has been completed as disclosed in the Company’s 8-K filed on December 2, 2022) was offered by the Company as a remedial measure.

XML

Summary of Significant Accounting Policies (Policies)

3 Months Ended

Nov. 30, 2022

Accounting Policies [Abstract]

Basis of Presentation

Basis of Presentation

The accompanying condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and the rules of the Securities and Exchange Commission (“SEC”) applicable to interim reports of companies filing as a small reporting company. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for fair presentation have been included. The results of condensed operations for the three months ended November 30, 2022 are not necessarily indicative of the results that may be expected for the full year ending August 31, 2023.

For further information, refer to the consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K and 10-K/A for the fiscal year ended August 31, 2022 (“Fiscal 2022”), filed with the SEC on December 13, 2022 and December 14, 2022, respectively.

Principles of Consolidation

Principles of Consolidation

The condensed consolidated financial statements include the accounts of ShiftPixy, Inc., and its wholly-owned subsidiaries. The condensed consolidated financial statements also include the accounts of (a) Industrial Human Capital, Inc. ("IHC"), which is a special purpose acquisition company, or "SPAC", for which we serve as the financial sponsor (as described below), and which is deemed to be controlled by us as a result of the Company's 15% equity ownership stake, the overlap of three of our executive officers as executive officers of IHC, and significant influence that we currently exercise over the funding and acquisition of

new operations for an initial business combination ("IBC"). (See Note 2, Variable Interest Entity). All intercompany balances have been eliminated in consolidation.

Use of Estimates

Use of Estimates

The preparation of financial statements in conformity with GAAP requires the Company to make estimates and assumptions that affect certain reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include:

•Assumption as a going concern; management assumes that the Company will continue as a going concern , which contemplates continuity of operations, realization of assets and liquidation of all liabilities in the normal course of business;

•Liability for legal contingencies;

•Useful lives of property and equipment;

•Deferred income taxes and related valuation allowance;

•Valuation of illiquid non-controlling interest in SPAC shares transferred; and

•Projected development of workers’ compensation claims.

These significant accounting estimates or assumptions bear the risk of change due to the fact that there are uncertainties attached to these estimates or assumptions are difficult to measure of value.

Management regularly reviews the key factors and assumptions to develop the estimates utilizing currently available information, changes in facts and circumstances, historical experience, and reasonable assumptions. After such valuation, if deemed appropriate, those estimates are adjusted accordingly.

Revenue and Direct Cost Recognition

Revenue and Direct Cost Recognition

For the year ended August 31, 2021 ("Fiscal 2021"), we adopted Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (Topic 606), using the modified retrospective approach. Under this method, the guidance is applied only to the most current period presented in the financial statements. ASU No. 2014-09 outlines a single comprehensive revenue recognition model for revenue arising from contracts with customers and superseded most of the previous revenue recognition guidance, including industry-specific guidance. Under ASU No. 2014-09, an entity recognizes revenue for the transfer of promised goods or services to customers in an amount that reflects the consideration for which the entity expects to be entitled in exchange for those goods or services. The Company's revenue recognition policies remained substantially unchanged as a result of the adoption of ASU No. 2014-09 and the Company did not have any significant changes in the Company's business processes or systems.

The Company’s revenues are primarily disaggregated into fees for providing staffing solutions and EAS/HCM services. The Company enters into contracts with its clients for Staffing or EAS based on a stated rate and price in the contract. Contracts generally have a term of 12 months, however are cancellable at any time by either party with 30 days’ written notice. The performance obligations in the agreements are generally combined into one performance obligation, as they are considered a series of distinct services, and are satisfied over time because the client simultaneously receives and consumes the benefits provided as the Company performs the services. Payments for the Company’s services are typically made in advance of, or at the time that the services are provided. The Company does not have significant financing components or significant payment terms for its customers and consequently has no material credit losses. The Company uses the output method based on a stated rate and price over the payroll processed to recognize revenue, as the value to the client of the goods or services transferred to date appropriately depicts the Company's performance towards complete satisfaction of the performance obligation.

Staffing Solutions

The Company records gross billings as revenues for its staffing solutions clients. The Company is primarily responsible for fulfilling the staffing solutions services and has discretion in establishing price. The Company includes the payroll costs in

revenues with a corresponding increase to cost of revenues for payroll costs associated with these services. As a result, we are the principal in this arrangement for revenue recognition purposes.

EAS Solutions

EAS solutions revenue is primarily derived from the Company’s gross billings, which are based on (i) the payroll cost of the Company’s worksite employees (“WSEs”) and (ii) a mark-up computed as a percentage of payroll costs for payroll taxes and workers’ compensation premiums.

Gross billings are invoiced to each EAS client concurrently with each periodic payroll of the Company’s WSEs, which coincides with the services provided and which is typically a fixed percentage of the payroll processed. Revenues, which exclude the payroll cost component of gross billings and therefore consist solely of markup, are recognized ratably over the payroll period as WSEs perform their services at the client worksite. Although the Company assumes responsibility for processing and remitting payroll and payroll related obligations, it does not assume employment-related responsibilities such as determining the amount of the payroll and related payroll obligations. As a result, the Company records revenue on a “net” basis in this arrangement for revenue recognition purposes. Revenues that have been recognized but not invoiced for EAS clients are included in unbilled accounts receivable on the Company’s consolidated balance sheets and were $2,706,000 and $2,105,000, as of November 30, 2022 and August 31, 2022, respectively.

Consistent with the Company’s revenue recognition policy for EAS clients, direct costs do not include the payroll cost of its WSEs. The cost of revenue associated with the Company’s revenue generating activities is primarily comprised of all other costs related to its WSEs, such as the employer portion of payroll-related taxes, employee benefit plan premiums and workers’ compensation insurance costs.

The fees collected from the worksite employers for benefits (i.e. zero-margin benefits pass-through), workers’ compensation and state unemployment taxes are presented in revenues and the associated costs of benefits, workers’ compensation and state unemployment taxes are included in operating expenses for EAS clients, as the Company does retain risk and acts as a principal with respect to this aspect of the arrangement. With respect to these fees, the Company is primarily responsible for fulfilling the service and has discretion in establishing price.

Disaggregation of Revenue

The Company’s primary revenue streams include HCM and staffing services. The Company’s disaggregated revenues for the three months ended November 30, 2022 and November 30, 2021, respectively, were as follows:

	For the Three Months Ended
Revenue (in millions):	November 30, 2022		November 30, 2021
	(Unaudited)
HCM1	$	1.5	$	1.8
Staffing	3.8		7.1
	$	5.3	$	8.9

1 HCM revenue is presented net, $11.7 million gross billings less WSE payroll costs of $10.3 million for the three months ended November 30, 2022 and $14.1 million gross billings less WSE payroll costs of $12.3 million for the three months ended November 30, 2021.

During Fiscal 2021 the Company announced the launch of ShiftPixy Labs. ShiftPixy Labs generated no revenue for any periods presented in these financial statements.

For the three months ended November 30, 2022 and November 30, 2021, respectively, the following geographical regions represented more than 10% of total revenues:

	For the Three Months Ended
Region:	November 30, 2022		November 30, 2021
	(Unaudited)
California	48.8	%	53.7	%
Washington	12.2	%	13.3	%
New Mexico	10.2	%	6.73

Incremental Cost of Obtaining a Contract

Pursuant to the “practical expedients” provided under ASU No 2014-09, the Company expenses sales commissions when incurred because the terms of its contracts are cancellable by either party upon 30 days' notice. These costs are recorded in commissions in the Company’s condensed consolidated statements of operations.

Segment Reporting

Segment Reporting

Prior to August 31, 2021, the Company operated as one reportable segment under ASC 280, Segment Reporting. The chief operating decision maker regularly reviews the financial information of the Company at a consolidated level in deciding how to allocate resources and in assessing performance. During Fiscal 2021, the Company entered into new business lines and geographic areas that, to date, are not material. However, with the migration to Staffing during the fiscal quarter ending May 31, 2021, the Company is beginning to manage the business on a segmented basis and therefore intends to report such information once systems and processes are updated accordingly. Reporting and monitoring activities on a segment basis will allow the chief operating decision maker to evaluate operating performance more effectively.

Cash and Cash Equivalents

Cash and Cash Equivalents

The Company considers all highly liquid investments with an original maturity of three months or less when purchased as cash equivalents. The Company had no cash equivalent as of November 30, 2022 and August 31, 2022.

Marketable Securities Held in Trust Account

Marketable Securities Held in Trust Account

As of November 30, 2022 and August 31, 2022, substantially all of the assets held in the Trust Account were invested in U.S. Treasury securities with maturities of 180 days or less. These funds are restricted for use and may only be used for purposes of completing an initial business combination ("IBC") or redemption of the public common shares of IHC. In December 2022, the Company distributed $117,574,000 to the shareholder's of IHC.

Concentration of Credit Risk

Concentration of Credit RiskThe Company maintains cash with a commercial bank, which is insured by the Federal Deposit Insurance Corporation (“FDIC”). At various times, the Company has deposits in this financial institution in excess of the amount insured by the FDIC. The Company has not experienced any losses related to these balances and believes its credit risk to be minimal.

Fixed Assets

Fixed Assets

Fixed assets are recorded at cost, less accumulated depreciation and amortization. Expenditures for major additions and improvements are capitalized and minor replacements, maintenance, and repairs are charged to expense as incurred. When fixed assets are retired or otherwise disposed of, the cost and accumulated depreciation are removed from the accounts and any resulting gain or loss is included in the results of operations for the respective period. Leasehold improvements are amortized over the shorter of the useful life or the initial lease term.

Fixed assets are recorded at cost and are depreciated over the estimated useful lives of the related assets using the straight-line method. The estimated useful lives of property and equipment for purposes of computing depreciation are as follows:

Equipment:	5 years
Furniture & Fixtures:	5 - 7 years
Leasehold improvements	Shorter of useful life or the remaining lease term, typically 5 years

Depreciation and amortization expense is included on the condensed consolidated statements of operations.

Computer Software Development

Computer Software Development

Software development costs relate primarily to software coding, systems interfaces and testing of the Company’s proprietary employer information systems and are accounted for in accordance with ASC 350-40, Internal Use Software.

Internal software development costs are capitalized from the time the internal use software is considered probable of completion until the software is ready for use. Business analysis, system evaluation and software maintenance costs are expensed as incurred. The capitalized computer software development costs are reported under the section fixed assets, net in the consolidated balance sheets and are amortized using the straight-line method over the estimated useful life of the software, generally three to five years from when the asset is placed in service.

The Company determined that there were no material capitalized internal software development costs for the three months ended November 30, 2022. All capitalized software recorded was purchased from third party vendors. Capitalized software development costs are amortized using the straight-line method over the estimated useful life of the software, generally three to five years from when the asset is placed in service.

Lease Recognition

Lease Recognition

In February 2016, the FASB established Topic 842, Leases, by issuing ASU No. 2016-02 (“ASC 842”), which required lessees to recognize leases on-balance sheet and disclose key information about leasing arrangements. Topic 842 was subsequently amended by ASU No. 2018-01, Land Easement Practical Expedient for Transition to Topic 842; ASU No. 2018-10, Codification Improvements to Topic 842, Leases; and ASU No. 2018-11, Targeted Improvements. The standard established a right-of-use model (“ROU”) that required a lessee to recognize an ROU asset and lease liability on the balance sheet for all leases with a term longer than 12 months. Leases are classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the condensed consolidated statement of operations.

The Company adopted the standard on December 1, 2021 with an effective date of September 1, 2021. A modified retrospective transition approach was required, applying the standard to all leases existing at the date of initial application. An entity could choose to use either (1) the effective date of the standard or (2) the beginning of the earliest comparative period presented in the financial statements as its date of initial application. If an entity chose the second option, the transition requirements for existing leases also applied to leases entered into between the date of initial application and the effective date. The entity had to also recast its comparative period financial statements and provide the disclosures required by the standard for the comparative periods. The Company elected to use the effective date as its date of initial application. Consequently, financial information was not updated and the disclosures required under the standard were not provided for dates and periods prior to September 1, 2021.

The standard provided a number of optional practical expedients as part of transition accounting. The Company elected the “package of practical expedients”, which allowed the Company to avoid reassessing its prior conclusions about lease identification, lease classification and initial direct costs under the standard. The Company did not elect the use-of-hindsight or the practical expedient pertaining to land easements as these were not applicable to the Company.

The standard had a material effect on the Company’s Condensed Consolidated Financial Statements. The most significant changes related to (1) the recognition of ROU assets and lease liabilities on the Condensed Consolidated Balance Sheet for the Company's office equipment and real estate operating leases and (2) providing significant disclosures about the Company’s leasing activities.

Upon adoption, the Company recognized additional operating liabilities of approximately $7.7 million, with corresponding ROU operating lease asset, based on the present value of the remaining minimum rental payments under current leasing standards for existing operating leases. The Company determined if an arrangement was a lease at inception. The Company used an incremental borrowing rate based on the information available at the commencement date of the lease to determine the present value of lease payments. In determining the ROU asset and lease liability at lease inception, the lease terms could include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term.

The standard also provided practical expedients for an entity’s ongoing accounting for leases. The Company elected the short-term lease recognition exemption for office equipment leases. For those current and prospective leases that qualify as short-term, the Company will not recognize ROU assets or lease liabilities. The Company also elected the practical expedient to not separate lease and non-lease components for all of its real estate leases.

Impairment and Disposal of Long-Lived Assets

Impairment and Disposal of Long-Lived AssetsThe Company periodically evaluates its long-lived assets for impairment in accordance with ASC 360-10, Property, Plant, and Equipment. ASC 360-10 requires that an impairment loss be recognized for assets to be disposed of or held-for-use when the carrying amount of an asset is deemed not to be recoverable. If events or circumstances were to indicate that any of the Company's long-lived assets might be impaired, the Company would assess recoverability based on the estimated undiscounted future cash flows to be generated from the applicable asset. In addition, the Company may record an impairment loss to the extent that the carrying value of the asset exceeds the fair value of the asset. Fair value is generally determined using an estimate of discounted future net cash flows from operating activities or upon disposal of the asset.

Workers' Compensation

Workers’ Compensation

Everest Program

Until July 2018, a portion of the Company’s workers’ compensation risk was covered by a retrospective rated policy through Everest National Insurance Company, which calculates the final policy premium based on the Company’s loss experience during the term of the policy and the stipulated formula set forth in the policy. The Company funds the policy premium based on standard premium rates on a monthly basis and based on the gross payroll applicable to workers covered by the policy. During the policy term and thereafter, periodic adjustments may involve either a return of previously paid premiums or a payment of additional premiums by the Company or a combination of both. If the Company’s losses under that policy exceed the expected losses under that policy, then the Company could receive a demand for additional premium payments. The Company is currently engaged in litigation regarding such a demand for additional premium payments, which we believe to be without merit, as discussed at Note 11, Contingencies, Everest Litigation, below.

Sunz Program

From July 2018 through February 28, 2021, the Company’s workers’ compensation program for its WSEs was provided primarily through an arrangement with United Wisconsin Insurance Company and administered by Sunz Insurance Solutions, LLC (“Sunz”). Under this program, the Company has financial responsibility for the first $0.5 million of claims per occurrence. The Company provides and maintains a loss fund that is earmarked to pay claims and claims related expenses. The workers’ compensation insurance carrier establishes monthly funding requirements comprised of premium costs and funds to be set aside for payment of future claims (“claim loss funds”). The level of claim loss funds is primarily based upon anticipated WSE payroll levels and expected workers’ compensation loss rates, as determined by the insurance carrier. Monies funded into the program for incurred claims expected to be paid within one year are recorded as Deposit - workers’ compensation, a short-term asset, while the remainder of claim funds are included in Deposit- workers’ compensation, a long-term asset in our condensed consolidated balance sheets. The Company is currently engaged in litigation regarding demands by Sunz for additional claims loss funds, which we believe to be without merit, as discussed at Note 11, Contingencies, Sunz Litigation, below.

Under the Everest and Sunz programs, the Company utilized a third party to estimate its loss development rate, which was based primarily upon the nature of WSEs’ job responsibilities, the location of WSEs, the historical frequency and severity of workers’ compensation claims, and an estimate of future cost trends. Each reporting period, changes in the assumptions resulting from changes in actual claims experience and other trends are incorporated into its workers’ compensation claims cost estimates.

There were no workers compensation deposits related to theses programs as of November 30, 2022 and as of August 31, 2022, respectively..

Current Program

Effective March 1, 2021, the Company migrated its clients to a guaranteed cost program. Under this program, the Company’s financial responsibility is limited to the cost of the workers’ compensation premium. The Company funds the workers’ compensation premium based on standard premium rates on a monthly basis and based on the gross payroll applicable to workers covered by the policy. Any final adjustments to the premiums are based on the final audited exposure multiplied by the applicable rates, classifications, experience modifications and any other associated rating criteria.

The Company’s estimate of incurred claim costs expected to be paid within one year is included in short-term liabilities, while its estimate of incurred claim costs expected to be paid beyond one year is included in long-term liabilities on its consolidated balance sheets. As of November 30, 2022 and August 31, 2022, the Company had short term accrued workers’ compensation costs of $0.6 million and $0.6 million, and long term accrued workers’ compensation costs of $1.2 million and $1.2 million, respectively.

The Company retained workers’ compensation asset reserves and workers’ compensation related liabilities for former WSEs of clients transferred to Shiftable HR Acquisition, LLC, a wholly-owned subsidiary of Vensure Employer Services, Inc. (“Vensure”), in connection with the Vensure Asset Sale described in Note 3, Discontinued Operations, below. As of November 30, 2022, the retained workers’ compensation assets and liabilities are presented as a discontinued operation net asset or liability. As of November 30, 2022, the Company had $1.4 million in short term liabilities, and $3.4 million in long term liabilities. The Company had no related worker's compensation assets as of November 30, 2022 and August 31, 2022, respectively.

Because the Company bears the financial responsibility for claims up to the level noted above, such claims, which are the primary component of its workers’ compensation costs, are recorded in the period incurred. Workers’ compensation insurance includes ongoing health care and indemnity coverage whereby claims are paid over numerous years following the date of injury. Accordingly, the accrual of related incurred costs in each reporting period includes estimates, which take into account the ongoing development of claims and therefore requires a significant level of judgment. In estimating ultimate loss rates, the Company utilizes historical loss experience, exposure data, and actuarial judgment, together with a range of inputs that are primarily based upon the WSE’s job responsibilities, their location, the historical frequency and severity of workers’ compensation claims, and an estimate of future cost trends. For each reporting period, changes in the actuarial assumptions resulting from changes in actual claims experience and other trends are incorporated into the Company’s workers’ compensation claims cost estimates. The estimated incurred claims are based upon: (i) the level of claims processed during each quarter; (ii) estimated completion rates based upon recent claim development patterns under the plan; and (iii) the number of participants in the plan.

The Company has had very limited and immaterial COVID-19 related claims between March 2020 through the date of this Quarterly Report, although there is a possibility of additional workers’ compensation claims being made by furloughed WSEs as a result of the employment downturn caused by the pandemic. On May 4, 2020, the State of California indicated that workers who become ill with COVID-19 would have a potential claim against workers’ compensation insurance for their illnesses. There is a possibility that additional workers’ compensation claims could be made by employees required to work by their employers during the COVID-19 pandemic, which could have a material impact on the Company's workers’ compensation liability estimates. While the Company has not seen significant additional expenses as a result of any such potential claims to date, which would include claims for reporting periods after November 30, 2022, we continue to monitor closely all workers’ compensation claims made as the COVID-19 pandemic continues.

Fair Value of Financial Instruments

Fair Value of Financial Instruments

ASC 820, Fair Value Measurement, requires entities to disclose the fair value of financial instruments, both assets and liabilities recognized and not recognized on the balance sheet, for which it is practical to estimate fair value. ASC 820 defines fair value of a financial instrument as the amount at which the instrument could be exchanged in a current transaction between willing parties. As of November 30, 2022 and August 31, 2022, the carrying value of certain financial instruments (cash, accounts receivable and payable) approximated fair value due to the short-term nature of the instruments. Notes Receivable is valued at the Company's estimate of expected collections value as described below and in Note 3, Discontinued Operations.

The Company measures fair value under a framework that utilizes a hierarchy prioritizing the inputs to relevant valuation techniques. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or

liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of inputs used in measuring fair value are:

•Level 1: Inputs to the valuation methodology are unadjusted quoted prices for identical assets or liabilities in active markets that the Company has the ability to access.

•Level 2: Inputs to the valuation methodology include:

◦Quoted prices for similar assets or liabilities in active markets;

◦Quoted prices for identical or similar assets or liabilities in inactive markets;

◦Inputs other than quoted prices that are observable for the asset or liability;

◦Inputs that are derived principally from or corroborated by observable market data by correlation or other means; and

◦If the asset or liability has a specified (contractual) term, the Level 2 input must be observable for substantially the full term of the asset or liability.

•Level 3: Inputs to the valuation methodology are unobservable and significant to the fair value measurement.

Funds held in trust represent U.S. treasury bills that were purchased with funds raised through the initial public offering of IHC. The funds raised from SPACs are held in trust accounts that are restricted for use and may only be used for purposes of completing an IBC or redemption of the public shares of common stock of the SPACs as set forth in their respective trust agreements. The funds held in trust are included within Level 1 of the fair value hierarchy and included in Cash and marketable securities held in Trust Account in the accompanying condensed consolidated balance sheets.

The Company did not have other Level 1 or Level 2 assets or liabilities at November 30, 2022 or August 31, 2022. We recorded the fair value of the SPAC founder shares that the Company transferred to the underwriters using non-recurring Level 3 assumptions, including quoted asset prices for SPAC shares and warrants and estimates of the likelihood of the IPOs and IBCs of the Company's sponsored SPACs being consummated. See also Note 4, Special Purpose Acquisition company (SPAC) and Note 5, Deferred Offering Costs – SPACS, below.

When the Company changes its valuation inputs for measuring financial assets and liabilities at fair value, either due to changes in current market conditions or other factors, it could be required to transfer those assets or liabilities to another level in the hierarchy based on the new inputs used. The Company recognizes these transfers at the end of the reporting period that the transfers occur. The development and determination of the unobservable inputs for Level 3 fair value measurements and the fair value calculations are the responsibility of the Company’s chief financial officer and are approved by the chief executive officer. There were no transfers out of Level 3 for the three months ended November 30, 2022.

Advertising Costs

Advertising CostsThe Company expenses all advertising as incurred.

Income Taxes

Income Taxes

The Company accounts for income taxes pursuant to ASC 740, Income Taxes. Under ASC 740, deferred income taxes are provided on a liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss carryforwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. The provision for income taxes represents the tax expense for the period, if any, and the change during the period in deferred tax assets and liabilities. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. ASC 740 also provides criteria for the recognition, measurement, presentation and disclosure of uncertain tax positions. Under ASC 740, the impact of an uncertain tax position on the income tax return may

only be recognized at the largest amount that is more-likely-than-not to be sustained upon audit by the relevant taxing authority. A full valuation allowance was recorded as of November 20, 2022 and August 31, 2022, respectively,

Earnings (Loss) Per Share

Earnings (Loss) Per Share

The Company utilizes ASC 260, Earnings per Share. Basic Net Income (Net Loss) per common share is computed by dividing Net Income (Net Loss) attributable to common shareholders by the weighted-average number of shares of common stock outstanding during the reporting period. Common stock outstanding for purposes of Net Income (Net Loss) per share calculations include unexercised Preferred Options and unexercised prefunded warrants, as described in Note 7, Stockholders' Equity, below. Diluted earnings (loss) per share is computed similar to basic earnings (loss) per share except that the denominator is increased to include additional common stock equivalents available upon exercise of stock options and warrants using the treasury stock method. Dilutive common stock equivalents include the dilutive effect of in-the-money stock equivalents, which are calculated based on the average share price for each period using the treasury stock method, excluding any common stock equivalents if their effect would be anti-dilutive. In periods in which a net loss has been incurred, all potentially dilutive common stock shares are considered anti-dilutive and thus are excluded from the calculation. Securities that are excluded from the calculation of weighted average dilutive common stock, because their inclusion would have been antidilutive, are:

For the Three Months Ended	November 30, 2022	November 30, 2021
	(Unaudited) )	(Unaudited)
Options (See Note 8)	10,603	4,023
Warrants (See Note 7)	1,252,748	174,918
Total potentially dilutive shares	1,263,351	178,941

For the table above, “Options” represent all options granted under the Company’s 2017 Stock Option/Stock Issuance Plan (the "Plan"), as described in Note 8, Stock Based Compensation, below.

Share-Based Compensation

Stock-Based Compensation

As of November 30, 2022, the Company had one stock-based compensation plan under which the Company may issue awards, as described in Note 8, Stock Based Compensation, below. The Company accounts for the Plan under the recognition and measurement principles of ASC 718, Compensation-Stock Compensation, which requires all stock-based payments to employees, including grants of employee stock options, to be recognized in the condensed consolidated statements of operations at their fair values.

The grant date fair value is determined using the Black-Scholes-Merton (“Black-Scholes”) pricing model. For all employee stock options, the Company recognizes expense on an accelerated basis over the employee’s requisite service period (generally the vesting period of the equity grant).

The Company’s option pricing model requires the input of highly subjective assumptions, including the expected stock price volatility and expected term. The expected volatility is based on the historical volatility of the Company’s common stock since the Company's initial public offering. Any changes in these highly subjective assumptions significantly impact stock-based compensation expense.

The Company elects to account for forfeitures as they occur. As such, compensation cost previously recognized for an unvested award that is forfeited because of the failure to satisfy a service condition is revised in the period of forfeiture.

The methods and assumptions used in the determination of the fair value of stock-based awards are consistent with those described in the Company's Annual Report on Form 10-K and 10-K/A for Fiscal 2022, filed with the SEC on December 3, 2021 and on February 28, 2022, respectively, which includes a detailed description of the Company's stock-based compensation awards, including information related to vesting terms, service and performance conditions, payout percentages, and process for estimating the fair value of stock options granted.

Financial Instruments-Credit Losses and Recent Accounting Standards

Financial Instruments-Credit Losses

In June 2016, the FASB issued ASU 2016-13, “Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” (“ASU 2016-13”). This standard requires an impairment model (known as the current expected credit loss (“CECL”) model) that is based on expected losses rather than incurred losses. Under the new guidance, each reporting entity should estimate an allowance for expected credit losses, which is intended to result in more timely

recognition of losses. This model replaces multiple existing impairment models in current U.S. GAAP, which generally requires a loss to be incurred before it is recognized. The new standard applies to trade receivables arising from revenue transactions such as contract assets and accounts receivable. Under ASC 606, revenue is recognized when, among other criteria, it is probable that an entity will collect the consideration it is entitled to when goods or services are transferred to a customer. When trade receivables are recorded, they become subject to the CECL model and estimates of expected credit losses on trade receivables over their contractual life will be required to be recorded at inception based on historical information, current conditions, and reasonable and supportable forecasts. This guidance is effective for smaller reporting companies for annual periods beginning after December 15, 2022, including the interim periods in the year. Early adoption is permitted. The Company will adopt the guidance when it becomes effective.

Recent Accounting Standards

As of November 30,2022, there were no new accounting standards that would need to be disclosed.

Variable Interest Entity

Variable Interest Entity

The Company has been involved in the formation of various entities considered to be Variable Interest Entities (“VIEs”). The Company evaluates the consolidation of these entities as required pursuant to ASC Topic 810 relating to the consolidation of VIEs. These VIEs are SPACs.

The Company’s determination of whether it is the primary beneficiary of a VIE is based in part on an assessment of whether or not the Company and its related parties are exposed to the majority of the risks and rewards of the entity. Typically, the Company is entitled to substantially all or a portion of the economics of these VIEs. The Company is the primary beneficiary of the VIE entities.

During the Fiscal 2022, the Company's sponsored SPAC, IHC, completed its IPO, selling 11,500,000 units (the "IHC Units") pursuant to a registration statement and prospectus, as described below. The IPO closed on October 22, 2021, raising gross proceeds of $115 million. These proceeds were deposited in a trust account established for the benefit of the IHC public shareholders and, along with an additional $1.7 million deposited in trust by the Company reserved for interest payments for future possible redemptions by IHC stockholders, are included in Cash and marketable securities held in Trust Account in the accompanying condensed consolidated balance sheet at November 30, 2022. These proceeds are invested only in U.S. treasury securities in accordance with the governing documents of IHC.

Each IHC Unit had an offering price of $10.00 and consisted of one share of IHC common stock and one redeemable warrant. Each warrant entitles the holder thereof to purchase one share of IHC common stock at a price of $11.50 per share. The IHC public stockholders have a right to redeem all or a portion of their shares of IHC common stock upon the completion of its IBC, subject to certain limitations. Under the terms of the registration statement and prospectus, IHC is required to consummate its IBC within 12 months of the completion of the IPO. If IHC is unable to meet this deadline, IHC could request an extension. If no extension is granted, then IHC will redeem 100% of the public shares of common stock outstanding for cash, subject to applicable law and certain conditions. In December 2022, the Company distributed $117,574,000 to the shareholders of IHC as described below and in Note 12, Subsequent Events.

In connection with the IPO, we purchased, through the Company's wholly-owned subsidiary, ShiftPixy Investments, Inc. ("Investments" or the "Sponsor"), 4,639,102 private placement warrants ("Placement Warrants") at a price of $1.00 per warrant, for an aggregate purchase price of $4,639,102, and we currently own 2,110,000 Founder Shares of IHC common stock, representing approximately 15% of the issued and outstanding common stock of IHC. Before the closing of the IPO, the Sponsor transferred 15,000 Founder Shares to IHC's independent directors, reducing its shareholdings from 2,125,000 to 2,110,000. Each Placement Warrant is identical to the warrants sold in the IPO, except as described in the IPO registration statement and prospectus. Following the completion of the IHC IPO, we determined that IHC is a Variable Interest Entity ("VIE") in which we have a variable interest because IHC does not have enough equity at risk to finance its activities without additional subordinated financial support. We have also determined that IHC's public stockholders do not have substantive rights, and their equity interest constitutes temporary equity, outside of permanent equity, in accordance with ASC 480-10-S99-3A. As such, we have concluded that we are currently the primary beneficiary of IHC as a VIE, as we have the right to receive benefits or the obligation to absorb losses of the entity, as well as the power to direct a majority of the activities that significantly impact IHC's economic performance. Since we are the primary beneficiary, IHC is consolidated into the Company condensed consolidated financial statements.

Shares Subject to Possible Redemption

Shares Subject to Possible Redemption

The Company accounts for its common stock holdings in its sponsored SPACs (which are consolidated in the Company condensed consolidated financial statements) that are subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Shares of common stock subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable shares of common stock (including shares of common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, shares of common stock are classified as shareholders’ equity. Each sponsored SPAC's shares of common stock feature certain redemption rights that are considered to be outside of the SPAC's control and subject to occurrence of uncertain future events. Accordingly, as of November 30, 2022, shares of common stock subject to possible redemption are presented as temporary equity, outside of the shareholders’ equity section of the Company’s condensed consolidated balance sheets.

The Company recognizes changes in redemption value of these shares immediately as they occur and adjusts the carrying value of redeemable shares of common stock to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of the redeemable common stock are affected by charges against additional paid in capital and accumulated deficit.

XML

Summary of Significant Accounting Policies (Tables)

3 Months Ended

Nov. 30, 2022

Accounting Policies [Abstract]

Disaggregation of Revenue

The Company’s disaggregated revenues for the three months ended November 30, 2022 and November 30, 2021, respectively, were as follows:

	For the Three Months Ended
Revenue (in millions):	November 30, 2022		November 30, 2021
	(Unaudited)
HCM1	$	1.5	$	1.8
Staffing	3.8		7.1
	$	5.3	$	8.9

1 HCM revenue is presented net, $11.7 million gross billings less WSE payroll costs of $10.3 million for the three months ended November 30, 2022 and $14.1 million gross billings less WSE payroll costs of $12.3 million for the three months ended November 30, 2021.

Revenue from External Customers by Geographic Areas

For the three months ended November 30, 2022 and November 30, 2021, respectively, the following geographical regions represented more than 10% of total revenues:

	For the Three Months Ended
Region:	November 30, 2022		November 30, 2021
	(Unaudited)
California	48.8	%	53.7	%
Washington	12.2	%	13.3	%
New Mexico	10.2	%	6.73

Schedule of Estimated Useful Lives of Property and Equipment

The estimated useful lives of property and equipment for purposes of computing depreciation are as follows:

Equipment:	5 years
Furniture & Fixtures:	5 - 7 years
Leasehold improvements	Shorter of useful life or the remaining lease term, typically 5 years

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

Securities that are excluded from the calculation of weighted average dilutive common stock, because their inclusion would have been antidilutive, are:

For the Three Months Ended	November 30, 2022	November 30, 2021
	(Unaudited) )	(Unaudited)
Options (See Note 8)	10,603	4,023
Warrants (See Note 7)	1,252,748	174,918
Total potentially dilutive shares	1,263,351	178,941

XML

Discontinued Operations (Tables)

3 Months Ended

Nov. 30, 2022

Discontinued Operations and Disposal Groups [Abstract]

Schedule of Disposal Groups Including Discontinued Operations, Reconciliation of Gross Proceeds to Net Proceeds as Presented in Cash Flow Statement

The following reconciliation of the gross proceeds to the net proceeds from the Vensure Asset Sale is presented in the condensed consolidated balance sheets for the period ended November 30, 2022 and August 31, 2022.

	As of
	November 30, 2022 (Unaudited)		August 31, 2022
Gross proceeds	$	19,166,000	$	19,166,000
Cash received at closing – asset sale	(9,500,000)		(9,500,000)
Cash received at closing – working capital	(166,000)		(166,000)
Gross note receivable	$	9,500,000	$	9,500,000
Less:  Transaction reconciliation – estimated working capital adjustments	(2,604,000)		(2,604,000)
Adjusted Note Receivable	6,896,000		6,896,000
Reserve for estimated potential claims	(2,892,000)		(2,892,000)
Reserve for potential collectability concerns	$	(4,004,000)	$	(4,004,000)
Long-term note receivable, estimated net realizable value	$	—	$	—

Disposal Groups, Including Discontinued Operations

The carrying amounts of the classes of assets and liabilities from the Vensure Asset Sale included in discontinued operations are as follows:

	As of
	November 30, 2022		August 31, 2022
	(Unaudited)
Deposits – workers’ compensation	—		—
Total current assets	—		—
Deposits – workers’ compensation	—		—
Total assets	$	—	$	—
Accrued workers’ compensation cost	1,438,000		1,362,000
Total current liabilities	1,438,000		1,362,000
Accrued workers’ compensation cost	3,394,000		3,269,000
Total liabilities	4,832,000		4,631,000
Net liability	$	(4,832,000)	$	(4,631,000)

Schedule of Disposal Groups Including Discontinued Operations Income Statement

Reported results for the discontinued operations by period were as follows:

	For the Three Months Ended
	November 30, 2022		November 30, 2021
	(Unaudited)
Revenues	$	—	$	—
Cost of revenue	200,000		134,000
Gross profit (loss)	(200,000)		(134,000)
Total operating expenses	—		—
(Loss) income from discontinued operations	$	(200,000)	$	(134,000)

XML

Stockholders' Deficit (Tables)

3 Months Ended

Nov. 30, 2022

Equity [Abstract]

Schedule of Stockholders' Equity Note, Warrants or Rights

The following table summarizes the changes in the Company’s common stock and Prefunded  Warrants from August 31, 2022 to November 30, 2022

	Number of shares	Weighted average remaining life (years)	Weighted average exercise price
Warrants outstanding, August 31, 2022	522,786	7.2	$	47.99
Issued	854,166	7.1	12.00
Cancelled	—	—	—
Exercised	(124,204)	0	—
Warrants outstanding, November 30, 2022	1,252,748	6.9	34.78
Warrants exercisable, November 30, 2022	50,173	3.0	$	459.36

The following table summarizes the Company’s warrants outstanding as of November 30, 2022 (Unaudited):

	Warrants Outstanding	Weighted average Life of Outstanding Warrants in years	Exercise price
September 2022 Common Warrants(1)	833,333	6.8	$	12.00
September 2022 Underwriter Warrants	20,833	4.3	$	13.20
July 2022 Common Warrants(2)	348,408	7.6	$	26.00
Sep 2021Underwriter Warrants	3,762	6.4	175.00
May 2021Underwriter Warrants	2,474	3.5	267.00
October 2020 Common Warrants	23,000	2.9	330.00
October 2020 Underwriter Warrants	2,000	2.9	330.00
May 2020 Common Warrants	12,776	2.5	540.00
May 2020 Underwriter Warrants	1,111	2.5	540.00
March 2020 Exchange Warrants	4,237	2.9	1,017.00
Amended March 2019 Warrants	663	1.3	4,000.00
March 2019 Services Warrants	34	1.3	7,000.00
June 2018 Warrants	63	1.0	4,000.00
June 2018 Services Warrants	54	1.0	9,960.00
	1,252,748	6.9	$	34.78

(1)The September 2022 Common Warrants are exercisable exercisable commencing March 23, 2023 (six months from the date of issuance) and will terminate March 23, 2030.

(2)The July 2022 Common Warrants are not exercisable until January 19, 2023.

XML

Stock Based Compensation (Tables)

3 Months Ended

Nov. 30, 2022

Share-Based Payment Arrangement [Abstract]

Share-based Payment Arrangement, Option, Activity

The following table summarizes option activity during the three months ended November 30, 2022 (Unaudited):

	Options Outstanding and Exercisable
	Number of Options	Weighted Average Remaining Contractual Life	Weighted Average Exercise Price
		(In years)
Balance Outstanding, August 31, 2022	11,753	8.1	$	733.00
Granted
Exercised
Forfeited	(1,150)		217.00
Balance Outstanding at November 30, 2022	10,603	7.8	$	789.00

Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable

Option vesting activity from August 31, 2022, through November 30, 2022 was as follows:

Options Vested	Number of Options	Weighted Remaining Contractual Life	Weighted Average Exercise Price
		(In years)
Balance, August 31, 2022	5,269	8.1	$	1,146.00
Vested	830	8.0	426.00
Exercised			—
Forfeited	(369)		286.00
Balance, November 30, 2022	5,730	7.6	$	1,101.00

Summarizes of Stock Options Outstanding

The following table summarizes information about stock options outstanding and vested as of November 30, 2022: 

	Options Outstanding				Options Vested
Exercise Prices	Number of Options Exercisable	Weighted Average Remaining Contractual Life	Weighted Average Exercise Price		Number of Options	Weighted Average Remaining Contractual Life	Weighted Average Exercise Price
		(In Years)				(In Years)
$0.50 - 10.00	10,241	7.8	$	438.00	5,375	7.8	$	467.00
$10.01 - $40.00	20	6.5	1,895.00		18	7.3	1,897.00
$40.01 - $80.00	121	6.3	5,121.00		116	6.6	5,120.00
$80.01 - $120.00	101	5.5	10,298.00		101	5.5	10,298.00
$120.01 - $160.00	109	4.6	15,584.00		109	4.6	15,584.00
$160.01 - $391.60	11	4.6	30,160.00		11	4.6	39,160.00
	10,603	7.6	$	789.00	5,730	7.6	$	1,101.00

XML

Commitments (Tables)

3 Months Ended

Nov. 30, 2022

Commitments and Contingencies Disclosure [Abstract]

Lease, Cost

The components of lease expense are as follows:

	Three Months Ended November 30, 2022
Operating Lease Cost	$	256,000

Lessee, Operating Lease, Liability, Maturity

Future minimum lease and licensing payments under non-cancelable operating leases at November 30, 2022, are as follows:

	Minimum lease commitments
2023	$	919,000
2024	1,064,000
2025	1,099,000
2026	777,000
2027	568,000
Thereafter	351,000
Total minimum payments	$	4,778,000
Less: present value discount	621,000
Lease Liability	$	4,157,000
Weighted-average remaining lease term - operating leases (months)	72
Weighted-average discount rate	5.54		%

XML

Nature of Operations (Details)	Sep. 01, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Stock split conversion ratio	0.01

XML

Summary of Significant Accounting Policies - Additional Information (Details)			1 Months Ended	3 Months Ended		12 Months Ended
	Oct. 22, 2021 USD ($) $ / shares shares	Oct. 21, 2021 shares	Dec. 31, 2022 USD ($)	Nov. 30, 2022 USD ($) plan $ / shares shares	Nov. 30, 2021 USD ($)	Aug. 31, 2022 USD ($) $ / shares shares	Aug. 31, 2020 segment	Oct. 19, 2021 shares	Sep. 01, 2021 USD ($)	Aug. 31, 2021 USD ($)
Concentration Risk [Line Items]
Contract with customer, term				12 months
Contract with customer, cancellation period				30 days
Unbilled accounts receivable				$ 2,706,000		$ 2,105,000
Number of reportable segments | segment							1
Cash, uninsured amount				463,000		615,000
Capitalized computer software, additions				0	$ 0
Research and development expense				2,200,000	700,000
Operating lease, liability				4,157,000
Workers' compensation, claim responsibility per occurrence				500,000
Workers' compensation asset, current				0		0
Workers' compensation asset, noncurrent				0		0
Workers' compensation liability, current				575,000		567,000
Workers' compensation liability, noncurrent				1,196,000		$ 1,227,000
Disposal group, including discontinued operation, workers' compensation liability, current				1,400,000
Disposal group, including discontinued operation, workers' compensation liability, noncurrent				3,400,000
Disposal group, including discontinued operation, workers' compensation asset, current				0
Disposal group, including discontinued operation, workers' compensation asset, noncurrent				0
Advertising expense				$ 700,000	1,400,000
Number of stock-based compensation plans | plan				1
Exercise price of warrants (in dollars per share) | $ / shares				$ 34.78		$ 47.99
Class of warrant or right, outstanding (in shares) | shares				1,252,748		522,786
Common stock, shares, transferred (in shares) | shares		15,000
Financial instruments subject to mandatory redemption, settlement terms, share value, amount, current				$ 117,770,000		$ 116,969,000
Increase in Marketable securities in trust account and Class A mandatory redeemable common shares	$ 13,000,000				13,270,000
Deferred offering costs – SPACs (See Note 5)				0						$ 48,261,000
Payments of stock issuance costs				$ 0	$ 3,502,000
IHC
Concentration Risk [Line Items]
Deferred offering costs – SPACs (See Note 5)	$ 9,500,000									$ 9,800,000
Accounting Standards Update 2018-11
Concentration Risk [Line Items]
Operating lease, liability									$ 7,700,000
IHC
Concentration Risk [Line Items]
Variable interest entity, qualitative or quantitative information, ownership percentage				15.00%
Common stock, shares, owned (in shares) | shares	2,110,000	2,125,000		2,110,000
Increase in Marketable securities in trust account and Class A mandatory redeemable common shares	$ 9,500,000
Payments of stock issuance costs	3,500,000					$ 3,500,000
IPO | Subsequent Event
Concentration Risk [Line Items]
Redemption funds distributed to shareholders			$ 117,574,000
IPO | IHC
Concentration Risk [Line Items]
Sale of stock, number of shares issued in transaction (in shares) | shares						11,500,000
Proceeds from initial public offering of IHC	115,000,000
Assets held-in-trust	$ 1,725,000			$ 1,700,000
Sale of stock, price per share (in dollars per share) | $ / shares	$ 10.00
Sale of stock, number of common shares issued per unit (in shares) | shares	1							1
Sale of stock, number of warrants issued per unit (in shares) | shares	1
Class of warrant or right, number of securities called by each warrant or right (in shares) | shares	1							1
Exercise price of warrants (in dollars per share) | $ / shares	$ 11.50
Initial business combination consummation period	12 months
Redemption percentage	100.00%
IPO | IHC | Placement Warrants
Concentration Risk [Line Items]
Exercise price of warrants (in dollars per share) | $ / shares	$ 11.50
Class of warrant or right, outstanding (in shares) | shares	4,639,102
Sale of warrants, price per share (in dollars per share) | $ / shares	$ 1.00
Aggregate purchase price	$ 4,639,102
Minimum
Concentration Risk [Line Items]
Capitalized software development, useful life				3 years
Minimum | Software Development
Concentration Risk [Line Items]
Property, plant and equipment, useful life				3 years
Maximum
Concentration Risk [Line Items]
Capitalized software development, useful life				5 years
Maximum | Software Development
Concentration Risk [Line Items]
Property, plant and equipment, useful life				5 years
Seven Clients | Customer Concentration Risk | Accounts Receivable
Concentration Risk [Line Items]
Concentration risk, percentage				88.00%
Three Clients | Customer Concentration Risk | Accounts Receivable
Concentration Risk [Line Items]
Concentration risk, percentage					98.00%

XML

Summary of Significant Accounting Policies - Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended
	Nov. 30, 2022	Nov. 30, 2021
Disaggregation of Revenue [Line Items]
Revenues	$ 5,266	$ 8,940
Gross billings	11,700	14,100
Worksite employee payroll cost	10,300	12,300
HCM
Disaggregation of Revenue [Line Items]
Revenues	1,500	1,800
Staffing
Disaggregation of Revenue [Line Items]
Revenues	$ 3,800	$ 7,100

XML

Summary of Significant Accounting Policies - Revenue from External Customers by Geographical Areas (Details) - Revenue from Contract with Customer Benchmark - Geographic Concentration Risk	3 Months Ended
	Nov. 30, 2022	Nov. 30, 2021
California
Concentration Risk [Line Items]
Concentration risk, percentage	48.80%	53.70%
Washington
Concentration Risk [Line Items]
Concentration risk, percentage	12.20%	13.30%
New Mexico
Concentration Risk [Line Items]
Concentration risk, percentage	10.20%	673.00%

XML

Summary of Significant Accounting Policies - Schedule of Estimated Useful Lives of Property and Equipment (Details)	3 Months Ended
	Nov. 30, 2022
Equipment:
Property, Plant and Equipment [Line Items]
Property, plant and equipment, useful life	5 years
Furniture & Fixtures: | Minimum
Property, Plant and Equipment [Line Items]
Property, plant and equipment, useful life	5 years
Furniture & Fixtures: | Maximum
Property, Plant and Equipment [Line Items]
Property, plant and equipment, useful life	7 years
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property, plant and equipment, useful life	5 years

XML

Summary of Significant Accounting Policies - Weighted Average Dilutive Common Shares (Details) - shares	3 Months Ended
	Nov. 30, 2022	Nov. 30, 2021
Total potentially dilutive shares (in shares)	1,263,351	178,941
Options (See Note 8)
Total potentially dilutive shares (in shares)	10,603	4,023
Warrants
Total potentially dilutive shares (in shares)	1,252,748	174,918

XML

Discontinued Operations - Narrative (Details) - USD ($)		3 Months Ended	12 Months Ended
	Jan. 03, 2020	Nov. 30, 2022	Aug. 31, 2022	Aug. 31, 2020	Mar. 12, 2021
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Reserve on potential collectability		$ 4,004,000	$ 4,004,000
Disposal by sale | Overall business
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Percentage of business sold	88.00%
Working capital assets transferred	$ 1,500,000
Gross proceeds	19,200,000	19,166,000	19,166,000
Proceeds from divestiture of businesses	9,700,000
Gross note receivable	$ 9,500,000	9,500,000	9,500,000
Period for payment of gross proceeds (in years)	4 years
Customer retention period (in years)	12 months
Working capital adjustment		2,604,000	2,604,000		$ 10,700,000
Disposal group, including discontinued operations, additional reserve for estimated potential claims		2,892,000	2,892,000
Note receivable, net		0	$ 0
Discontinued operation, gain (Loss) on disposal of discontinued operation, net of tax				$ 15,600,000
Disposal group, including discontinued operation, consideration receivable, notes receivable, working capital adjustments		2,600,000
Lower net assets transferred at closing		100,000
Disposal group, including discontinued operations, consideration receivable, notes receivable, working capital adjustments for cash remitted to bank account by former client		$ 2,500,000
Disposal group including discontinued operations, estimated lower percentage of gross wages		90.00%
Disposal group including discontinued operations, contingent consideration		$ 1,400,000
Disposal by sale | PEO business
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Percentage of business sold	100.00%

XML

Discontinued Operations - Reconciliation of Gross Proceeds to Net Proceeds From Sale Transaction (Details) - USD ($)	3 Months Ended	12 Months Ended
	Nov. 30, 2022	Aug. 31, 2022	Mar. 12, 2021	Jan. 03, 2020
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Reserve for potential collectability concerns	$ (4,004,000)	$ (4,004,000)
Overall business | Disposal by sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Gross proceeds	19,166,000	19,166,000		$ 19,200,000
Cash received at closing – asset sale	(9,500,000)	(9,500,000)
Cash received at closing – working capital	(166,000)	(166,000)
Gross note receivable	9,500,000	9,500,000		$ 9,500,000
Less:  Transaction reconciliation – estimated working capital adjustments	(2,604,000)	(2,604,000)	$ (10,700,000)
Adjusted Note Receivable	6,896,000	6,896,000
Reserve for estimated potential claims	(2,892,000)	(2,892,000)
Long-term note receivable, estimated net realizable value	$ 0	$ 0

XML

Discontinued Operations - Carrying Amounts of Assets and Liabilities (Details) - USD ($)	Nov. 30, 2022	Aug. 31, 2022
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Deposits – workers’ compensation	$ 0
Deposits – workers’ compensation	0
Accrued workers’ compensation cost	1,400,000
Total current liabilities	1,438,000	$ 1,362,000
Accrued workers’ compensation cost	3,400,000
Disposal by sale | Overall business
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Deposits – workers’ compensation	0	0
Total current assets	0	0
Deposits – workers’ compensation	0	0
Total assets	0	0
Accrued workers’ compensation cost	1,438,000	1,362,000
Total current liabilities	1,438,000	1,362,000
Accrued workers’ compensation cost	3,394,000	3,269,000
Total liabilities	4,832,000	4,631,000
Net liability	$ (4,832,000)	$ (4,631,000)

XML

Discontinued Operations - Reported Results for the Discontinued Operations (Details) - Disposal by sale - Overall business - USD ($) $ in Thousands	3 Months Ended
	Nov. 30, 2022	Nov. 30, 2021
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Revenues	$ 0	$ 0
Cost of revenue	200	134
Gross profit (loss)	(200)	(134)
Total operating expenses	0	0
(Loss) income from discontinued operations	$ (200)	$ (134)

XML

Special Purpose Acquisition Company ("SPAC") Sponsorship (Details)			3 Months Ended		12 Months Ended
	Mar. 18, 2022 USD ($)	Oct. 22, 2021 USD ($) $ / shares shares	Nov. 30, 2022 USD ($) shares	Nov. 30, 2021 USD ($)	Aug. 31, 2022 USD ($) shares	Oct. 15, 2022 shares	Oct. 14, 2022 USD ($) shares	Oct. 19, 2021 shares	Apr. 29, 2021 USD ($)	Apr. 29, 2021	Apr. 29, 2021 company	Apr. 29, 2021 sponsorship
Investments in and Advances to Affiliates [Line Items]
Other commitments, number of special purpose acquisition company sponsorships											4	4
Other commitments, capital investment sought, per acquisition company									$ 150,000,000
Withdrawal from SPAC S-1 forms	$ 38,000,000
Class of warrant or right, outstanding (in shares) | shares			1,252,748		522,786
Temporary equity, carrying amount, attributable to parent		$ 116,725,000
Increase in Marketable securities in trust account and Class A mandatory redeemable common shares		13,000,000		$ 13,270,000
Payments of stock issuance costs			$ 0	3,502,000
Investment income, interest			900,000	$ 3,000
Other commitments, percentage of outstanding shares, per acquisition company										15.00%
IHC
Investments in and Advances to Affiliates [Line Items]
Increase in Marketable securities in trust account and Class A mandatory redeemable common shares		9,500,000
Payment of deferred offering costs		300,000
Payments of stock issuance costs		$ 3,500,000			$ 3,500,000
TechStackery
Investments in and Advances to Affiliates [Line Items]
Payments of stock issuance costs					0
Vital Human Capital
Investments in and Advances to Affiliates [Line Items]
Payments of stock issuance costs					0
Firemark Global Capital
Investments in and Advances to Affiliates [Line Items]
Payments of stock issuance costs					$ 0
IHC SPAC Sponsorship
Investments in and Advances to Affiliates [Line Items]
Other commitments, interest rate		1.50%
IHC
Investments in and Advances to Affiliates [Line Items]
Assets held-in-trust, net tangible assets threshold							$ 5,000,001
IHC | Public Shares
Investments in and Advances to Affiliates [Line Items]
Common stock, shares, outstanding (in shares) | shares						248,653
IHC | Redeeming Shareholders
Investments in and Advances to Affiliates [Line Items]
Common stock, shares, outstanding (in shares) | shares							11,251,347
IPO | IHC
Investments in and Advances to Affiliates [Line Items]
Sale of stock, number of common shares issued per unit (in shares) | shares		1						1
Class of warrant or right, number of securities called by each warrant or right (in shares) | shares		1						1
Proceeds from initial public offering of IHC		$ 115,000,000
Assets held-in-trust		$ 1,725,000	$ 1,700,000
IPO | IHC | Placement Warrants
Investments in and Advances to Affiliates [Line Items]
Class of warrant or right, outstanding (in shares) | shares		4,639,102
Sale of warrants, price per share (in dollars per share) | $ / shares		$ 1.00
Aggregate purchase price		$ 4,639,102
IPO | IHC
Investments in and Advances to Affiliates [Line Items]
Class of warrant or right, number of securities called by each warrant or right (in shares) | shares								1

XML

Deferred Offering Costs - SPACs - Narrative (Details)			3 Months Ended		12 Months Ended
	Oct. 22, 2021 USD ($)	Apr. 22, 2021 USD ($) year $ / shares shares	Nov. 30, 2022 USD ($)	Nov. 30, 2021 USD ($)	Aug. 31, 2022 USD ($)	Mar. 18, 2022 sponsorship	Aug. 31, 2021 USD ($)	Apr. 29, 2021 company	Apr. 29, 2021 sponsorship
Noncontrolling Interest [Line Items]
Other commitments, number of special purpose acquisition company sponsorships								4	4
Deferred costs, noncurrent			$ 0				$ 48,261,000
Accrued professional fees							789,000
Deferred offering costs, excluding fees					$ 38,000,000		47,472,000
Increase in Marketable securities in trust account and Class A mandatory redeemable common shares	$ 13,000,000			$ 13,270,000
Deferred offering costs, increase (decrease)					38,500,000
Other commitments, number of special purpose acquisition company sponsorships withdrawn from | sponsorship						3
Expensed SPAC offering costs					$ 500,000
IHC
Noncontrolling Interest [Line Items]
Increase in Marketable securities in trust account and Class A mandatory redeemable common shares	9,500,000
TechStackery
Noncontrolling Interest [Line Items]
Deferred offering costs, increase (decrease)			0
Vital Human Capital
Noncontrolling Interest [Line Items]
Deferred offering costs, increase (decrease)			0
Firemark Global Capital
Noncontrolling Interest [Line Items]
Deferred offering costs, increase (decrease)			$ 0
IHC
Noncontrolling Interest [Line Items]
Deferred costs, noncurrent	$ 9,500,000						$ 9,800,000
Measurement Input, Discount Rate
Noncontrolling Interest [Line Items]
Noncontrolling interest, measurement input | year		0.488
Measurement Input, Consummation Rate
Noncontrolling Interest [Line Items]
Noncontrolling interest, measurement input | year		0.20
Measurement Input, Special Acquisition Company Completion Rate
Noncontrolling Interest [Line Items]
Noncontrolling interest, measurement input | year		0.20
Measurement Input, Concession Rate
Noncontrolling Interest [Line Items]
Noncontrolling interest, measurement input | year		0.21
IHC, TechStackery, Vital And Firemark | Third Party Representative | Special Acquisition Company
Noncontrolling Interest [Line Items]
Sale of stock, number of shares issued in transaction (in shares) | shares		10,000,000
Sale of stock, consideration received on transaction		$ 47,472,000
Sale of stock, price per share (in dollars per share) | $ / shares		$ 4.7472
Sale of stock, stock and warrant price per share (in dollars per share) | $ / shares		10
Sale of stock, price per warrant (in dollars per share) | $ / shares		0.75
Sale of stock, unit price per common share (in dollars per share) | $ / shares		$ 9.25
IHC | Third Party Representative | Special Acquisition Company
Noncontrolling Interest [Line Items]
Sale of stock, number of shares issued in transaction (in shares) | shares		2,000,000
TechStackery | Third Party Representative | Special Acquisition Company
Noncontrolling Interest [Line Items]
Sale of stock, number of shares issued in transaction (in shares) | shares		2,000,000
Vital Human Capital | Third Party Representative | Special Acquisition Company
Noncontrolling Interest [Line Items]
Sale of stock, number of shares issued in transaction (in shares) | shares		2,000,000
Firemark Global Capital | Third Party Representative | Special Acquisition Company
Noncontrolling Interest [Line Items]
Sale of stock, number of shares issued in transaction (in shares) | shares		4,000,000

XML

Going Concern - (Details) - USD ($) $ in Thousands	1 Months Ended	3 Months Ended
	Sep. 30, 2022	Nov. 30, 2022	Nov. 30, 2021	Aug. 31, 2022
Going Concern [Line Items]
Cash		$ 900
Working capital deficit		32,000
Net cash provided by (used in) operating activities, continuing operations		(3,743)	$ (6,673)
Retained earnings (accumulated deficit)		$ (198,148)		$ (192,725)
Private Placement
Going Concern [Line Items]
Sale of stock, consideration received on transaction, gross	$ 5,000
Sale of stock, consideration received on transaction	$ 4,400

XML

Stockholders' Deficit - Additional Information (Details)									3 Months Ended		4 Months Ended
	Sep. 20, 2022 USD ($) warrant $ / shares shares	Aug. 12, 2022 USD ($) $ / shares shares	Jul. 19, 2022 $ / shares shares	Jul. 14, 2022 USD ($) multiple $ / shares shares	Oct. 22, 2021 shares	Aug. 13, 2021 $ / shares shares	Jun. 05, 2020 shares	Jun. 04, 2020 USD ($) shares	Nov. 30, 2022 USD ($) $ / shares shares	Nov. 30, 2021 USD ($)	Nov. 30, 2020 shares	Aug. 31, 2022 $ / shares shares	Jan. 28, 2022 shares	Sep. 03, 2021 shares	Jun. 04, 2021 $ / shares	Jan. 31, 2020 shares	Sep. 30, 2016 $ / shares shares
Class of Warrant or Right [Line Items]
Preferred stock, par or stated value per share (in dollars per share) | $ / shares									$ 0.0001			$ 0.0001					$ 0.0001
Convertible preferred stock, shares issued upon conversion (in shares)																	1
Stock options exercised (in shares)
Share-based compensation arrangement by share-based payment award, options, forfeitures in period (in shares)									1,150
Preferred options outstanding (in shares)									10,603			11,753
Share-based compensation arrangement by share-based payment award, expiration period									10 years
Options forfeited (in shares)									369
Common stock, par or stated value per share (in dollars per share) | $ / shares									$ 0.0001			$ 0.0001			$ 0.0001
Decrease in employee related liabilities | $									$ (2,711,000)	$ (743,000)
Preferred stock preferential dividend | $									$ 127,145,000	$ 0
Exercise price of warrants (in dollars per share) | $ / shares									$ 34.78			$ 47.99
Class of warrant or right, outstanding (in shares)									1,252,748			522,786
Common Stock Warrants
Class of Warrant or Right [Line Items]
Class of warrant or right, deemed dividend | $	$ 106,000
Chief Executive Officer | Scott W Absher
Class of Warrant or Right [Line Items]
Preferred stock, par or stated value per share (in dollars per share) | $ / shares						$ 0.0001
Share-based compensation arrangement by share-based payment award, fair value assumptions, exercise price (in dollars per share) | $ / shares		$ 0.0001		$ 0.0001		$ 0.0001			$ 0.0001
Share-based compensation arrangement by share-based payment award, expiration period		10 years		10 years		24 months
Share-based compensation arrangement by share-based payment award, assets or earning power threshold for option exercise						50.00%
Convertible preferred stock, shares issuable upon conversion per preferred share (in shares)						1
Options forfeited (in shares)				12,500,000
Price per share (in dollars per share) | $ / shares		$ 0.2		$ 0.3
Share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate		3.00%		3.10%
Share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate		125.70%		125.70%
Decrease in employee related liabilities | $		$ 820,793
Shares issued for services rendered (in shares)		4,100,000
Preferred Stock Issued
Class of Warrant or Right [Line Items]
Stock options exercised (in shares)											294,490
Preferred options outstanding (in shares)									37,570
Preferred Stock Issued | Chief Executive Officer | Scott W Absher
Class of Warrant or Right [Line Items]
Preferred stock, par or stated value per share (in dollars per share) | $ / shares				$ 0.0001
Stock options exercised (in shares)								12,500,000
Number of options available for grant to founder shareholders (in shares)						12,500,000		12,500,000	12,500,000
Proceeds from issuance of preferred stock | $				$ 5,000				$ 1,250
Number option additionally available for grant to founder shareholders (in shares)							12,500,000
Multiples of par value paid for preferred stock | multiple				4
Preferred Stock Issued | Founding Shareholder | J Stephen Holmes
Class of Warrant or Right [Line Items]
Share-based compensation arrangement by share-based payment award, options, forfeitures in period (in shares)					11,790,000
Common Stock Issued | Chief Executive Officer | Scott W Absher
Class of Warrant or Right [Line Items]
Convertible preferred stock, shares issued upon conversion (in shares)			8,000,000
Common shares lock up period		6 months	6 months
Common stock, par or stated value per share (in dollars per share) | $ / shares			$ 0.0001
Stock Option | Chief Executive Officer | Scott W Absher
Class of Warrant or Right [Line Items]
Number of options available for grant to founder shareholders (in shares)									25,000,000
Stock Option | Preferred Stock Issued
Class of Warrant or Right [Line Items]
Convertible preferred stock (in shares)																24,634,560
Common Share Units
Class of Warrant or Right [Line Items]
Shares issued upon conversion (in shares)											294,490
Common shares lock up period											6 months
Common Share Units | Chief Executive Officer | Scott W Absher
Class of Warrant or Right [Line Items]
Shares issued upon conversion (in shares)							12,500,000
Common shares lock up period							24 months
Preferred Class A | Preferred Stock Issued | Chief Executive Officer | Scott W Absher
Class of Warrant or Right [Line Items]
Number of options available for grant to founder shareholders (in shares)				12,500,000
Convertible Preferred Stock | Chief Executive Officer | Scott W Absher
Class of Warrant or Right [Line Items]
Price per share (in dollars per share) | $ / shares		$ 0.2025		$ 0.2322
Private Placement
Class of Warrant or Right [Line Items]
Sale of stock, number of shares and warrants issued in transaction (in shares)	416,667
Exercise price of warrants (in dollars per share) | $ / shares	$ 0.01
Private Placement | Common Stock Warrants
Class of Warrant or Right [Line Items]
Share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate	3.70%
Share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate	149.40%
Warrants to acquire shares of common stock (in shares)	833,334
Sale of stock, number of warrants accompanying each common share | warrant	2
Sale of stock, stock and warrant price per share (in dollars per share) | $ / shares	$ 12.00
Warrants term	7 years
Exercise price of warrants (in dollars per share) | $ / shares	$ 12.00
Proceeds from issuance of private placement | $	$ 4,738,000
Share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate	0.00%
Private Placement | Common Stock Warrants | Minimum
Class of Warrant or Right [Line Items]
Share-based compensation arrangement by share-based payment award, fair value assumptions, expected term	6 years 8 months 12 days
Private Placement | Common Stock Warrants | Maximum
Class of Warrant or Right [Line Items]
Share-based compensation arrangement by share-based payment award, fair value assumptions, expected term	6 years 9 months 18 days
Private Placement | September 2021 Modified Warrants
Class of Warrant or Right [Line Items]
Class of warrant or right, outstanding (in shares)														25,233
Private Placement | January 2022 Modified Warrants
Class of Warrant or Right [Line Items]
Class of warrant or right, outstanding (in shares)													98,969
Overallotment
Class of Warrant or Right [Line Items]
Warrants to acquire shares of common stock (in shares)	20,833
Warrants term	4 years
Exercise price of warrants (in dollars per share) | $ / shares	$ 13.20
Sale of stock, placement fee	7.00%
Sale of stock, common stock shares as a percent of offering	5.00%
Warrants and rights outstanding, requisite exercise period	6 months

XML

Stockholders' Deficit - Summary of Information About Warrants Outstanding (Details) - $ / shares	3 Months Ended	12 Months Ended
	Nov. 30, 2022	Aug. 31, 2022
Number of shares
Number of shares outstanding, beginning balance (in shares)	522,786
Issued (in shares)	854,166
Exercised (in shares)	(124,204)
Number of shares outstanding, ending balance (in shares)	1,252,748	522,786
Number of shares exercisable (in shares)	50,173
Weighted average remaining life (years)
Weighted average Life of Outstanding Warrants in years	6 years 10 months 24 days	7 years 2 months 12 days
Issued	7 years 1 month 6 days
Weighted remaining life (years) exercisable	3 years
Weighted average exercise price
Weighted average exercise price (in dollars per share)	$ 34.78	$ 47.99
Issued (in dollars per share)	12.00
Weighted average exercise price exercisable (in dollars per share)	$ 459.36

XML

Stockholders' Deficit - Summary of Warrants Outstanding (Details) - $ / shares	3 Months Ended	12 Months Ended
	Nov. 30, 2022	Aug. 31, 2022
Class of Warrant or Right [Line Items]
Class of warrant or right, outstanding (in shares)	1,252,748	522,786
Weighted average Life of Outstanding Warrants in years	6 years 10 months 24 days	7 years 2 months 12 days
Exercise price of warrants (in dollars per share)	$ 34.78	$ 47.99
Warrants
Class of Warrant or Right [Line Items]
Class of warrant or right, outstanding (in shares)	1,252,748
Weighted average Life of Outstanding Warrants in years	6 years 10 months 24 days
Exercise price of warrants (in dollars per share)	$ 34.78
September 2022 Common Warrants
Class of Warrant or Right [Line Items]
Warrants and rights outstanding, requisite exercise period	6 months
September 2022 Common Warrants | Warrants
Class of Warrant or Right [Line Items]
Class of warrant or right, outstanding (in shares)	833,333
Weighted average Life of Outstanding Warrants in years	6 years 9 months 18 days
Exercise price of warrants (in dollars per share)	$ 12.00
September 2022 Underwriter Warrants | Warrants
Class of Warrant or Right [Line Items]
Class of warrant or right, outstanding (in shares)	20,833
Weighted average Life of Outstanding Warrants in years	4 years 3 months 18 days
Exercise price of warrants (in dollars per share)	$ 13.20
July 2022 Common Warrants | Warrants
Class of Warrant or Right [Line Items]
Class of warrant or right, outstanding (in shares)	348,408
Weighted average Life of Outstanding Warrants in years	7 years 7 months 6 days
Exercise price of warrants (in dollars per share)	$ 26.00
Sep 2021Underwriter Warrants | Warrants
Class of Warrant or Right [Line Items]
Class of warrant or right, outstanding (in shares)	3,762
Weighted average Life of Outstanding Warrants in years	6 years 4 months 24 days
Exercise price of warrants (in dollars per share)	$ 175.00
May 2021Underwriter Warrants | Warrants
Class of Warrant or Right [Line Items]
Class of warrant or right, outstanding (in shares)	2,474
Weighted average Life of Outstanding Warrants in years	3 years 6 months
Exercise price of warrants (in dollars per share)	$ 267.00
October 2020 Common Warrants | Warrants
Class of Warrant or Right [Line Items]
Class of warrant or right, outstanding (in shares)	23,000
Weighted average Life of Outstanding Warrants in years	2 years 10 months 24 days
Exercise price of warrants (in dollars per share)	$ 330.00
October 2020 Underwriter Warrants | Warrants
Class of Warrant or Right [Line Items]
Class of warrant or right, outstanding (in shares)	2,000
Weighted average Life of Outstanding Warrants in years	2 years 10 months 24 days
Exercise price of warrants (in dollars per share)	$ 330.00
May 2020 Common Warrants | Warrants
Class of Warrant or Right [Line Items]
Class of warrant or right, outstanding (in shares)	12,776
Weighted average Life of Outstanding Warrants in years	2 years 6 months
Exercise price of warrants (in dollars per share)	$ 540.00
May 2020 Underwriter Warrants | Warrants
Class of Warrant or Right [Line Items]
Class of warrant or right, outstanding (in shares)	1,111
Weighted average Life of Outstanding Warrants in years	2 years 6 months
Exercise price of warrants (in dollars per share)	$ 540.00
March 2020 Exchange Warrants | Warrants
Class of Warrant or Right [Line Items]
Class of warrant or right, outstanding (in shares)	4,237
Weighted average Life of Outstanding Warrants in years	2 years 10 months 24 days
Exercise price of warrants (in dollars per share)	$ 1,017
Amended March 2019 Warrants | Warrants
Class of Warrant or Right [Line Items]
Class of warrant or right, outstanding (in shares)	663
Weighted average Life of Outstanding Warrants in years	1 year 3 months 18 days
Exercise price of warrants (in dollars per share)	$ 4,000
March 2019 Services Warrants | Warrants
Class of Warrant or Right [Line Items]
Class of warrant or right, outstanding (in shares)	34
Weighted average Life of Outstanding Warrants in years	1 year 3 months 18 days
Exercise price of warrants (in dollars per share)	$ 7,000
June 2018 Warrants | Warrants
Class of Warrant or Right [Line Items]
Class of warrant or right, outstanding (in shares)	63
Weighted average Life of Outstanding Warrants in years	1 year
Exercise price of warrants (in dollars per share)	$ 4,000
June 2018 Services Warrants | Warrants
Class of Warrant or Right [Line Items]
Class of warrant or right, outstanding (in shares)	54
Weighted average Life of Outstanding Warrants in years	1 year
Exercise price of warrants (in dollars per share)	$ 9,960

XML

Stock Based Compensation - Additional Information (Details) - USD ($)	3 Months Ended
	Nov. 30, 2022	Nov. 30, 2021	Aug. 31, 2022	Jun. 04, 2021	Jul. 01, 2020	Jun. 30, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares of common stock issuable (in shares)				3,000,000	3,000,000	250,000
Common stock, par or stated value per share (in dollars per share)	$ 0.0001		$ 0.0001	$ 0.0001
Share-based compensation arrangement by share-based payment award, expiration period	10 years
Compensation expense	$ 255,000	$ 408,000
Share-based compensation arrangement by share-based payment award, options, outstanding, intrinsic value	$ 0
Share-based payment arrangement, nonvested award, cost not yet recognized, period for recognition	1 year 9 months 18 days
Share-based payment arrangement, nonvested award, cost not yet recognized, amount	$ 1,458,000
Options Granted on or After July 1, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation arrangement by share-based payment award, award vesting period	4 years
Share-based payment arrangement, tranche one | Granted Prior to July 1, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation arrangement by share-based payment award, award vesting rights, percentage	25.00%
Share-based compensation arrangement by share-based payment award, award vesting period	12 months
Share-based payment arrangement, tranche one | Options Granted on or After July 1, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation arrangement by share-based payment award, award vesting rights, percentage	25.00%
Share-based compensation arrangement by share-based payment award, award vesting period	1 year
Share-based payment arrangement, tranche two | Granted Prior to July 1, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation arrangement by share-based payment award, award vesting period	36 months

XML

Stock Based Compensation - Summary of Option Activity (Details) - $ / shares	3 Months Ended	12 Months Ended
	Nov. 30, 2022	Aug. 31, 2022
Number of Options
Beginning balance (in shares)	11,753
Granted (in shares)
Exercised (in shares)
Forfeited (in shares)	(1,150)
Ending balance (in shares)	10,603	11,753
Options exercisable (in shares)	10,603	11,753
Weighted Average Remaining Contractual Life
Balance, outstanding	7 years 9 months 18 days	8 years 1 month 6 days
Balance, exercisable	7 years 9 months 18 days	8 years 1 month 6 days
Weighted Average Exercise Price
Outstanding (in dollars per share)	$ 789.00	$ 733.00
Exercisable (in dollars per share)	789.00	$ 733.00
Granted (in dollars per share)
Exercised (in dollars per share)
Forfeited (in dollars per share)	$ 217.00

XML

Stock Based Compensation - Schedule of Option Vesting Activity (Details) - $ / shares	3 Months Ended	12 Months Ended
	Nov. 30, 2022	Aug. 31, 2022
Number of Options
Options vested, beginning balance (in shares)	5,269
Vested (in shares)	830
Forfeited (in shares)	(369)
Options vested, ending balance (in shares)	5,730	5,269
Weighted Remaining Contractual Life
Outstanding	7 years 7 months 6 days	8 years 1 month 6 days
Vested	8 years
Exercised	0 years
Weighted Average Exercise Price
Outstanding (in dollars per share)	$ 1,101	$ 1,146
Vested (in dollars per share)	426.00
Forfeited (in dollars per share)	$ 286.00

XML

Stock Based Compensation - Stock Options Outstanding and Vested (Details) - $ / shares	3 Months Ended
	Nov. 30, 2022	Aug. 31, 2022
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Number of Options Exercisable, Outstanding (in shares)	10,603
Number of Options Exercisable, Exercisable (in shares)	10,603
Weighted Average Remaining Contractual Life, Outstanding	7 years 7 months 6 days
Weighted Average Remaining Contractual Life, Exercisable	7 years 7 months 6 days
Weighted Average Exercise Price, Outstanding (in dollars per share)	$ 789.00	$ 733.00
Weighted Average Exercise Price (in dollars per share)	$ 789.00	$ 733.00
Number of Options Vested (in shares)	5,730	5,269
Weighted Average Remaining Contractual Life	7 years 7 months 6 days
Weighted Average Exercise Price (in dollars per share)	$ 1,101	$ 1,146
Exercise Price Range One
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Number of Options Exercisable, Outstanding (in shares)	10,241
Number of Options Exercisable, Exercisable (in shares)	10,241
Weighted Average Remaining Contractual Life, Outstanding	7 years 9 months 18 days
Weighted Average Remaining Contractual Life, Exercisable	7 years 9 months 18 days
Weighted Average Exercise Price, Outstanding (in dollars per share)	$ 438.00
Weighted Average Exercise Price (in dollars per share)	$ 438.00
Number of Options Vested (in shares)	5,375
Weighted Average Remaining Contractual Life	7 years 9 months 18 days
Weighted Average Exercise Price (in dollars per share)	$ 467.00
Exercise Price Range Two
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Number of Options Exercisable, Outstanding (in shares)	20
Number of Options Exercisable, Exercisable (in shares)	20
Weighted Average Remaining Contractual Life, Outstanding	6 years 6 months
Weighted Average Remaining Contractual Life, Exercisable	6 years 6 months
Weighted Average Exercise Price, Outstanding (in dollars per share)	$ 1,895
Weighted Average Exercise Price (in dollars per share)	$ 1,895
Number of Options Vested (in shares)	18
Weighted Average Remaining Contractual Life	7 years 3 months 18 days
Weighted Average Exercise Price (in dollars per share)	$ 1,897
Exercise Price Range Three
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Number of Options Exercisable, Outstanding (in shares)	121
Number of Options Exercisable, Exercisable (in shares)	121
Weighted Average Remaining Contractual Life, Outstanding	6 years 3 months 18 days
Weighted Average Remaining Contractual Life, Exercisable	6 years 3 months 18 days
Weighted Average Exercise Price, Outstanding (in dollars per share)	$ 5,121
Weighted Average Exercise Price (in dollars per share)	$ 5,121
Number of Options Vested (in shares)	116
Weighted Average Remaining Contractual Life	6 years 7 months 6 days
Weighted Average Exercise Price (in dollars per share)	$ 5,120
Exercise Price Range Four
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Number of Options Exercisable, Outstanding (in shares)	101
Number of Options Exercisable, Exercisable (in shares)	101
Weighted Average Remaining Contractual Life, Outstanding	5 years 6 months
Weighted Average Remaining Contractual Life, Exercisable	5 years 6 months
Weighted Average Exercise Price, Outstanding (in dollars per share)	$ 10,298
Weighted Average Exercise Price (in dollars per share)	$ 10,298
Number of Options Vested (in shares)	101
Weighted Average Remaining Contractual Life	5 years 6 months
Weighted Average Exercise Price (in dollars per share)	$ 10,298
Exercise Price Range Five
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Number of Options Exercisable, Outstanding (in shares)	109
Number of Options Exercisable, Exercisable (in shares)	109
Weighted Average Remaining Contractual Life, Outstanding	4 years 7 months 6 days
Weighted Average Remaining Contractual Life, Exercisable	4 years 7 months 6 days
Weighted Average Exercise Price, Outstanding (in dollars per share)	$ 15,584
Weighted Average Exercise Price (in dollars per share)	$ 15,584
Number of Options Vested (in shares)	109
Weighted Average Remaining Contractual Life	4 years 7 months 6 days
Weighted Average Exercise Price (in dollars per share)	$ 15,584
Exercise Price Range Six
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Number of Options Exercisable, Outstanding (in shares)	11
Number of Options Exercisable, Exercisable (in shares)	11
Weighted Average Remaining Contractual Life, Outstanding	4 years 7 months 6 days
Weighted Average Remaining Contractual Life, Exercisable	4 years 7 months 6 days
Weighted Average Exercise Price, Outstanding (in dollars per share)	$ 30,160
Weighted Average Exercise Price (in dollars per share)	$ 30,160
Number of Options Vested (in shares)	11
Weighted Average Remaining Contractual Life	4 years 7 months 6 days
Weighted Average Exercise Price (in dollars per share)	$ 39,160
Minimum | Exercise Price Range One
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Prices (in dollars per share)	0.50
Minimum | Exercise Price Range Two
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Prices (in dollars per share)	10.01
Minimum | Exercise Price Range Three
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Prices (in dollars per share)	40.01
Minimum | Exercise Price Range Four
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Prices (in dollars per share)	80.01
Minimum | Exercise Price Range Five
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Prices (in dollars per share)	120.01
Minimum | Exercise Price Range Six
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Prices (in dollars per share)	160.01
Maximum | Exercise Price Range One
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Prices (in dollars per share)	10.00
Maximum | Exercise Price Range Two
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Prices (in dollars per share)	40.00
Maximum | Exercise Price Range Three
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Prices (in dollars per share)	80.00
Maximum | Exercise Price Range Four
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Prices (in dollars per share)	120.00
Maximum | Exercise Price Range Five
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Prices (in dollars per share)	160.00
Maximum | Exercise Price Range Six
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Prices (in dollars per share)	$ 391.60

XML

Related Parties and Certain Directors and Officers (Details) - USD ($)			3 Months Ended		12 Months Ended
	Sep. 01, 2022	Nov. 18, 2021	Nov. 30, 2022	Nov. 30, 2021	Aug. 31, 2023	Aug. 31, 2022	Aug. 31, 2021	Sep. 30, 2016
Related Party Transaction [Line Items]
Convertible preferred stock, shares issued upon conversion (in shares)								1
Preferred stock preferential dividend			$ 127,145,000	$ 0
Professional fees			1,195,000	1,737,000
Chief Executive Officer
Related Party Transaction [Line Items]
Payments to employees			127,644	153,307
Unpaid compensation accrual			58,832
Chief Executive Officer | Forecast
Related Party Transaction [Line Items]
Salaried compensation, amount					$ 750,000
Chief Executive Officer | Preferred Stock Issued
Related Party Transaction [Line Items]
Conversion of stock, shares converted (in shares)	8,600,000
Chief Executive Officer | Common Stock Issued
Related Party Transaction [Line Items]
Convertible preferred stock, shares issued upon conversion (in shares)	8,600,000
Chief Operating Officer
Related Party Transaction [Line Items]
Payments to employees			66,078	66,038
Unpaid compensation accrual			58,967
J Stephen Holmes | Management
Related Party Transaction [Line Items]
Payments to employees			0	120,000
Professional fees			0				$ 750,000
Domonic J Carney | Former CFO and Treasurer
Related Party Transaction [Line Items]
Unpaid compensation accrual			87,858
Mark Absher | Affiliated Entity
Related Party Transaction [Line Items]
Payments to employees			60,296	8,307
Salaried compensation, amount		$ 240,000
David May | Affiliated Entity
Related Party Transaction [Line Items]
Payments to employees			37,319	42,857		$ 149,000
Jason Absher | Affiliated Entity
Related Party Transaction [Line Items]
Payments to employees			30,017	30,000
Phil Eastvold | Affiliated Entity
Related Party Transaction [Line Items]
Payments to employees			56,083	56,038
Connie Absher, Elizabeth Eastvold, and Hannah Woods | Affiliated Entity
Related Party Transaction [Line Items]
Payments to employees			$ 48,764	$ 53,611

XML

Commitments - Narrative (Details)		3 Months Ended	12 Months Ended	13 Months Ended
	Oct. 22, 2021 USD ($) $ / shares shares	Nov. 30, 2022 USD ($) $ / shares shares	Aug. 31, 2022 USD ($) $ / shares shares	Nov. 30, 2022 USD ($) $ / shares shares	May 02, 2022	Oct. 19, 2021 shares	Jun. 21, 2021 ft²	Jun. 07, 2021 ft²	Apr. 29, 2021 USD ($)	Apr. 29, 2021	Apr. 29, 2021 company	Apr. 29, 2021 sponsorship	Oct. 01, 2020 ft²	Aug. 13, 2020 ft²
Operating Leased Assets [Line Items]
Operating lease, impairment loss			$ 3,900,000
Loss contingency accrual		$ 3,800,000	$ 3,800,000	$ 3,800,000
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]		Accounts payable and other accrued liabilities	Accounts payable and other accrued liabilities	Accounts payable and other accrued liabilities
Other commitments, number of special purpose acquisition company sponsorships											4	4
Other commitments, percentage of outstanding shares, per acquisition company										15.00%
Class of warrant or right, outstanding (in shares) | shares		1,252,748	522,786	1,252,748
Exercise price of warrants (in dollars per share) | $ / shares		$ 34.78	$ 47.99	$ 34.78
Outstanding uncollectible loans		$ 744,000		$ 744,000
IPO | IHC
Operating Leased Assets [Line Items]
Sale of stock, number of common shares issued per unit (in shares) | shares	1					1
Class of warrant or right, number of securities called by each warrant or right (in shares) | shares	1					1
Proceeds from initial public offering of IHC	$ 115,000,000
Exercise price of warrants (in dollars per share) | $ / shares	$ 11.50
IPO | IHC | Placement Warrants
Operating Leased Assets [Line Items]
Class of warrant or right, outstanding (in shares) | shares	4,639,102
Sale of warrants, price per share (in dollars per share) | $ / shares	$ 1.00
Aggregate purchase price	$ 4,639,102
Exercise price of warrants (in dollars per share) | $ / shares	$ 11.50
IPO | IHC
Operating Leased Assets [Line Items]
Class of warrant or right, number of securities called by each warrant or right (in shares) | shares						1
Shiftpixy Founders
Operating Leased Assets [Line Items]
Other commitments, percentage of outstanding shares, per acquisition company										15.00%
Special Purpose Acquisition Company, 1
Operating Leased Assets [Line Items]
Other commitment									$ 25,000
Special Purpose Acquisition Company, 2
Operating Leased Assets [Line Items]
Other commitment									25,000
Special Purpose Acquisition Company, 3
Operating Leased Assets [Line Items]
Other commitment									25,000
Special Purpose Acquisition Company, 4
Operating Leased Assets [Line Items]
Other commitment									$ 25,000
Special Purpose Acquisition Company, Maximum Amount Per Individual Loan
Operating Leased Assets [Line Items]
Other commitment	$ 500,000
Special Purpose Acquisition Companies
Operating Leased Assets [Line Items]
Payments for other commitments				$ 861,000
Miami Office Space Facility
Operating Leased Assets [Line Items]
Operating lease term														7 years
Area of real estate property | ft²														13,246
Operating lease, monthly expense		57,000
ShiftPixy Labs Facility
Operating Leased Assets [Line Items]
Operating lease term													64 months
Area of real estate property | ft²													23,500
Operating lease, monthly expense		34,000
Miami Verifone Facility
Operating Leased Assets [Line Items]
Area of real estate property | ft²								8,000
Operating lease, monthly expense		26,000
Sublease term								3 years
Sunrise Facility
Operating Leased Assets [Line Items]
Operating lease term							77 months
Area of real estate property | ft²							13,418
Operating lease, monthly expense		27,000
Second Irvine Facility
Operating Leased Assets [Line Items]
Operating lease term					60 months
Operating lease, monthly expense		$ 24,000
Operating lease, rent abatement percentage		50.00%
Operating lease, rent abatement period		4 months

XML

Commitments - Lease, Cost (Details) $ in Thousands	3 Months Ended
	Nov. 30, 2022 USD ($)
Commitments and Contingencies Disclosure [Abstract]
Operating Lease Cost	$ 256

XML

Commitments - Lessee, Operating Lease, Liability, Maturity (Details) $ in Thousands	Nov. 30, 2022 USD ($)
Commitments and Contingencies Disclosure [Abstract]
2023	$ 919
2024	1,064
2025	1,099
2026	777
2027	568
Thereafter	351
Total minimum payments	4,778
Less: present value discount	621
Lease Liability	$ 4,157
Weighted-average remaining lease term - operating leases (months)	72 months
Weighted-average discount rate	5.54%

XML

Contingencies (Details) - USD ($) $ in Thousands							1 Months Ended		3 Months Ended	5 Months Ended	79 Months Ended
	Jan. 04, 2023	Nov. 23, 2022	Mar. 19, 2021	Mar. 12, 2021	Dec. 18, 2020	Jan. 03, 2020	Apr. 30, 2019	May 31, 2016	Nov. 30, 2022	Aug. 31, 2021	Nov. 30, 2022	Aug. 31, 2022	Nov. 04, 2021
Disposal by sale | Overall business
Loss Contingencies [Line Items]
Gross proceeds						$ 19,200			$ 19,166		$ 19,166	$ 19,166
Period for payment of gross proceeds (in years)						4 years
Kadima Litigation | Pending Litigation
Loss Contingencies [Line Items]
Litigation settlement, compensatory damages		$ 5,000
Kadima Litigation | Settled Litigation | Subsequent Event
Loss Contingencies [Line Items]
Litigation settlement, compensatory damages	$ 5,000
Litigation settlement, prejudgement interest	1,800
Litigation settlement, expert witness fees	$ 250
Everest Litigaton
Loss Contingencies [Line Items]
Loss contingency, damages sought, value					$ 600				$ 1,600
Sunz Litigation
Loss Contingencies [Line Items]
Loss contingency, damages sought, value			$ 10,000
Loss contingency, damages sought, value as a percentage of incurred and unpaid claims			200.00%
Vensure Litigation
Loss Contingencies [Line Items]
Loss contingency, damages sought, value				$ 1,500
Discontinued operation, proposed adjustments period						90 days
Discontinued operation, negotiation period						30 days
Vensure Litigation | Pending Litigation
Loss Contingencies [Line Items]
Gain contingency, unrecorded amount													$ 9,500
Vensure Litigation | Withdrawn Claim
Loss Contingencies [Line Items]
Loss contingency, damages sought, value										$ 1,500
Vensure Litigation | Disposal by sale | Overall business
Loss Contingencies [Line Items]
Gross proceeds						$ 19,000
Gross note receivable						$ 9,500
Period for payment of gross proceeds (in years)						48 months
Software Development | Kadima Litigation
Loss Contingencies [Line Items]
Software development cost								$ 2,200
Revised development costs								7,200
Software modules cost											$ 11,000
Additional software modules cost demanded								$ 12,000
Loss contingency, damages sought, value							$ 11,000

XML

Subsequent Events (Details) $ in Thousands	Jan. 04, 2023 USD ($)	Sep. 01, 2022	Jan. 17, 2023
Subsequent Event [Line Items]
Stock split conversion ratio		0.01
Subsequent Event
Subsequent Event [Line Items]
Warrants and rights outstanding, percentage of total shares outstanding threshold			20.00%
Warrants and rights outstanding, requisite exercise period			6 months
Kadima Litigation | Settled Litigation | Subsequent Event
Subsequent Event [Line Items]
Litigation settlement, compensatory damages	$ 5,000
Litigation settlement, prejudgement interest	1,800
Litigation settlement, expert witness fees	$ 250